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Summary 
Microbial fuel cell technology and other bioelectrochemical systems arose both out of a 
need to address important global issues, such as the availability of clean water and the 
need for renewable energy sources, and the opportunity afforded by bacteria capable 
of utilise extracellular, insoluble metals as electron acceptors as a part of their 
metabolism. Since then our understanding of extracellular electron transfer has 
increased dramatically, with electroactivity demonstrably engineered into Escherichia 
coli, and progress made in a range of synthetic biology applications. This thesis aimed to 
further explore the limitations and challenges faced when working with these 
heterologous extracellular electron transfer systems in the interest of progressing the 
field towards promising applications. 
In order to overcome the variability between testing apparatus, a single chamber 
bioelectrochemical cell protocol was developed and presented with comparisons 
between the strains of various bodies of work. In the process of doing so a previously 
unobserved electrochemical effect specific to recombinant systems was discovered and 
investigated, revealing the mediator-like behaviour of the products of the 
chloramphenicol resistance mechanism. This work went on to present the development 
of a high throughput dye assay for the screening of electroactivity. This was 
subsequently used on genomic libraries of Shewanella oneidensis MR-1, a dissimilatory 
metal reducing bacteria, within E. coli, and a novel heterologous electroactive factor 
identified. Finally, the sensitivity of recombinant E. coli strains to variations in media 
within a bioelectrochemical cell was highlighted, prompting further investigation. A 
global proteomics-based approach was taken to characterising changes within E. coli 
expressing a heterologous extracellular electron transfer pathway within a 
bioelectrochemical cell. This recommended avenues for future developments of 
engineered, electroacive E. coli strains. 
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Chapter 1 – Introduction  
Biotechnology has been a useful resource for over a century, with some definitions 
placing its inception back thousands of years with the breeding of plant species to 
produce farmable crops. However, it is only recently, with the advent of genetic 
engineering, that it has grown to become a booming sector with great potential to tackle 
many of the challenges facing the world1,2.  The scarcity of clean water in developing 
nations, organic and metallic environmental pollutants from various industries3, and the 
rising acknowledgement of the need for more renewable energy sources among them4. 
Microbial fuel cell (MFC) technology and other bioelectrochemical systems (BESs) arose 
in order to address some of these challenges5,6.  
Extracellular electron transfer (EET) is an ability of dissimilatory metal reducing bacteria 
that allows them to utilise insoluble metals in their environment as end terminal 
electron acceptors in the absence of more energetically favourable alternatives such as 
oxygen7. These bacteria are often found in metal rich environments, within lake beds8 
or underground8 and owing to their ability to reduce such metals are often resistant to 
levels that many other lifeforms would find toxic9. 
However, in an MFC this ability has been exploited as it allows them to reduce an anode 
instead, using it as an end terminal electron acceptor and ultimately generating 
current10. This has been coupled with wastewater treatment, using strains of these 
bacteria capable of feeding on the complex organic contaminant molecules, breaking 
them down while extracting energy, rather than expending it unlike traditional 
methods11. Other BESs have also been employed with a variety of designs and scales in 
a host of other industrial processes3,12. For example, microbial electrolysis cells (MECs) 
can be used to produce hydrogen, rather than electricity, taking advantage of its energy 
storage capabilities12,13. While microbial electrosynthesis (MES) operates using similar 
principles, but provides electrons to bacterial cells via a cathode to produce complex 
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organic molecules in a way that is far less energy intensive and may produce less 
chemical waste than alternative synthesis methods14. 
While MFCs and other BES technologies have great potential to help with the issues 
previously mentioned, and have advanced much since its inception, they still face their 
own challenges in order to become more feasible and cost effective for widespread 
adoption. The limited up-scaled application of MFCs in the literature can be viewed as 
the culmination of the technological challenges involved12,15,16. Given the need for 
electrodes that have high surface areas and catalyse the exchange of electrons readily 
in order to maximise efficiency17, therefore being composed of expensive materials such 
as platinum, there is a financial investment involved in creating large scale MFCs for 
waste processing. This is compounded by the fact that many of the contaminants of 
complex waste streams can deteriorate these electrodes, shortening their lifespan and 
so driving up the cost for the technology12,17, and can adversely affect other components 
of the equipment, such as membranes3. Add to that the need to maintain a stable 
culture of the microbial organisms that power the technology, which is complicated by 
contaminants in the waste streams they can feed on3,12, and you see why the technology 
is not widespread. 
Other BESs share some of these concerns, and more recent technologies (such as MES) 
have arisen from exploring design options and applying the principles of MFCs and EET 
to other applications18. Consequently, an increased understanding of EET can benefit all 
BES technologies. And applying engineering principles to the design of strains that can 
be modified to suit these different applications – strains possessing of extensive 
toolboxes of techniques and biological parts – could help realise these technologies and 
more. This synthetic biology approach desires host strains that are well studied and 
easily genetically manipulable19. However, the use of synthetic biology to overcome 
some of the limitations detailed above presents its own concomitant difficulties. For 
example, the handling and environmental contamination avoidance required for 
genetically modified microorganisms, as well as the challenges of heterologous 
expression20,21. However, for certain applications these may be outweighed by the 
potential benefits, or even addressed with further development. 
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While the bacterial component remains an essential part of the technology, the focus of 
much of the literature has fallen on the physical components. Though systems for EET 
have been identified and extensively researched in their native organisms, much still 
remains to be understood about the processes DMRBs use to achieve EET and how these 
interact with various BESs22. The limited genetic toolsets available for the more 
commonly used DMRBs have further hampered research into synthetic biology 
approaches. It was recognised, however, that the most well understood model 
organism, Escherichia coli, might be of use in this regard, and studies have been made 
of E. coli engineered with EET capabilities from the model DMRB Shewanella oneidensis 
MR-123,24. This is a strong development from early attempts to make the E. coli 
electrogenic, which involved expensive and highly toxic chemical mediators to affect 
EET25. 
The design of MFCs and similar BES for testing electroactivity continues to rely on the 
same fundamental principles as at the technology’s inception, however individual 
designs, equipment, and materials all vary from lab to lab3,16,26–28. The lack of 
standardisation of testing apparatus, and even methods, units, and data presentation in 
this interdisciplinary field, are a keen challenge facing development in the field (REF). It 
makes comparing results from different studies using the same strains incredibly 
difficult. And with the typically low throughput of such experimental procedures, this 
means that multifactorial investigation of small changes to experimental conditions that 
could impact metabolism are difficult. For example, media usage varies across published 
studies (REF REF), even within the same research group (REF REF) but provided 
reasoning behind these selections is limited. While less concerning for DMRB that have 
evolved regulatory apparatus to manage their EET, the same is not true for engineered 
E. coli strains, the regulatory responses of which may have unforeseen interactions with 
the heterologous EET pathway. 
Heterologous expression of a complex pathway meant to interact with metabolic 
processes in E. coli strains to effect EET has presented its own challenges, and it is some 
of these that this thesis aims to address. The inferior electroactivity of existing strains, 
compared with natural DMRB, limit their usefulness directly for MFCs and other BESs. 
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Yet with the greater toolsets available for this model organism more may be achieved 
in the way of sensitive control and modification for specific applications. For example, 
the development of biosensors that tie the detection of specific molecules (biological 
circuits for many of which already exist) to current production, allowing a direct 
interface with devices29–31. Additionally, given the redundant nature of EET pathway 
components in DMRB, the use of E. coli may provide insights into electroactive proteins 
that wouldn’t be possible when not studied in isolation, even given the concerns 
heterologous expression necessitates. 
The EET pathway introduced into engineered E. coli strains is heterologous, and so does 
not have pre-evolved interactions with regulatory machinery to be fully utilised. 
Furthermore, an issue relevant to heterologous expression in general and therefore one 
to be aware of, there may be unanticipated interactions with other proteins within the 
cell leading to phenotypes that are likely to be detrimental32. Understanding how the E. 
coli metabolism links to the heterologous EET pathway to utilise an electrode as an end 
terminal electron acceptor, may be the key to future work to bridge the gap in 
electroactivity between such strains and DMRB. Such information could inform 
metabolic engineering that would allow E. coli strains to take full advantage of the EET 
pathway. Given that this is arguably the main disadvantage of engineered E. coli 
compared to DMRB it would open up its use in the applications previously discussed, 
allowing the extensive tools and libraries of genetic parts to be brought to bear on them. 
These topics and more are outlined and explored in further detail in the proceeding 
chapter. 
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1.1. Chapter Structure and Aims 
In this thesis we set out to establish a BES meant for investigation of electroactivity in E. 
coli strains at a throughput higher than easily achieved with MFCs, comparing several 
strains and investigating factors affecting electroactivity, and in so doing proceed to 
investigate a novel bioelectrochemical interaction, presented in Chapter 4. 
In Chapter 5 a Fosmid library of S. oneidensis MR-1 in E. coli was created with the aim of 
identifying novel heterologous electroactive factors. A high throughput, azo-dye based 
approach to the screening is presented, along with the results of the screening process. 
The focus of Chapter 6 lies on the investigation into metabolic and proteomic differences 
between engineered and control strains of E. coli that have adapted to conditions within 
our BES, as well as how their behaviour is affected by growth conditions beforehand, 
with an aim to inform future iterative improvement of an engineered electroactive E. 
coli strain. 
Beyond these research chapters a review of the relevant literature is presented in 
Chapter 2, followed by the presentation of the materials and methods used in the 
proceeding work, in Chapter 3. Finally, the conclusions and possible directions for future 
work are discussed in Chapter 7. An appendix of relevant data follows this. 
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Chapter 2 – Literature Review  
2.1. Introduction to Microbial Fuel Cell Technology 
Issues with the worldwide reliance on fossil fuels have prompted much investigation 
into sources of renewable energy, with a myriad of technologies resulting 33. Both for 
the sake of the global economy and to combat climate change resulting from our current 
energy consumption, technological advances must be made34. Microbial Fuel Cell (MFC) 
technology is one such technology, being developed to assist in cleanly reclaiming 
energy from waste water using bioelectrochemically active microbes35. The potential of 
the science on which it is built extends beyond this, however, as ongoing research into 
applications such as bioremediation36 and microbial electrolysis13 have arisen from it. 
Additionally, insights gained into electroactive organisms, which are able to transfer 
electrons to an acceptor outside of their cells, may benefit research into other areas of 
bioelectrochemical research, such as microbial electrosynthesis, wherein a current is 
used to stimulate a process of production37, and biosensing30 where bacterial 
environmental sensing is communicated in a technologically translatable fashion38.  
MFCs, much like other types of fuel cell, typically consist of two connected electrodes. 
They are distinguished by their use of a microbial catalyst, present on the anode, to 
produce a current39. In simple terms, organic matter is metabolised by the microbial 
community that has colonised the anode, with the anode being used as an electron 
acceptor40. Electrons donated to the anode flow through the circuit connecting the 
electrodes, resulting in an electrical current. Meanwhile, the protons released during 
microbial metabolism move to the cathode, where they meet the electrons and then 
typically react with oxygen to produce water, though other electron acceptors are 
possible, resulting in other products15. 
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Figure 2.1. – Two Chambered Microbial Fuel Cell Diagram 
 
Fuel is added to the anaerobic anode chamber, and metabolised by the bacteria 
colonising the electrode, transferring electrons to it. Electrons react with oxygen and 
protons to form water at the aerobic cathode. With a load placed across these two 
electrodes power is generated. 
A typical two chambered MFC41 is depicted in Fig 2.1., with an aerobic cathode chamber 
separated from an anaerobic anode chamber by a proton permeable membrane (PPM), 
the two electrodes connected with a load placed across them, and microbial 
colonisation of the anode. Other designs exist, often tailored for specific applications 
such as scaling up42. The most common alternative involves an air cathode without a 
catholyte; the cathode is coated in a PPM (though it is absent in some designs) at its 
interface with the anolyte but is otherwise exposed to air, and therefore oxygen. Such 
designs often comprise a single chamber, with the cathode on the outside43. Consistent 
among these variations is, of course, a need for the microbiological component. 
2.1.1. Current Microbial Fuel Cell Research  
While the scaling up of MFCs to an industrial level is a challenge being worked on by 
many groups, with a small number of pilot studies having been conducted11,44, there are 
many aspects of the fundamental MFC design that are still being researched to improve 
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performance15. Internal resistances and electron transfer resistances within an MFC 
design represent the most important limiting factors to power generation at theoretical 
maxima45. Given the engineering standpoint taken by many who work in the area, there 
is a great deal of research aimed at overcoming these limitations through the 
modification of materials, particularly the electrodes46,47, and physical design of the 
technology48. However improving understanding and control of bioelectrochemical 
processes will help push the practical technology to a state of increased industrial 
viability, and will assist in the progression of other BES based technology49. For other 
applications this is more accepted, such as for bioremediation and nanoparticle 
production where studies often investigate the interaction between electroactive 
strains and specific metals or organic compounds50,51. 
Research into scaling up BES technologies to pilot scale are ongoing. Though pilot scales 
exist for wastewater treatment MFCs, these tend to focus on rich wastewater, such as 
that from breweries12 or the dairy industry52. Nonetheless they seek to address the 
primary challenges in scaling up the technology, which all ultimately come to financial 
viability. Reducing the cost of materials, while maintaining a design that is effective and 
which maximises power output is essential18. 
2.1.2. Electrode Composition 
The redesign of electrodes used in MFC technology is believed by many to be the largest 
problem in improving power generation and lowering costs enough to make it 
industrially feasible49,53. Electrodes must often be made of high-surface-area, 
conductive, catalytic materials such as platinum to ensure maximal efficiency17 and for 
complex wastewater streams the deterioration of the electrodes can be fast12,17. While 
materials are a concern for reasons of cost, internal resistance, and robustness, the fact 
that the surface of the anode is colonised by the biological catalyst requires 
consideration. Cheap materials that provide a high surface area are used in a lot of 
biologically focussed MFC research; carbon electrodes, either felt, fibre, or graphite, are 
used primarily, though various metallic electrodes can also be found to be used54 and 
an amount of platinum composing counter electrodes is desirable55. There is ongoing 
research into the potential use of nanoparticles, such as gold56, or nanotubes in the 
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electrode design to improve their suitability to levels closer to more expensive options47. 
While these may provide a benefit to surface area, biofilm formation, and 
electrochemical interaction, the former still presents the issue of cost, of great 
importance when considering scaling up, and both have toxicity considerations, either 
for the bacteria47,57 or for the environment given the wastewater treatment application 
of MFCs58. 
2.1.3. Microbial Fuel Cell Organisms 
While research has been conducted using a range of organisms in MFCs, bacteria are 
most prominent, either in isolation or as consortia of different species; consortia often 
proving more effective than single strains59. In particular, the majority of research in the 
field focusses on species of the gram negative genera Geobacter and Shewanella, which 
often display extracellular metal reducing capabilities60. Specifically, within these genera 
there is a significant body of work on Shewanella oneidensis MR-1, Geobacter 
metallireducens and Geobacter sulfurreducens in particular61,62, such that they are the 
best known electroactive organisms and may be reasonably called model organisms for 
MFC research63. Much of our current understanding of mechanisms employed by 
electroactive bacteria to transfer electrons to extracellular acceptors comes from their 
study. Geobacter sp. tend to be strictly anaerobic, while Shewanella sp. are typically 
facultative, non-fermentative anaerobes, making them easier to work with, though 
optimal electroactivity typically requires anaerobicity as oxygen is preferentially used as 
end-terminal electron acceptor7. 
These naturally electroactive bacteria are referred to as dissimilatory metal reducing 
bacteria, as the mechanisms that make them suitable for MFCs are naturally used by 
many of them to reduce extracellular metals64. A number of specific mechanisms have 
been identified that facilitate this process, which fall into three categories: direct 
electron transfer through membrane bound proteins, such as cytochromes; creation 
and secretion of electron shuttling mediators; and transfer through conductive pili-like 
structures known as nanowires41. 
10 | P a g e  
 
2.2. Practical Considerations for Laboratory Scale Investigation of Bacterial 
Electroactivity 
2.2.1. Measurements 
Those working in the field of MFC research come from a variety of different 
backgrounds, and, while this can prove a boon for looking at problems from a range of 
viewpoints, it also results in a fair amount of variation in the way results are presented 
and equipment described65. It is important to bear the need for standardisation in mind, 
both for experimental design purposes and data presentation, and for the purposes of 
this study an understanding of the equipment and methods used to collect data from 
MFCs is crucial to doing so.  
It is important to measure the potentials of the anode, particularly, and cathode, using 
a reference electrode; this measurement allows other equipment to maintain specific 
poised potentials at electrodes, which is important to facilitate electron transfer from 
microbial cells66. This poised potential makes the transfer of electrons to the electrode 
a more energetically favourable process. A potential of 0.2 V is typically used in work 
with S. oneidensis MR-127, but the ideal poised potential can vary with different 
organisms66; it may be necessary to test this with different engineered E. coli strains. 
While it is theoretically possible to predict potentials, variations in conditions within the 
cell and uncertain losses at interfaces necessitate measurement65. Combined with 
measurement of current and details of load (resistance placed across the circuit 
connecting the two electrodes in MFCs), chamber volume (including defined medium), 
and electrode surface area, data can be interpreted and presented in a way that allows 
conversion to a preferred format by those working from different perspectives; 
engineers typically give power and current readings with respect to volume, while those 
concerned with the electrochemistry prefer results to be given in the context of 
membrane or electrode surface area65.  
Other important ways of processing and presenting data include Coulombic efficiency 
for each electrode, and overall, which relates the number of electrons supplied by 
electron donors in a defined media to the current and/or reduction products created. 
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The substrate used in the defined media can affect this, so acetate is ideally used67, 
though sodium lactate is used more widely due to early studies concluding that it was 
the optimal carbon source for maximising electroactivity68. Energetic efficiency is 
similar, relating energy input and output, while removal efficiency deals with the desired 
levels of degradation of specific compounds, being more useful for bioremediation or 
wastewater treatment studies49. 
2.2.2. Equipment and Throughput 
Despite the extensive testing in this field, or perhaps because of it, there remains very 
little standardisation in terms of equipment29; there is no field-wide accepted 
commercially available standard. And this state of affairs only deteriorates when 
considering higher throughput. While ‘multi-well’ MFC designs have been published 
they are not commercially available nor are they used in studies beyond their initial 
publication69. Consequently, testing is limited, both by a need for comparative 
establishing experiments to verify that equipment behaves as expected, but also, 
typically, simply by the limited throughput possible with existing protocols. That being 
said, in spite of ranging methodologies, no baseline experiments are provided to 
facilitate cross comparison between setups, something we believe to be a gross 
oversight in the literature. 
2.3. Bacterial Electrochemistry 
Much early MFC research utilised exogenous mediators, such as methyl viologen, 
thionine, and neutral red40, to communicate electrons from bacterial cells to electrodes, 
but doing so was prohibitively expensive and suffered from issues of toxicity that 
prevented commercialisation70. The use of bacteria capable of reducing extracellular 
solid metals such as Iron (Fe(III)), often referred to as dissimilatory metal reducing 
bacteria (DMRB), allowed development of MFCs that didn’t require these mediators71. 
Though it has been shown since that the ability to reduce Fe(III) does not always 
correlate with the ability to generate current in an MFC, many bacteria identified as 
metal reducing have been shown to be capable of doing so72. Several specific 
mechanisms by which these bacteria transfer their electrons to extracellular sources 
have been discovered, but research is ongoing to identify more. 
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2.3.1. Endogenous Mediators 
Endogenous mediators are low molecular weight electron shuttling molecules, naturally 
produced and secreted by many naturally exoelectrogenic strains, which facilitate 
electron transfer between cytochromes of the bacterial cell and an electrode or 
extracellular metal73. It has been demonstrated that they are able to facilitate this 
transfer even in strains not naturally exoelectrogenic, having implications for mixed 
culture MFCs, and being promising candidates for transformation into other organisms 
that might have issues with other mechanisms49.  
In contrast to Geobacter sp., various Shewanella sp. have been confirmed to produce 
and secrete their own mediators to facilitate access to electron acceptors74, including 
riboflavin and flavin mononucleotide75, though it was earlier hypothesised that 
quinones acted in this capacity49. Figure 2.2. shows the skeletal formulae for these 
mediators. Noteworthy for their electrochemical role are the hydroxyl groups which will 
be reduced by the cell in order to transport electrons extracellularly76. These mediators 
have been shown to selectively interact with cytochromes in known direct electron 
transfer pathways, such as MtrC, increasing the efficiency of electron transfer77. 
Catalytic haem groups nearby FMN binding domains have been identified in a paralog 
of MtrC, for example78. Indeed it has been demonstrated that the ability of S. oneidensis 
MR-1 to utilise its mediators to respire extracellular electron acceptors is dependent on 
its expression of outer-membrane cytochromes79,80. 
  
13 | P a g e  
 
Figure 2.2. Formulae of Riboflavin and Flavin Mononucleotide 
  
Structure of riboflavin (A) and FMN (B) created using ChemDraw. Of particular 
relevance to their role as electron mediators, they both possess many hydroxyl 
(OH) groups, which can be readily reduced, while maintaining sufficient 
electronegativity to be oxidised by insoluble iron (III) or an anode within an MFC. 
It has been shown that E. coli can produce some polar species that can act as mediators 
under anaerobic conditions, despite not being considered an exoelectrogenic 
bacterium, which may provide an additional avenue for improving its 
exoelectrogenicity49. However these polar species are not as effective as the Shewanella 
mediators previously described. Unlike Shewanella sp., Geobacter sp. are not known to 
produce mediators71.  
2.3.2. Direct Electron Transfer 
Direct electron transfer (DET) is achieved by electrochemically active proteins on the cell 
surface interacting directly with the extracellular electron acceptor40; though as 
previously discussed they can also reduce soluble mediators77. Understandably for this 
process to work, proximity is essential, which is why biofilm formation and 
characteristics may impact exoelectrogenicity; S. oneidensis was shown to bind iron 
surfaces under anaerobic conditions more strongly than it did aerobically, for example71. 
A great many c-type cytochromes have been identified in S. oneidensis and other 
A                                                                                B 
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species, which are believed to be involved in DET, composing multiple pathways, though 
few have been characterised or studied in detail81.  
C-type cytochromes are a widely studied group of proteins, that utilise bound c-type 
haem to effect electron transfer within many important redox reactions82. They can bind 
a single or multiple haem cofactors through covalent thioester bonds83, and are 
frequently membrane associated82. Structurally they are predominantly composed of 
alpha helices, with loops covering or providing access to the iron centre of their 
prosthetic haem groups84, which in multihaem cytochromes are positioned to keep 
reaction centres within 15.5 Å of each other85. S. oneidensis MR-1 has 42 c-type 
cytochromes identified for it81 with the recognised ability to reduce more than 10 end-
terminal electron acceptors under anaerobic conditions86,87. 
The omcAmtrCAB operon comprises a particularly well studied pathway of DET, the 
process of which has been shown to be more effective at transferring electrons than 
that managed through the riboflavin mediator, with a standard rate constant two orders 
of magnitude higher88. OmcA, MtrC, and MtrA are all decahaem c-type cytochromes, 
with the former two exposed on the outside of the outer membrane and the latter being 
present on the inner side89,90; MtrB is a transmembrane porin that complexes with the 
cytochromes to transfer electrons across the membrane89. 
The current model of the pathway also involves CymA, which communicates electrons 
to the MtrCAB complex from the menaquinone pool in the inner membrane91 via MtrA, 
which then passes them to MtrC; MtrC is then able to transfer them to extracellular 
acceptors directly, or indirectly, similar to OmcA27. Figure 2.3. illustrates this pathway 
transferring electrons from lactate, a commonly used substrate in defined media in MFC 
research. NapC, a substitute for CymA present in E. coli is also described27,49. Much like 
with OmcA there exist many homologous of these cytochromes within S. oneidensis MR-
1, adding redundancy and adding specificity for additional terminal electron acceptors82. 
Orthologues exist plentifully in other species of the genus, typically well conserved92. 
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Figure 2.3. – Extracellular Electron Transfer Pathway 
 
Lactate is metabolised to pyruvate, transferring electrons to the quinone pool via 
its specific dehydrogenase enzyme. From this pool in the inner membrane NapC 
in E. coli or CymA in S. oneidensis MR-1 transfers electrons to MtrA, part of the 
outer membrane MtrCAB complex. From MtrA they are passed to MtrC, thence 
to an extracellular acceptor either directly, through another outer membrane 
cytochrome such as OmcA, or an indirect mechanism.  
Shewanella sp. are not alone in possessing cytochrome based DET pathways, as many 
have been identified in other bacteria, such as Geobacter sulferreducens, which has over 
100 putative c-type cytochromes evident in its genome sequence49, with a few involved 
in specific pathways having been characterised, similar to research in S. oneidensis93. 
2.3.3. Nanowires 
The term “nanowires” covers multiple different structures, and these vary significantly, 
particularly between the Shewanella and Geobacter genera. Generally, nanowires are 
long, thin structures that extend from cell surfaces, linking cells to each other and the 
surface of any colonised extracellular acceptor, such as insoluble metal or an 
Extracellular 
acceptor 
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electrode94. They are theorised to be involved in extracellular electron transfer by 
providing a conductive conduit for electrons from the cell to the surface of an electron 
acceptor95; other roles, such as in biofilm growth and structure, may also be performed 
by them96. It has been verified that they play an important role in electron transfer in 
MFCs culturing Geobacter sp., where they are required for extracellular electron 
transfer97.  
Geobacter nanowires are based on Type IV pili, helical peptide filaments that extent 
outside of their outer membranes to a multitude of purposes92. Those produced by 
Geobacter, though evidenced to have roles in biofilm formation96 and cell aggregation98, 
have been demonstrated to be conductive and play an essential role in the reduction of 
iron and other external electron acceptors99. Given their ordered structure, small size, 
and relative ease of production these structures are being investigated for 
biotechnological applications within and beyond BESs98,99. 
Morphologically distinct (from Geobacter sp.) nanowires have been identified in 
Shewanella oneidensis MR-1 that are found in thick bundles and have been confirmed 
to be conductive100. Geobacter nanowires typically extrude from one side of the cell 
towards the electron acceptor surface100. However it has been demonstrated that 
Shewanella nanowires likely consist of a number of c-type cytochromes set at intervals 
within a membranous structure, allowing electrons to hop along them101. Furthermore, 
the importance of outer membrane cytochromes in order to maintain conductivity has 
been shown102. These structures, in contrast to Geobacter sp., are thought to be an 
extension of the outer membrane, rather than pili-like structures, formed through 
fusion of outer membrane vesicles103. Work is still needed to fully understand how they 
might be exploited in BES applications and the mechanisms involved, however49,101. 
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2.4. E. coli for Electroactivity Research 
E. coli, the gram negative, facultative anaerobic bacteria, has long been among the most 
highly studied organisms within science104. This has led to a wealth of tools and 
techniques for genetically manipulating it and achieving a level of control and 
understanding not possible in other bacteria. However, while it is well studied from a 
pure scientific standpoint, the principles of synthetic biology, which are so minded 
towards application and modularity, have only come to the fore to make use of this 
resource relatively recently21. 
2.4.1. E. coli and Synthetic Biology 
Synthetic Biology is a relatively young field, though growing exponentially, which applies 
the principles of engineering to molecular biological research in order to produce either 
completely synthetic organisms, or modify existing organisms and biological systems, all 
towards a useful purpose19. It employs concepts such as standardisation and 
interchangeability of abstracted “parts” and “devices”, genetic components that make 
up genes and operons with products that perform specific functions, to facilitate rational 
design of useful biological system in much the same manner as circuit design in electrical 
engineering105. The field enables a more applications-based view of genetic engineering 
and aims to progress towards a point where organisms can be tailor-made for specific 
tasks easily using simple abstracted design without a need to manually modify or string 
together sequences106. With fully characterised parts and well-designed computational 
tools for the strain design process, a thorough understanding of each individual part 
should not be necessary, speeding up the process of biological engineering. 
Many standards exist in the field, and these have changed over time as it has developed. 
BioBricks are an example of such a standard. A BioBrick part is a DNA sequence that has 
a function, such as a ribosome binding site, coding sequence, or promoter. The principle 
behind the standard is that parts can be strung together easily to form devices that 
operate to each achieve a specific effect. Originally developed by Tom Knight107, it has 
since been improved and is used by teams competing in the iGEM competition, which 
contribute to the growing registry of parts available in the public domain. Specific prefix 
and suffix restriction sites are used around the sequences for individual parts for ease 
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of genetic manipulation and interchangeability108. Unfortunately, while thousands of 
parts are available, very few have been characterised108, and the usefulness of 
characterisation can vary due to the differences in functionality when different host 
organisms are used20. As such, while the registry can be a valuable resource it is not 
quite at the level of electrical engineering. Characterisation remains a challenge in 
general in the field109. Particularly as even the best studied model organisms are only 
partially understood, though it is clear that additional chassis organisms to suit different 
purposes are required to advance the field110. 
A few other key challenges further separate synthetic biology from other engineering 
disciplines, requiring consideration. The complexity of biological systems, coupled with 
our own incomplete understanding of them, features prominently. Continuing from that 
point is that parts, when assembled, will not always function together as expected, 
taking a great amount of time to correct111. The biological chassis organisms used, such 
as Saccharomyces cerevisiae112 or E. coli, can also have interacting proteins of their own, 
and have limits in the amount they can be made to reliably express on plasmid based 
systems, with greater insert sizes resulting in lower viability and cell growth113.  
As the complexity of these designed systems grows, the more components used, the 
amount of time required to create them and test their functionality also increases. This 
increase in required resources can limit the feasibility of many studies; the full potential 
cost in time of any device creation and testing in future work should be carefully 
considered in advance to prevent overly ambitious plans20. Computational predictions 
may assist in the process, saving time by highlighting potential issues with designs, but 
can be limited by our understanding of the biological systems being used, which for 
exoelectrogenic processes is incomplete. Work to automate characterisation, not only 
of parts but of interactions between parts is ongoing111, but is greatly aided by advances 
in high-throughput equipment such as with liquid handling robots104. Additionally, 
directed evolution, in which a sub-optimal device is mutated and mutants screened and 
selected for based on the desired phenotype, may be used to overcome the need to 
manually tinker with the design of a device in order to fully optimise it20,114,115. 
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While Shewanella oneidensis MR-1 may be the initial resource for genes involved in 
exoelectrogenicity, E. coli strains, as previously mentioned, have been extensively 
studied with arguably more resources for genetic modification and other biochemical 
techniques than any other organism, which reinforces their position as optimum chassis 
organisms, and evidence them to be easily genetically manipulable 109,116,117. They are 
also capable of growing under the anaerobic conditions required in an MFC anode 
chamber and utilising a wide variety of carbon sources118. However it is important to 
remember that incompatibilities may arise when expressing any foreign proteins, 
though tools exist to counteract certain effects 21. 
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2.4.2. The Challenges of Heterologous Expression 
As discussed, for a synthetic biology approach to succeed characterisation of the 
required parts is needed, and unintended interactions between different parts and 
devices must be minimised by ensuring predictability20. Both of these depend upon an 
understanding of the mechanism of the devices involved. In the case of electroactivity, 
this means both a wider and deeper understanding of the mechanisms of EET not just 
in their native organisms, but how these operate heterologously. Given the requirement 
for effective dependence on a foreign electron transport chain for terminal electron 
transport, due consideration needs to be given to the host metabolism; full advantage 
may not be taken because the regulatory machinery for host processes hasn’t evolved 
to be able to interpret the new situation. Localisation issues may also occur if signal 
sequences are not compatible between species, though fortunately there is not a 
problematic phylogenetic distance between S. oneidensis MR-1 and E. coli119. This 
applies, too, to gene expression where a promoter is not manually installed before 
heterologous genes – of particular relevance in library studies, as E. coli transcription 
and translation systems can recognise S. oneidensis MR-1 promoters to affect the 
expression of their associated genes120. 
One factor often considered when attempting to optimally express heterologous genes 
is differences in codon bias between organisms32. During the process of translation, 
where an RNA sequence is read by a ribosome, tRNAs convey the relevant amino acids 
to the translation machinery by recognising codons through complementarity – three 
base pair sequences that the ribosome exposes121. There are 64 possible codons, given 
the four nucleotides used, and of these all but three correspond to amino acids, while 
the rest signify stop signals32,121. However, as there are only 20 amino acids employed 
universally to form proteins, there is codon redundancy for each. Codon bias refers to 
the relative balance or prevalence of these redundant codons within an organism’s 
highly expressed coding sequences32. The available tRNA pool for a specific codon can 
be depleted by expression, which is more likely to occur when it is a little used codon by 
the organism in question. In order to maximise efficient expression, then, the codon bias 
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of a given heterologous sequence is often adjusted to match that of the chassis 
organism. 
Other concerns for heterologous expression go beyond transcription and translation. 
Assuming a sufficiently conserved or synthetic promoter prompts transcription, and that 
codon bias and conserved ribosome binding sites permit translation, maturation and 
localisation remain. This is particularly a concern for the large, multi-haem, integral 
membrane cytochromes involved in the MtrCAB EET pathway, as haem production and 
correct addition to the polypeptide resulting from translation of their transcripts is 
required for them to function, as is transport to and insertion into the outer membrane 
where relevant23,122. While E. coli host strains typically have their own cytochrome 
maturation genes to assist with the first part of this, most published engineered strains 
employ additional cytochrome maturation genes (induced or constitutively expressed) 
to ensure correct maturation26,122. These studies have also demonstrated that signal 
sequences are sufficiently conserved to facilitate correct localisation of these proteins. 
For heterologous proteins or pathways that are correctly transcribed, translated, 
matured and localised, full functionality can still not be guaranteed. Interactions with 
host processes not evolved to utilise, regulate, or operate in the presence of this new 
pathway are the principle challenge then faced104. Unintended and often detrimental 
reactions between proteins or metabolites can occur, or the overexpression of a 
heterologous enzyme can deplete metabolites in a way that would cause the host to 
alter its regulation in an undesirable way104. For E. coli strains engineered to be more 
electroactive, the host strain hasn’t evolved to utilise the heterologous EET pathway, 
and with the link between it and the host metabolism, we cannot be sure where rate 
limiting steps lie, or what regulatory process are resulting from its activity. At least not 
without further study.  
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2.6. Conclusions 
Much remains to be understood about bacterial EET, not only in naturally electroactive 
bacteria, but also in recombinant E. coli strains. Yet we feel that the lack of 
standardisation and comparability between testing setups and strains has hindered 
progress. Researchers in the field do not do it any service by not being detailed about 
the specifics of their equipment and testing methodologies, but there is only so much 
that can be done without standardised, commercially available equipment and 
materials. This may come in time, but while BES design continues to change at a rapid 
pace it may not be feasible for private companies to invest in providing such 
technologies to small scale researchers. 
E. coli particularly may be a powerful tool for research into electroactivity, given the 
ability afforded to study factors in relative isolation. With the greater genetic control 
and biological understanding possessed for it, it may even be a superior candidate for 
certain bioelectrochemical applications than DMRB. A focus however needs to be placed 
on characterisation and iterative improvement of an electrogenic E. coli strain, to make 
synthetic biology applications feasible in the near future. Closing the gap between the 
performance of engineered E. coli strains and the naturally electroactive DMRB will be 
essential to facilitate its success going forwards. The S. oneidensis MR-1 derived MtrCAB 
pathway, however, is a solid foundation on which to build. There is no strong argument 
to start from the ground up and develop strains reliant on Geobacter sp. nanowires, for 
example. Other features may later be introduced to improve electroactivity, and 
identification of such would be useful in the long run, but it would be best to focus on 
understanding and addressing the factors limiting current strains and their derivatives 
before investing in such alternatives. 
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Chapter 3 – Materials and Methods  
3.1. Bacterial Culturing 
3.1.1. General Microbiology 
Unless otherwise noted, all bacterial starter cultures were inoculated by the transfer, 
via sterile inoculating loop, of a colony from an LB agar (Fisher Scientific) plate containing 
relevant antibiotics, into a 50 ml Falcon tube containing 10 ml sterile LB broth (Fisher 
Scientific). These were then incubated at 37 oC or 30 oC as appropriate to the strain (E. 
coli the former, S. oneidensis MR-1 the latter), 150 rpm overnight before use. 
100 ml LB agar were prepared according to manufacturer’s recommended 
concentration in 200 ml conical flasks. These were stoppered with sponge bungs and 
topped with tin foil before autoclaving at 121 oC, 1.05 bar pressure, for 20 minutes. 
Solidified sterile agar was melted prior to use over 2 minutes in an 800 W microwave, 
then placed in a 55 oC water bath to cool. Antibiotics were added before pouring, always 
to a 1 in 1000 dilution, due to stock concentrations. Benches were sterilised with 70% 
denatured ethanol (Crystel SILVER – Tristel), and a Bunsen maintained on a blue flame 
for the duration of the pouring and subsequent sterile work. Molten agar was poured 
into vented Nunc petri dishes (Thermo Scientific) and left to cool, before briefly drying 
in a drying oven at 37 oC. Between 4 and 6 plates were poured from each 100 ml flask, 
and storage of spare plates was maintained at 4 oC up to one week before use. 
LB agar plates were inoculated by sterile loop. A metal loop was sterilised in a blue 
Bunsen flame for no less than 10 s before cooling beside it. This was then used to either 
transfer a colony from another plate, or dipped into a liquid culture, and streaked across 
the plate. After resterilisation of the loop, the plate was further streaked crosswise. This 
was repeated twice more, in order to ensure single colonies on the plate. Plates were 
then incubated at 37 oC or 30 oC as appropriate to the strain (E. coli the former, S. 
oneidensis MR-1 the latter). 
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Larger broth cultures were inoculated from starter cultures with a 1 in 100 dilution 
unless otherwise described. The sterile media was prepared similarly to LB agar, 
sterilised in the same way. Either LB broth or 2xYT (Fisher Scientific) was used, though 
the former more frequently and thus by default if not otherwise noted. These cultures 
were incubated under the same conditions as their respective starter cultures. 
Sterile liquid transfer was most commonly achieved by either 10 ml or 25 ml serological 
pipette (Stripette – Sigma) using a serological pipette bulb (Fisher Scientific), with sterile 
technique. Alternatively, smaller volumes transferred by pipette (StarLab). 
Glycerol stocks were prepared by mixing 500 µl overnight culture with 500 µl sterile 50% 
glycerol in a sterile 1.5 ml microcentrifuge tube (Eppendorf), vortexing or inverting 
briefly, then storing at -80 oC. 
3.1.1.1. Antibiotic Stocks 
Chloramphenicol (Cm), Ampicillin (Amp), and Kanamycin (Kan), were prepared at stock 
concentrations of 20, 100, and 20 mg/ml respectively. Each was diluted 1 in 1000 for 
use. Cm was prepared in 100% ethanol, Ampicillin in 50% ethanol, and Kan in dH2O. Kan 
was filter sterilised with a 0.22 µm filter. All were aliquoted into 1.5 ml microcentrifuge 
tubes and stored at -20 oC. 
3.1.2. Chemically Competent Cell Preparation 
Prepared and autoclaved in advance were 80+ 1.5 ml microcentrifuge tubes 
(Eppendorf), 100mM CaCl2.2H20 (1.47g in 100ml), 100mM MgCl2.6H2O (2.01g in 
100ml), 50% glycerol, and 200 ml LB in a 500 ml conical flask, as well as an overnight 
culture of the relevant strain. The morning of the protocol, the overnight culture was 
diluted 1 in 100 into the 200 ml LB flask and incubated at 37 oC, 150 rpm. After 1.5 hours 
the OD600 was measured spectrophotometrically at intervals of 15 minutes against an LB 
broth blank, until an OD600 of between 0.5 and 0.8 was reached, favouring a reading 
closer to the former. After this point was reached the flask was placed on ice for 10 
minutes, with gentle agitation. 
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The cells were transferred to 4 50 ml Falcon tubes and centrifuged at 4000 xg for 10 min, 
4 oC. The supernatants were discarded and the pellets each gently resuspended in 20 ml 
100 mM MgCl2, by swirling. They were then centrifuged again under the same 
conditions, and supernatant discarded. 
The first pellet was gently resuspended in 6 ml 100 mM CaCl2, by swirling, then the 
suspension transferred to the second tube and the process repeated until all four pellets 
were resuspended in the 6 ml volume. This was then placed on ice for 1.5 h to facilitate 
competency, after which time 1.8 ml sterile 50% glycerol was added, gently swirling, to 
homogeneity. Aliquots of 100-200 µl were transferred into sterile 1.5 ml microcentrifuge 
tubes that had been pre-chilled at -20 oC, and placed on ice. These were then stored at 
-80 oC. 
3.2. Molecular Biology 
3.2.1. DNA Extraction 
In order to conduct polymerase chain reactions (PCRs), digests, or sequencing, the 
extraction of DNA necessary for the purpose was required. In the case of plasmids, the 
Qiagen Spin Miniprep kit was predominantly used according to the manufacturer’s 
instructions, with elution in 30 µl of nuclease free (nf) water previously heated in a 50 
oC water bath to maximise DNA concentration. Fosmids were initially extracted by the 
same method, but it was found that using the recommended cell volumes for Midiprep 
kits with the Qiagen Miniprep kit (note: not the Spin Miniprep kit) gave greater 
concentrations, and so was used instead subsequently. Genomic DNA was extracted 
with the Qiagen DNeasy blood and tissue kit, again according to manufacturer’s 
instructions. 
DNA extraction from gels was either achieved with a Qiagen Gel Extraction kit in the 
case of agarose gels, or with the GELase (epibio) enzyme preparation, each according to 
their respective manuals. Gel fragments were recovered by excising with a scalpel. 
3.2.2. Agarose Gel Electrophoresis 
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Concentrations of DNA extractions were tested by running a 1 µl aliquot on a 1% agarose 
gel as follows. 1.2g of agarose (Fisher Scientific) were added to 120 ml 1xTAE (diluted 
from 10x UltraPure TAE buffer - Thermo Fisher Scientific) and dissolved by heating in a 
microwave. 10 µl of ethidium bromide solution (Fisher Scientific) the intercalating agent 
that allows visualisation of DNA through fluorescence under ultraviolet light (UV), was 
carefully added after the solution was no longer bubbling, and the gel solution poured 
into the prepared gel casting tray with the appropriate gel comb inserted. After 
approximately 20 minutes of setting the gel was ready for use. The autoclave tape used 
to seal the ends of the casting tray were removed and the tray placed in the gel tank in 
the correct orientation. The tank was then filled with 1x TAE up to the fill line, and the 
gel comb removed to permit filling of the wells. 
Standard well volumes would accommodate up to 20 µl, however, where necessary 
larger wells were created by taping comb teeth together. 5 µl hyperladder 1 (Bioline, 
UK) was run in alongside samples as standard, typically in the first lane. Samples were 
prepared by adding 1 µl (or more as required) DNA to 2 µl 6x loading buffer, then made 
up to 12 µl with nf water. 
Gels were run at 120 mA for 40 minutes, though an additional 20 minutes of run time 
was used in cases where greater separation was desired. For fosmid separation, 30 V 
overnight was originally used to test shearing. Size selection was achieved by running a 
1% low melting point (LMP) agarose unstained by ethidium bromide (Thermo Fisher 
Scientific) gel for three days at 4 oC (in a controlled temperature room); the 
recommended protocol in the CopyControl manual proved insufficient. 
Gels were imaged using a UVP GelDoc-It TS, following the completion of their runs and 
removal from their tanks. These images were then transferred to a computer via 
memory card. 
3.2.2.1. DNA Concentration Quantification 
Comparative analysis of band intensity between samples and ladder was predominantly 
used for quantification of DNA concentration, however this was supplemented by 
spectrophotometric quantification using the nanodrop. 
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2 µl of dH2O was pipetted onto the nanodrop and used to blank the machine before 
being wiped away. A further 2 µl dH2O was applied and measured to check the 
cleanliness of the equipment. This process was repeated until appropriate readings were 
consistently detected (twice in succession). Subsequently, 2 µl of sample were pipetted 
out, then measured. For multiple samples, a 2 µl dH2O was step was conducted as 
previous between each sample measurement. 
3.2.3. PCR 
Polymerase chain reaction was used to amplify specific sections of DNA through the 
binding and extension of primers. It was also used to add restriction sites to the ends of 
an amplified sequence as required. Details of this are discussed further in the primer 
design section. While a standard protocol is presented herein, for many PCR reactions 
conducted changes in annealing temperature was required to suit the primers, and 
variations in temperature, time, and DNA concentration were made in order to produce 
the products desired. 
For an individual PCR mixture, 35 µl of nf water are added alongside 10 µl HF buffer, 1 
µl dNTPs, 1 µl 100 µM forward primer, 1 µl 100 µM reverse primer, 1 µl template DNA, 
and 1 µl Phusion Hot Start DNA polymerase. All components other than the nf water, 
primers, and DNA were provided in the Phusion Hot Start II High Fidelity DNA 
Polymerase kit (New England Biolabs, UK). For multiple PCRs a mastermix was created 
of the components common to them all to save on pipetting time and equalising 
pipetting error across all PCRs being conducted. These reaction volumes were all set up 
in 200 µl PCR tubes before insertion into a PCR thermocycler. 
While the Phusion DNA polymerase method was used predominantly in this work, for 
the fosmid overlap individual gene constructs success was ultimately achieved with Q5 
High-Fidelity 2x Master Mix (New England Biolabs, UK). 25 µl were used for a 50 µl 
reaction, while volumes of template DNA and primers remained the same. The 
remaining volume was adjusted to the final volume with nuclease free water. 
The standard temperatures and times used in the PCR thermocycler are as follows: 95 
oC for two minutes in the first stage; 95 oC for 30 s, followed by annealing temperature 
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(typically between 50-72 oC) for 15 s, then 72 oC for 15-30 s per kb of product for the 
second stage; the second stage is repeated 30 times before the third stage consisting of 
72 oC for 10 minutes, then 4 oC until end. 
3.2.3.1. Primer Design 
Primers initially and primarily comprise a complementary sequence to the target strand 
desired. Care must be taken to select the correct strand for complementarity as 
extension occurs only in a 5’ to 3’ direction. The sequence chosen should be specific, 
and lack repetitive sequences or long strings of adenine or thymine. Often a non-
complementary sequence is added on to the 5’ end of the primer in order to add in a 
restriction site. This restriction site must be selected with all sequences in the various 
stages of cloning in mind, as it should be a unique cutter to avoid complications. A few 
base pairs extra should be added onto the 5’ of the restriction site to facilitate restriction 
enzyme binding to the sequence. The length of the sequence, particularly the 
complementary region can be adjusted, with GC content in mind, in order to adjust the 
melting temperature of the primer. All primers were designed using snap gene, and New 
England Biolab’s online restriction calculator to check for buffer compatibility. 
3.2.4. Homologous Recombination 
While other approaches were attempted to replace the CmR cassette in the pEC86 
plasmid with an AmpR cassette, homologous recombination was the one that ultimately 
succeeded. It is first worth noting that all tubes solutions and cuvettes described herein 
were pre-chilled. 
A starter culture of E. coli bearing pKD46 was set up and incubated at 30 oC. When OD600 
reached 0.1 λ-red expression was induced by the addition of 20 µl L-arabinose stock, 
and growth continued to until OD600 reached 0.4-0.6. 1 ml aliquots were then made into 
2ml microcentrifuge tubes, which were chilled on ice for 10 minutes, before 
centrifugation at 4000 xg for 10 minutes at 4 oC. Following discard of the supernatant 
the cell pellet was gently resuspended in 1 ml ice-cold 10% glycerol (in dH2O), then 
centrifuged again under the same conditions. This wash step was repeated with 0.5 ml 
ice-cold 10% glycerol, then 50 µl ice-cold 10% glycerol. 
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The PCR product of the AmpR cassette with added homologous ends to either side of the 
CmR cassette in pEC86 was added to these cells to a concentration of 0.5 µg, and the 
mixture transferred to chilled electroporation cuvettes. It is worth noting that the DNA 
sample used was salt free, due to elution in nf water when purifying, as to do otherwise 
would result in arcing within the electroporation cuvette. The cuvette was also dried 
before insertion for the same reason. The cells were then electroporated at 200 Ω, 25 
µFd, under volts 1.8 kV, with a time constant of 4 ms. 1 ml of room temperature LB broth 
was immediately added to the cuvette following this, and the contents then transferred 
to a 1.5 ml microcentrifuge tube at room temperature. 
Following incubation of these cells for 1 h at 37 oC (removing the temperature sensitive 
pKD46), with gentle agitation, the cells were plated on LB agar + Amp plates and 
incubated for 24 h at 37 oC. Cells that were not electroporated, were plated out 
additionally as a control. Colonies on the recombined plate were subsequently 
subcultured, minipreped, and the plasmids sent off for sequencing to confirm correct 
homologous recombination before transformation into BL21(DE3) alongside other 
relevant plasmids for testing. 
3.2.5. Heat Shock 
Chemically competent cells prepared as previously described were further aliquoted 
into pre-chilled 1.5 ml microcentrifuge tubes to a volume of 50 µl. 10 µl of ligated DNA, 
or 20-40 ng of plasmid DNA was added, and the cells incubated on ice for 30 minutes. 
The cells were then heat shocked for 90 s at 42 oC then place on ice again for 2 minutes. 
1 ml of LB broth was added, and the sample incubated at 37 oC for 90 minutes, 150 rpm. 
The cells were then centrifuged at 4000 xg in a benchtop microcentrifuge, and 850 µl of 
supernatant discarded. The remainder was used to resuspend the pellet. 100 µl of the 
resuspended culture was then plated out on LB agar plates containing the relevant 
antibiotic(s) to the plasmid(s) used, which were then incubated for 16 h at 37 oC. In the 
case of ligations, a ligation mixture excluding the desired insert was used as a control. If 
unsuccessful in producing colonies, and assuming no or few colonies on the control 
plate, the remaining culture volume left incubating at room temperature was plated 
similarly. 
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3.2.6. Digest and Ligation Reactions 
The standard digest protocol followed for DNA digests used 2 µl of the appropriate 10x 
buffer to the enzymes required (often CutSmart), an amount of DNA depending on need 
and concentration, with the volume made up to 19 µl by nf water in a 1.5 ml 
microcentrifuge tube. While this concentration was adjusted to optimise some 
reactions, the majority of reactions used the maximum possible, given available 
samples. Finally, after mixing, 1 µl of enzyme was added. The mixture was then 
incubated at 37 oC for 1 h (though times could be extended depending on enzyme), and 
either analysed on an agarose gel, or 1 µl calf intestinal phosphatase added if plasmid 
DNA for ligation were being digested. If the latter, the reaction was incubated for a 
further hour. 
For ligation, once the samples were run on an agarose gel they were extracted as 
previously described. Alternatively, a Qiagen PCR cleanup kit could be used to facilitate 
purification. The ligation reaction was then set up as follows with template and insert 
volumes adjusted depending on concentration, size, and the results of a ligation 
calculator; typically a 3:1 ratio of vector to insert was used initially, but others were used 
in the course of optimisation for certain constructs. X µl linear plasmid DNA, X µl insert, 
2 µl ligase buffer, 1 µl ligase, difference to 20 µl made up with nf water.  
3.2.7. Fosmid Library Creation 
As previously described, a genomic DNA extraction was carried out using 1 ml of OD600 
1.0 overnight culture of Shewanella oneidensis MR-1. The Qiagen Blood and Tissue Kit 
was used according to the manufacturer’s instructions, though with the 200 µl eluted 
DNA passed through the spin column an additional time to maximise yield. 
Concentration was assessed by running a 2 µl aliquot on a 1% analytical agarose gel 
containing ethidium bromide at 120 mA for 1 hour. 
With the genomic DNA of a suitable concentration, the manufacturer’s instructions for 
creating a Fosmid Library using the CopyControl Fosmid Library Production Kit 
(Epicentre) were carried out. No Pulsed Field Gel Electrophoresis (PFGE) apparatus was 
available, so the manufacturer’s alternative for assessing DNA shearing in the extracted 
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genomic DNA was conducted. With genomic DNA of the right concentration and 
shearing, an end repair reaction was initiated, the products of which size selected using 
a 1% low melting point (LMP) agarose gel with no ethidium bromide, running in the large 
lanes created by taping comb teeth together. The melting and smearing of the gel 
resulted in a re-evaluation of the protocol. Subsequent gels were run at 30 V, at 4oC, for 
3 days. 
The sides of the gel containing the edges of the genomic DNA band, control DNA bands, 
and GeneRuler HR, were stained with ethidium bromide and visualised to guide the 
excision of the genomic DNA band in the desired size range. This excised gel band was 
stored temporarily at -20oC before the DNA was extracted using GELase (epibio) 
according to the manufacturer’s instructions, and its resulting concentration checked by 
running an aliquot of 1 µl on a 1% analytical agarose gel. Once the appropriate 
concentration was obtained, the ligation, packaging into phage capsid, and phage titre 
steps were carried out in order. The provided EPI300 E. coli cells were transfected at a 
titre expected to produce >600 clones. After the manufacturer’s protocol proved 
inefficient, clones were harvested from agar plates for storage at -80oC using a sterile 
plastic inoculating loop, resuspended in LB, with separate aliquots measured out before 
the addition of the glycerol to an end concentration of 20%. 
3.2.8. Sequencing 
All verification by sequencing was conducted using the University of Sheffield’s Core 
Genomics Facility in the Medical School. Data was analysed using FinchTV, with 
sequences subsequently compared using SnapGene. 
3.3. Bioelectrochemistry 
3.3.1. Half Cells 
Half Cells (HCs) were prepared using 250 ml Duran or Schott bottles, autoclaved 
containing 225 ml of M4m media supplemented with 0.4% Sodium Lactate. Red Rod 
reference electrodes (Radiometer Analytical REF201) were cleaned beforehand 
according to manufacturer’s instructions with an interior saturated KCl wash, a pepsin 
(Applichem) wash, and bleach wash (Renovo X). Platinum wire counter electrodes (IJ 
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Cambria Scientific Ltd, UK) were cleaned with ethanol during HC disassembly and prior 
to assembly. Carbon working electrodes (Wes) were prepared by cutting disks the size 
of the lids of the 250 ml bottles, out from carbon veil (PRF Composite), leaving an overlap 
between every pair of circles so they could be folded over to give a two layered disk. 
Four nichrome wires (Scientific Wire Company – Nickel Chrome wire 0.45 mm, 125 gr) 
were then threaded through from the centre to the edge in four separate directions, 
and then the wires twisted around each other to form a thick wire leading from the 
centre of the disk. These electrodes were autoclaved before use in a foil-topped 1 L 
beaker. Glass pipettes (SLS) were also autoclaved within foil to sterilise for HC assembly. 
Overnight cultures of 10 ml LB broth supplemented with any relevant antibiotics and 
grown at appropriate temperature (30oC for Shewanella spp., 37oC for E. coli) were used 
to inoculate conical flasks containing 200 ml LB broth (or 100 ml 2xYT in 200 ml flasks) 
with any antibiotics. These were grown at 200 rpm at 30oC until an OD600 greater than 
0.6 was achieved. 10 µM IPTG was used to induce MFe strains, while all others received 
0.5 mM. 
The volume required to be pelleted and resuspended in 25 ml, which was to be added 
to the 225 ml containing Half Cell to reach a final OD600 of 0.04 (or later for E. coli strains, 
0.4), was calculated and measured out. Cells were centrifuged at 5000 xg for 10 minutes 
at 4 oC. Resuspended cells were kept on ice until HC assembly was conducted. Antibiotics 
and other supplements were added to the HC bottles prior to the assembly step. 
HCs were assembled with all electrodes and glass pipettes accommodated through holes 
in the lid. The resuspended cells were then added to the labelled HCs. While a silicone 
sealant was previously used in the old two-electrode HC system to seal the top while 
assembly was conducted within an anaerobic cabinet, the permeability of silicone to 
oxygen made this unnecessary, and was ultimately replaced with the constant sparging 
through glass pipette. PicoLog voltage recorders (Pico Technology) similarly previously 
were used to measure potential at the WE while HCs inoculated to a starting OD600 of 
0.25 were incubated in a water bath at 25oC for a period ≥1 week. This was adjusted first 
to use a portable PG581 potentiostat (BioLogic) measuring the current of a single HC at 
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30 oC under a poised potential of 0.2 V vs Ag/AgCl reference electrode and constant 
sparging with N2, then to use an Arbin FCTS (Arbin Instruments) to test 12 HCs in parallel 
under the same conditions. 
One litre of M4m media was made from 0.221 g K2HPO4, 0.099 g KH2PO4, 0.168 g 
NaHCO3, 1.189 g (NH4)2SO4, 7.7305 g NaCl, 1.192 g HEPES, 10 ml CaCl2 stock (7.13 g 
CaCl2·2H2O in 1 L dH2O, autoclaved), and 10 ml trace mineral solution. 0.4% w/w of 
Sodium Lactate was added to media before autoclaving. Trace mineral solution 
comprised of 2.26 g Na2EDTA·2H2O, 24.89 g MgSO4·7H2O, 0.029 g MnSO4·4H2O, 0.058 g 
NaCl, 0.068 g FeCl2, 0.065 g CoCl2, 0.029 g ZnSO4·7H2O, 0.005 g CuSO4·5H2O, 0.35 g 
H3BO3, 0.08 g NaMoO4, 0.119 g NiCl2·6H2O, 0.028 g Na2SeO4·10H2O, in 1 L dH2O, 
autoclaved. 
Similarly one litre of M1 was composed of 15.12 g PIPES, 0.3 g NaOH, 1.5 g NH4Cl, 0.1 g 
KCl, 0.59 g NaH2PO4•H2O, 5.84 g NaCl, with 0.4% w/w Sodium Lactate added prior to 
autoclave, made up to 1 L with dH2O and adjusted to pH 7.4. Subsequent to autoclaving, 
2.5 ml each of the vitamin, mineral and amino acid stocks were added to each HC bottle 
just before assembly.  
100X M1 vitamin stock comprised the following made up to 1 L with dH2O, and filter 
sterilised: 2 mg D-biotin (B7), 2 mg folic acid (B9), 10 mg pyridoxine HCl (B6), 5 mg 
thiamine HCl (B1), 5 mg nicotinic acid (B3), 5 mg D-pantothenic acid, 5 mg hemicalcium 
salt (B5), 0.1 mg cobalamin (B12), 5 mg p-aminobenzoic acid, and 5 mg a-lipoic acid. 
Stored at 4°C, protected from light. 
100X M1 amino acid stock comprised the following made up to 1 L with dH2O, and filter 
sterilised before storage at 4 oC: 2g L-glutamic acid, 2 g L-arginine, and 2 g D,L-serine. 
100X M1 trace mineral stock, prepared and stored similarly included: 2017.4 mg 
C6H9NO6Na3 (Na-NTA), 3121.2 mg MgSO4·7H2O, 500.3 mg MnSO4·H2O, 1000 mg NaCl, 
100 mg FeSO4·7H2O, 100 mg CaCl2·2H2O, 100 mg CoCl2·6H2O, 129.5 mg ZnCl2, 10 mg 
CuSO4·5H2O, 10 mg AlK(SO4)2·12H2O, 1 mg H3BO3, 2.4 mg Na2MoO4·2H2O, 2.4 mg 
NiCl2·6H2O, and 25.1 mg Na2WO4·2H2O. 
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The HC experimental data were exported into a Microsoft Excel compatible format and 
subsequently analysed using GraphPad Prism. 
3.3.1.1. Sample Collection for Proteomics 
Following cessation of potentiostatic control by the Arbin FCTS (Arbin Instruments) HCs 
from which biomass was to be harvested were disconnected (reference electrode 
disconnected last), and removed from the water bath. Disconnected HCs were then 
disassembled, using sterile technique, with the WE removed last. WE removal was 
conducted after agitation to dissociate adhered cells. A final OD600 measurement was 
taken spectrophotometrically with 1 ml of the cell suspension against a blank of the 
appropriate media. The remaining volume was transferred to labelled 50 ml Falcon 
tubes and centrifuged at 5000 xg for 10 minutes at 4 oC, then the supernatant discarded. 
Cell pellets were then briefly stored at -20 oC before protein extraction. 
3.3.2. Dye Reduction Assay 
Overnight cultures were grown up in LB at 37oC for E. coli strains and 30oC for Shewanella 
spp. with agitation at 150 rpm for preliminary testing, however subsequent testing saw 
inoculation of a starter plate containing only LB broth with colonies picked from agar 
plates. The starter plates were grown under similar conditions. 1 in 100 dilutions in LB 
were performed for preliminary testing, while 15 µl per well were transferred from 
starter plate to dye plate subsequently. Antibiotics at necessary concentrations were 
included as required. Plates were prepared by pouring the media to be transferred to 
the plate into a sterile petri dish in a laminar flow hood, then transferring it to the 96-
well plate with a multichannel pipette. Stocks and dilutions of dyes are detailed in Table 
3.1. below. Once dye plates were inoculated, a Tecan plate reader (GENios Tecan) was 
used to take a zero reading at the absorbances indicated in Table 3.1., before separate 
plates were incubated at 25oC aerobically and anaerobically for 72 hours, except where 
otherwise described. Observations of colour changes were made and a final reading was 
taken in the Tecan. Where a range of dye concentrations were used, 1 in 100, 200, 400, 
600, 800, and 1000 dilutions were performed from stocks. 
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Following protocol changes the dye free wells were removed, granting space for 
multiple dyes to be used on the same plate, or higher throughput analysis with a single 
dye. Control wells containing just dye in LB were still used. After incubation and a pre-
centrifugation reading, plates were spun down at 4000 xg for 10 minutes, then 
supernatant transferred to a new plate to be read in the Tecan. Wavescans were carried 
out using the initial dilutions listed in Table 3.1. using the Ultrospec 2100 Pro 
spectrophotometer’s wavescan function.  
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Table 3.1. – Dyes Used in Colourimetric Screens 
Name Stock 
Concentration 
Dilution for 
Use 
(Initial) 
Dilution for 
Use 
(Optimised) 
Absorbance 
Filter Used 
Reactive Black 
5 
1% w/v 1 in 1000 1 in 100 595 nm 
Reactive Red 
120 
50 mg/ml 1 in 100 1 in 1000 530 nm 
Basic Green 5 2.7 mM 1 in 100 N/A 660 nm 
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3.4. Protein Methods 
3.4.1. Protein Extraction 
Cell pellets were thawed on ice before being resuspended in 1 ml extraction buffer (6 M 
Urea, 150 mM NaCl, 100 mM TEAB, 1 mM EDTA, pH8.0). Suspensions were sonicated on 
ice in 8 rounds of 15 seconds on, 45 seconds off, with the tip cleaned between rounds, 
then centrifuged at 21,000 xg for 30 minutes at 4 oC. Supernatant was extracted and 
placed in LoBind (Eppendorf) tubes. An aliquot of each was transferred to a separate 
tube and stored at -20 oC for analysis, while the rest was stored at -80 oC. 
3.4.2. SDS PAGE 
Precast 4-12% Sodium dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
gels (NuPage, Invitrogen, UK) were prepared according to instruction, being placed into 
the gel dock following removal of all packaging. The gel tank was then filled with MOPS 
SDS buffer, with 500 µl SDS-PAGE antioxidant solution added to the centre of the gel 
enclosure. The gel comb was removed prior to sample loading. Samples were prepared 
with 5 µl 4x loading buffer, 2 µl reducing agent, with 13 µl remaining for protein sample, 
the rest diluted to with dH2O. Non-urea containing samples were boiled at 95 oC for 10 
min prior to loading. Gels were run for 1 h 20 min at 150 V. Following this they were 
Coomassie stained with InstantBlue 
3.4.3. Bradford Protein Quantification 
To determine protein concentrations in solution using the Bradford reagent, which 
causes a spectrophotometric change at 595 nm, a standard curve must first be produced 
using known concentrations of BSA. BSA concentrations of 0.25, 0.5, 1, and 1.4 mg/ml 
were aliquoted out into multiple wells of a flat bottomed 96-well (nunclon) plate, then 
5 µl of each well transferred to a fresh plate. 250 µl of Bradford reagent allowed to warm 
to room temperature was added to each well of this plate. Following incubation at room 
temperature for at least 5 minutes the plates were measured spectrophotometrically at 
595 nm using a microplate reader (Genios Tecan). Measurement was carried out within 
60 minutes of reagent addition. This process was repeated for dilutions of protein 
samples, with absorptions compared against the standard curve. Averages of at least 5 
replicates were used to determine protein concentration. 
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3.4.4. Trypsin Digestion and iTraq Labelling 
LoBind microcentrifuge tubes (Eppendorf) were used throughout to prevent protein loss 
due to tube surface binding. A 1 in 6 dilution of each protein sample was made with 
TEAB in order to dilute urea and EDTA concentrations. Subsequently 60 µl of each 
diluted sample was aliquoted out, alongside buffer only and BSA controls, with 5 µl 
removed from each and stored for later analysis. Samples were reduced with 5.5 µl TCEP 
(50 mM), being incubated at 60 oC for 1 h, then alkylated with 2.8 µl MMTS (200 mM 
stock) and incubated at room temperature for 10 min. Following this, trypsin 
(resuspended in 5 µl 50 mM acetic acid, 35 µl TEAB, to 0.5 µg/µl) was added in a 1:20 
ratio to protein (5.5 µl stock) and incubated at 37 oC overnight to digest. 6 µl aliquots 
were obtained from all samples to compare to initial analysis aliquots by SDS-PAGE. 
Following verification of digestion, samples were dried down using a speed vac to reduce 
the sample volume to approximately 30 µl, then carefully arranged and labelled 
according to relative iTRAQ label reagents to be used. Reagents were removed from -20 
oC storage prior to use and briefly pulse centrifuged to ensure contents were collected 
at the bottom. 100 µl of isopropanol were added to each tube, vortexed briefly, then 
spun once more before transfer to each respective protein sample. A vortex and spin 
was repeated following mixing, then samples were incubated at room temperature, in 
the dark, for 2 hours. Following this samples were mixed together in a single tube, mixed 
and centrifuged once more, then separated into two tubes for drying via speed vac. One 
tube proceeded to fractionation, while the other was stored at -80 oC. 
3.4.5. HPLC Fractionation 
Samples were resuspended in 20 µl HPLC buffer (3 % CAN 0.1% TFA), vortexed, pulsed 
in a microfuge, then sonicated for 3 min in water bath, before centrifugation at 17,000 
xg for 3 min to remove particulates. This was repeated with a further 20 µl, before HPLC 
fractionation via hypercarb column. Fractions were collected at 2 minute intervals. 
Following drying samples were stored at -20 oC. 
3.4.6. Mass Spectrometry 
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Sample preparation for MS proceeded as above, resuspending dried fractions with 20 µl 
and extracting 4 µl to a mass spec sample tube following the centrifugation step. BSA 
standards were run before and after two fractions (40-42 and 50-52 min) were run on 
the amazon LC-MS (Bruker, UK) to assess quality. BSA scores and sample data 
permitting, 6 tubes with 4 µl of each of three consecutive fractions from 22-58 min were 
combined in mass spec sample tubes pending analysis on the Q Exactive HF Orbitrap 
(Thermo Scientific, UK). 
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Chapter 4 – Chloramphenicol 
Increases Current Production by 
Bacteria in a Single Chamber 
Bioelectrochemical Cell 
4.1. Introduction 
As discussed in Chapter 2, microbial fuel cells (MFCs) have their limitations for laboratory 
based study of bacterial electroactivity, particularly with regards to throughput.3,123,124 
The half-cells (HCs) used by Pereira-Medrano et al.125 present a higher throughput 
option, however sacrifice much of the electrochemical insight provided by MFCs.26 
Further compounding the issues of BES selection for investigation of electroactivity is 
the lack of standardisation of equipment in the field, a consequence of a focus on MFC 
design and electrode composition in MFC research3,12, which necessitates a comparison 
between any experimental protocol and the literature to confidently validate any data 
it is used to produce.  
In this chapter we initially set out to adapt the sedimentary HC protocol used by Pereira-
Medrano et al.125 for more thorough electrochemical analysis of engineered Escherichia 
coli strains. E. coli strains engineered with systems from model dissimilatory metal 
reducing bacteria (DMRB) have performed poorly relative to those organisms, though 
they might outperform their respective controls.26,28,126 However, while this makes them 
unlikely candidates for industrial scale, bioenergy MFC applications, the increased 
understanding of E. coli as a model organism for synthetic biology, and the concomitant 
toolsets available, makes them stronger contenders for other applications126, as 
discussed in Chapter 2. Applications in biosensing in particular may benefit from a 
greater control of electroactivity at the expense of flux, providing power density does 
not drop low enough to be reflected in decreased sensitivity.29 
41 | P a g e  
 
Our three electrode, single chamber setup, under potentiostatic control, matched 
expectations from the literature for Shewanella mutants.127,128 However, further 
adaptations were needed to resolve differences between engineered and control strains 
of E. coli. While testing these adaptations, unexpected observations led us to investigate 
potential interactions between chloramphenicol (Cm) and bacteria within a single 
chamber bioelectrochemical system (BES). Thus it is worth noting that Cm is an 
uncharged, bacteriostatic antibiotic that binds with ribosomes to inhibit protein 
synthesis.129,130 The most common gene conferring high-level resistance is for 
chloramphenicol acetyltransferase (CAT), which acetylates up to two hydroxyl groups of 
the Cm molecule, using acetyl Coenzyme A (acetyl CoA).131 This reversible reaction132 
prevents subsequent binding to the ribosome. 
4.2. Results and Discussion 
4.2.1. Half Cell Development 
After it became clear that the analysis of negative potentials observed using the 
sedimentary HC protocol26,125 would be insufficient to effectively differentiate E. coli 
strains for performance in other BESs, the protocol was adapted to make use of an 
additional electrode and employ a poised potential, necessitating the use of a 
potentiostat. The single channel, portable potentiostat used in preliminary testing was 
incapable of facilitating the number of replicates that would be required for a reliable 
study, let alone maintaining the throughput of the original protocol that we were 
interested in attaining. Through collaboration with Prof Peter Hall and his research 
group, access to a multi-channel potentiostat was utilised to produce the subsequent 
HC data. 
The HC setup described in Figure 4.1. underwent a series of minor modifications during 
preliminary testing (data not shown), to reach the setup detailed, notably including the 
use of a larger platinum counter electrode (CE). The media selected for use in the HCs 
was a more strictly defined minimal media adapted from the M4 media used by 
Goldbeck et al.27, and detailed in Chapter 3 (M4m). Sodium DL- Lactate remained the 
sole carbon source at 0.4% w/w. Briefly, replicate HCs were inoculated to a defined 
OD600 as later described with aerobic, LB flask-grown cultures of relevant strains, 
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through centrifugation and resuspension (in M4m) of a calculated volume based on 
culture OD600. HCs were subsequently assembled, then placed in a water bath at 30 oC, 
wherein they were sparged with N2, connected to the potentiostat, and the 
chronoamperometry experiment begun. All data presented is representative of at least 
three replicates unless otherwise noted. 
Figure 4.1. Half Cell Diagram 
 
A diagram of the HC equipment used. Accommodated within the lid of the 250 ml bottle, 
from left to right, are a Red Rod Ag/AgCl reference electrode, a NiChrome wire and 
carbon veil working electrode, a platinum counter electrode, and a glass pipette sparging 
the media with nitrogen. Assembled HCs contain 250 ml of culture. 
 
4.2.2. Comparison of Shewanella mutants 
Validation of our HC protocol was conducted using Shewanella oneidensis MR-1 and four 
deletion mutants produced by Coursolle and Gralnick128,133, and described in Table 4.1. 
These mutants had particular relevance as many of the deletions used were for 
Reference 
Electrode 
Working 
Electrode 
Counter 
Electrode 
Glass 
Pipette 
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decahaem cytochromes involved in an identified, extracellular electron transfer (EET) 
pathway of S. oneidensis, which had been successfully transplanted into E. coli.26,122,134 
It was planned that such E. coli strains would be used in subsequent testing. 
Table 4.1. Shewanella oneidensis Strains 
Strain Designation Gene Deletions Source 
MR-1 N/A – Wild Type Prof. Gralnik 
JG719 ΔomcA 128 
JG731 ΔmtrC 128 
JG1176 or “White” ΔmtrC ΔomcA ΔmtrF 
ΔmtrA ΔmtrD ΔdmsE 
ΔSO4360/ ΔcctA 
133 
Table of Shewanella strains used in this study. These were obtained from Prof. Gralnick 
and are all derived from MR-1. The white strain in particular has several deletions in 
recognised cytochromes involved in EET and their homologues. 
 
The results for the chronoamperometry experiments using HCs at a poised potential of 
0.2 V vs Ag/AgCl (+0.197 V compared with SHE), and inoculating OD600 of 0.04, are shown 
in Figure 4.2B, alongside the results reported by Coursolle et al.127 (reproduced with 
permission) in Figure 4.2A. 
Figure 4.2B shows an initial rapid current increase of around 50 µA for the MR-1 and 
ΔomcA strains within the first few hours, both levelling off to a slower, steadier rate also 
observed for the other strains. The change in current over time appears more linear in 
Figure 4.2A. This difference, which is likely attributable to the methodological 
differences between the two experiments rather than biological differences, does not 
however obscure the general trends which can be drawn from the data, nor contest the 
conclusions that can be drawn therefrom. The ΔomcA strain is outperformed by the MR-
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1 strain, and similarly outperforms the ΔmtrC strain, with the white strain producing the 
least of all. This reflects the importance of these cytochromes to EET to an 
electrode.127,128 
There is a greater separation between the observed current for MR-1 and ΔomcA in 
Figure 4.2A, than in 4.2B, which we believe reflects biological adaptation by the ΔomcA 
strain within our HCs to compensate for its deletion. 
Aside from equipment and electrode differences, the poised potential used by Coursolle 
et al.127 of 0.242 V vs standard hydrogen electrode (SHE) – equivalent to 0.045 V vs 
Ag/AgCl – may be particularly accountable for the observed differences. As discussed in 
Chapter 2, there is no completely accepted optimum poised potential, however 
comparisons for MR-1 have shown greater current production occurs at more oxidising 
(positive) potentials, peaking at 0.2 V vs Ag/AgCl. Coulombic efficiency was 
comparatively seen to reach maximal values at 0 V vs Ag/AgCl.126 Our selection of poised 
potential was made on the basis of this, and for ease of comparison to published BES 
data for E. coli strains.27,28,126 
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Figure 4.2 – S. oneidensis Mutant Comparison 
 
 
 
 
 
 
 
A comparison of published chronoamperometry data (A) and that produced by our HC 
setup (B) using the same strains. The unlabelled strains close to the x axis in (A) are not 
relevant to this study so not identified. Both graphs show a high performance for MR-1, 
followed by the ΔomcA strain, then the ΔmtrC (by a greater margin). The white strain 
also performs even more poorly, as expected. Error bars are not shown here to ensure 
clarity, but each line represents the average of three replicates.  
  
 ■ MR-1  
▲  ΔomcA  
 ♦    ΔmtrC  
A. 
B. 
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4.2.2.2. S. oneidensis Riboflavin Responsiveness 
As discussed in Chapter 2, riboflavin has been demonstrated to act as a mediator 
between the transmembrane EET pathway of MR-1 and extracellular electron acceptors 
(EEAs). Its supplementation into BESs can result in dramatic increases in current 
output.73 4 µM riboflavin was added to the HCs as described in Chapter 3 and Figure 4.3. 
clearly shows the effects of riboflavin addition to the HC setup for MR-1 to be consistent 
with expectation. A fourfold increase in maximal current after 4 hours was observed.  
Figure 4.3 – Riboflavin Responsiveness of S. oneidensis MR-1 
 
Chronoamperometry data showing the current produced by S. oneidensis MR-1 in the 
presence and absence of 4 µM riboflavin. The data for each line represents the average 
of three replicates with error bars highlighting the standard error of the mean. The 
presence of riboflavin clearly has a multiplicative effect on current output. 
 
4.2.3. Methodological Adaptations for Escherichia coli 
In order to achieve confidence in our experimental setup for the comparison of 
engineered E. coli strains we needed to observe differences between such strains and 
their relative controls that had been previously validated in other BESs. A full list of E. 
coli strains used in this chapter is presented in Table 4.2. The majority of plasmids were 
inserted into the expression strain BL21(DE3), save for those otherwise noted.  
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Table 4.2. – E. coli Strains 
Base Strain Plasmids Additional Genes Resistance Source 
C43(DE3) - -  Sigma 
BL21(DE3) - -  Sigma 
BL21(DE3) pACYC Duet-1 + pRGK333 ccmA-H Cm, Amp Jaffe26 
BL21(DE3) pACYC CAB + pRGK333 mtrCAB, ccmA-H Cm, Amp Jaffe26 
BL21(DE3) pACYC CABO + pRGK333 mtrCAB, omcA, 
ccmA-H 
Cm, Amp Jaffe26 
BL21(DE3) pRSF Duet-1 + pRGK333 ccmA-H Kan, Amp Jaffe26 
BL21(DE3) pRSF CABO + pRGK333 mtrCAB, omcA, 
ccmA-H 
Kan, Amp Jaffe26 
BL21(DE3) pRSF Duet-1 + pEC86 ccmA-H Kan, Cm Jaffe26 
BL21(DE3) pRSF CABO + pEC86 mtrCAB, omcA, 
ccmA-H 
Kan, Cm Jaffe26 
BL21(DE3) pEC86 ccmA-H Cm Jaffe26 
BL21(DE3) pRSF Duet-1 + 
pEC86Amp 
ccmA-H Kan, Amp This study 
BL21(DE3) pRSF CABO + pEC86Amp mtrCAB, omcA, 
ccmA-H 
Kan, Amp This study 
BL21(DE3) pSB1A2 CmR - Cm, Amp BioBrick108 
BL21(DE3) pACYC Duet-1 - Cm Novagen 
BL21(DE3) pBBR1MCS - Cm Addgene 
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Initial comparison of Escherichia coli BL21(DE3) pACYC Duet-1/mtrCAB + pRGK333 
(inducible ccm genes), as seen in Figure 4.4.A, using the same protocol as for MR-1 
showed no significant difference between the two, and had in the region of a tenfold 
current reduction compared with S. oneidensis. Consequently, the inoculating OD600 was 
revised upward tenfold. 
Figure 4.4.B presents these data, in which differences between the strains is observed. 
However, it is the control strain (pACYC Duet-1 pRGK333) which outperformed the 
engineered (pACYC CAB pRGK333). Furthermore, the two base strains tested (BL21(DE3) 
and C43(DE3)) behaved comparably to the strains in Figure 4.4.A, producing negligible 
current in the 0-5 µA range. Both observations were unexpected, and were further 
investigated in parallel. 
While examples of use are present in the literature26,135,136, the inducible pRGK333 
plasmid is more commonly replaced by the constitutive pEC86 plasmid for the 
expression of additional cytochrome maturation (ccm) genes.26,122,137,138 Optimising 
expression of the system is complicated by the co-induction of the mtrCAB genes with 
IPTG, which lie under a T7lac promoter. This promotor is known to be leaky (possessing 
non-zero basal expression) in many expression strains, including BL21(DE3), though this 
can be controlled with T7 lysozyme expression.104,139 However expression of membrane 
proteins under its control can be better without induction due to its relative strength 
and ability to overwhelm localisation and other host processes when induced, yet better 
still when under a tuneable promoter.27,140 Nevertheless the T7 RNA polymerase is 
effective at rapidly transcribing long sequences32, which can be of use when trying to 
co-express multiple recombinant genes.  
While the expression profile may have been suitable for detecting differences within an 
MFC, it may be the case that the HCs require a greater level of optimisation to be able 
to discern these differences. Alternatively, the decreased performance of this 
engineered strain relative to its control may be due to increased metabolic burden from 
the overexpression of the EET system, obscuring the EET activity, or other metabolic 
differences arising from varying conditions between the two setups. 
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The significant difference between the base strains and the plasmid containing strains 
must be accounted for in something contained on either the pACYC Duet-1 expression 
plasmid, the pRGK333 ccm plasmid, or both. It was hypothesised that there might be an 
unforeseen interaction between the host cytochromes and the working electrode (WE), 
subject to additional ccm gene expression. This, however seemed unlikely to have gone 
overlooked in previous studies. Alternatively, there may have been an interaction 
between the antibiotics, resistance mechanisms, or products, highlighted in our single 
chamber BES. 
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Figure 4.4. – Initial E. coli Strain Comparison 
 
 
 
Engineered (pACYC mtrCAB + pRGK333) and control (pACYC Duet-1 + pRGK333) strains 
of E. coli are compared in HCs using a starting OD600 of 0.04 (A) as with previous S. 
oneidensis HCs, and 0.4 (B). The data for each line represents the average of three 
replicates with error bars highlighting the standard error of the mean. Increasing the 
inoculation OD tenfold appears to comparably increase the observed current, which 
importantly allows the different plasmid bearing strains to be differentiated. The base 
strains (BL21(DE3) and C43(DE3)) produce negligible current, far below that of the 
control, plasmid-bearing strain. 
 
  
A. 
B. 
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4.2.3.2. E. coli Riboflavin Responsiveness 
Given the profound effect of riboflavin on MR-1, it was hoped that the addition of 4 µM 
riboflavin could improve electron transfer between the heterologous mtr pathway and 
the WE, overcoming potential limitations imposed by an increased metabolic burden of 
expression. These data are presented alongside those for the same strains from Figure 
4.4.B in Figure 4.5. The general trends and current levels remain the same for both 
pACYC Duet-1 + pRGK333 and pACYC CAB + pRGK333 bearing strains. 
However, since we cannot assume functionality of the mediator/EET pathway 
interaction heterologously, as discussed in Chapter 2, we could not conclude that the 
heterologous EET pathway itself was not working. Therefore, in order to further 
investigate both engineered/control strain performance and base strain discrepancy, 
additional plasmid systems were explored. 
Figure 4.5. – Riboflavin Responsiveness of E. coli Strains 
 
Engineered (blues – pACYC mtrCAB + pRGK333) and control strains (orange and red – 
pACYC Duet-1 + pRGK333) of E. coli are compared, with (light blue and orange) and 
without 4 µM riboflavin added to the starting HC media. Note that error bars for the 
engineered strain without riboflavin are excluded for the sake of clarity. The data for 
each line represents the average of three replicates with error bars highlighting the 
standard error of the mean. The data indicates not particular effect of riboflavin addition 
on current. 
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4.3. Effects of Plasmid Selection on Electroactivity in Half Cells 
In order to isolate the causative factor for the differences seen between base and 
plasmid containing strains in HCs, substitute vectors were compared. The strain bearing 
pRSF CABO + pRGK333 performed well against controls in previous work 24, and the 
complementary pACYC version was available. Both Duet-1 vectors were originally 
produced by Novagen, the primary difference between them lying in the antibiotic 
resistance gene; Cm for pACYC Duet-1 and Kan for pRSF Duet-1. 
Engineered and control strains were compared in HCs and the results presented in 
Figure 4.6. below. The pACYC CABO + pRGK333 strain performed similarly to its omcA 
lacking counterpart. Neither pRSF strain exceeded the 0-10 µA current range displayed 
by the base strains, however. This strongly pointed to the inclusion of Cm and its 
resistance gene being responsible for the dramatic increase in current output. 
Figure 4.6. – pRSF/pACYC Vector Comparison 
 
Chloramphenicol resistant strains are presented in red (control) and blue (engineered), 
while kanamycin resistant versions are presented in green and purple respectively, 
though overlap prevents these latter two from being easily visually distinguishable. The 
data for each line represents the average of three replicates with error bars highlighting 
the standard error of the mean. Both CmR strains demonstrate much higher 
electroactivity than the KanR counterparts, suggesting CmR or Cm is contributing to this 
phenotype 
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One advantage of the pRSF system over the pACYC, was its compatibility with the 
previously discussed pEC86 constitutive ccm plasmid. It was hoped that its use would 
improve heterologous cytochrome expression and maturation to produce higher 
current in HCs relative to a control plasmid bearing strain, and might otherwise support 
the role of Cm in increased EET. Additionally it would permit a comparison of induced 
against uninduced pRSF CABO, which might improve EET through a combination of 
expression and adjustment of metabolic burden. Figure 4.7. shows the results. 
The addition of pEC86 clearly leads to the higher current levels predicted, due to its Cm 
resistance cassette, in all strains. The pEC86 only strain is representative of the pRSF 
Duet-1 + pEC86 strain for the purposes of controlling against the pRSF CABO + pEC86 
bearing strain. Both the induced and uninduced HCs of which displayed increased 
current relative to the pEC86 control. Further controls are included for induced and 
uninduced pRSF CABO + pRGK333, which are not discernible from one another and 
remain comparable to BL21(DE3). However, as previously noted, due to the inducible 
nature of both plasmids, the lack of discernment may be due to a conflict between 
optimum expression for each of the plasmids to reach maximal matured and localised 
EET pathway. This could be explored further. Another potential factor to consider is the 
ampicillin resistance cassette used for pRGK333. Amp is weaker, degrades more readily, 
and so plasmid retention might be more likely affected. 
A clear and significant difference between the induced and uninduced pRSF CABO + 
pEC86 strain was not observed overall, though current levels for the uninduced rose 
faster initially. 
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Figure 4.7. – pEC86 Strain Comparison 
 
Engineered pRSF mtrCABomcA (purple and pink) and control pEC86 (turquoise) strains 
constitutively expressing additional cytochrome maturation genes on the pEC86 plasmid 
are presented. The pink and blue lines represent mtrCAB omcA expressing strains induced 
with 0.5 mM IPTG, with their uninduced equivalents represented by the purple and green 
respectively. The data for each line represents the average of three replicates with error 
bars highlighting the standard error of the mean. Induction with IPTG seems to have a 
minimal effect, however the use of pEC86 to express ccm genes results in an engineered 
strain that can outperform its control. 
In an effort to see if the pRSF CABO pEC86 engineered strain and its control could be 
differentiated in the absence of the proposed “Cm effect”, the CmR cassette of pEC86 
was replaced with an AmpR cassette from the BioBrick plasmid (pSB1A2). This was 
achieved through PCR of the original cassette, and plasmid excluding the CmR cassette, 
followed by digestion and ligation as described in Chapter 3. The construct was verified 
by sequencing. 
Strains containing pEC86Amp and either pRSF Duet-1 or CABO were subsequently 
observed in HCs, both induced and uninduced for the latter. Figure 4.8. presents these 
data, which are clearly incomparable to those for the relative pEC86 strains. Current 
readings remained in the 0-15 µA range, and were not differentiable from one another. 
This suggests that within our HCs the Cm effect may be necessary for discerning the 
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differences between engineered and control strains. Furthermore, it rebuffs the 
argument that the ccm gene expression was responsible for the pEC86 current increase, 
and that something else accounted for the pACYC Duet-1 increase. 
Figure 4.8. – pEC86Amp Strain Comparison 
 
Control (pRSF Duet-1 + pEC86Amp) and Engineered (pRSF mtrCABomcA + pEC86Amp) 
strains are compared, the latter both induced and uninduced, in a chronoamperometry 
experiment within our HC setup. These strains produce current levels comparable to their 
host strains without plasmids; far lower than the versions that use Cm resistance to 
maintain pEC86. The control and engineered strains cannot be distinguished. The data 
for each line represents the average of three replicates with error bars highlighting the 
standard error of the mean. 
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4.4. Investigating the Basis of the ‘Chloramphenicol Effect’ 
In order to investigate which component of the CmR pathway – that is whether the 
resistance protein, Cm itself, or the acetylated product – was accountable for the 
observed, increased HC current output, we aimed to test each component in isolation 
as much as practically possible. However, challenges were encountered in achieving this. 
Initially, a Cm concentration tolerable to BL21(DE3) was elucidated through the 
inoculation of starter cultures containing a range of Cm concentrations. A concentration 
of 200 ng/ml was found to be suitable (0.01x typical working concentration) and tested 
within HCs containing BL21(DE3), or BL21(DE3) containing the CmR BioBrick plasmid 
(maintained with an AmpR cassette) as described in Table 4.2. previously. Any observed 
increased current would identify if Cm or CAT were responsible for the Cm effect. Figure 
4.9. presents these data. 
All strains behaved similarly, producing current in the 0-10 µA range. Some separation 
can be discerned between the strains after 30 h, with the BL21(DE3) with no Cm reaching 
marginally higher levels than its Cm containing counterpart, and noticeably more than 
the plasmid bearing strains. We attribute this to the comparative lack of stress, or 
metabolic burden placed upon the strain, respectively. 
The absence of the Cm effect in the presence of the CmR cassette rules the CAT enzyme 
out as being independently responsible for the increase in current. Although, the low 
Cm concentrations used by necessity herein prevent us from concluding that Cm itself 
is not having an unforeseen interaction with bacterial constituents leading to increased 
EET. Conclusively demonstrating that acetylated chloramphenicol (aCm) was 
responsible could dismiss this concern, yet further investigation of this is limited by the 
reversible nature of the acetylation.141 Alternatively, were it shown that the ‘Cm effect’ 
occurred within abiotic HCs containing the CAT reaction with constituents at comparable 
concentrations, then the responsibility of aCm for this effect could be asserted. 
However, this is hindered by the infeasible cost of sourcing aCm or conducting the CAT 
reaction abiotically at the concentrations necessary, within our HCs. 
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Figure 4.9. Current Effect of CAT and Low Concentration Chloramphenicol 
 
HCs containing E. coli BL21(DE3) (green and red) and BL21(DE3) bearing pSB1A2 CmR 
are represented. 0.2 µg/ml Cm, representative of 0.01x normal working concentration, 
was present for HCs represented by red and blue. The data for each line represents the 
average of three replicates with error bars highlighting the standard error of the mean. 
No electrochemical advantage is conferred by sub-inhibitory concentrations of Cm in 
BL21(DE3) or the CmR strain, which also rules out CAT as soley responsible for the Cm 
effect. 
 
4.4.1. Chloramphenicol Effect in Shewanella oneidensis MR-1 
In order to validate that the CmR accountable current increase was not restricted to E. 
coli strains, S. oneidensis MR-1 was compared against a pBBR1MCS (expression plasmid 
with CmR marker) containing strain. The results, shown in Figure 4.10, conclusively 
describe an increase comparable to that seen for E. coli strains. A 2-3 fold increase in 
maximal current is observed. This was conducted concurrently with the HC work 
presented in Fowler et al.142. A faster drop off in current is observed proceeding the 
maximal current peak than for other HC experiments. A gradual decrease in current was 
noted for other strains following peak current, however this behaviour is suggestive of 
some sort of depletion, perhaps of carbon source or mediator, due to the higher levels 
of current involved. It is worth noting that sub-lethal Cm concentrations can be used to 
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boost plasmid copy numbers but given the CmR cassette only run did not suggest it was 
causative, we did not expect that this would have much of an impact on current. 
Figure 4.10. – The Chloramphenicol Effect in S. oneidensis MR-1 
 
S. oneidensis MR-1 and a strain with the pBBR1MCS expression plasmid added were 
tested in HCs. The latter has only an empty expression plasmid bearing a CmR cassette, 
with Cm added to the HC media. The data for each line represents the average of three 
replicates with error bars highlighting the standard error of the mean. It clearly 
demonstrates that the Cm effect is observable for other bacteria beyond E. coli. 
4.4.2. The Effect of Chloramphenicol Concentration on Current 
Concurrently with the deduction of the upper limit for Cm tolerance for non-Cm 
resistant E. coli, that for resistant strains was also investigated. It was found that growth 
wasn’t noticeably inhibited at up to 15 times typical working concentration aerobically. 
Consequently, a range of concentrations were tested within HCs to see if this would have 
an effect on current. 
The pRSF CABO + pEC86 strain was initially selected for this comparison as it was felt 
that if a mediator based EET facilitation were occurring as part of the Cm effect, this 
might be more strongly observed with our engineered strain. Figure 4.11A presents 
these data, showing increasing maximal current levels with increasing Cm 
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concentrations. Figure 4.11B plots this relationship, indicating it to be linear within the 
range tested. 
This observation is strongly supportive of a hypothesis for aCm (or another, unintended 
product of the CAT reaction in E. coli) acting as a mediator for the purposes of EET. 
That an increase in current of our engineered relative to our control strains was 
previously observed could support a hypothesis for mediator interaction with the 
expressed mtrCABomcA pathway in E. coli. However, it is also possible that this 
improvement is due to direct electron transfer (DET) through the mtrCABomcA 
pathway, and that the mediator driven EET is separate, but facilitates sufficient end 
terminal electron acceptor access that the metabolic activity of the cell is improved, 
resulting in greater, observable electron flow through the artificial circuit. 
The presence of ethanol in the media, used to solubilise Cm, is unlikely to account for 
the observed increases. The Amp stock solution used in this work contained 50% 
ethanol, and no comparative effect was observed for any AmpR strains at intermediate 
values as we’d expect given the observed relationship between Cm concentration and 
current. Furthermore, Cm only HCs produced no current so an interaction between Cm 
and the electrodes can also be discounted.  
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Figure 4.11. – Cm Concentration Relationship with Current 
 
 
 
Current over time from HCs containing different Cm concentrations is shown (A) for the 
engineered pRSF mtrCABomcA + pEC86 strain, with a sub-inhibitory concentrationused 
with BL21(DE3) shown for baseline reference. The data for each line represents the 
average of three replicates with error bars highlighting the standard error of the mean. 
This shows an increasing current output when Cm concentration is increased. The 
average current after 30 h was taken for each concentration and plotted (B), along with 
a line charting linear regression, which suggests that this relationship may be linear. 
  
A. 
B. 
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4.4.3. Plasmid Selection and Chloramphenicol Concentration 
In order to verify that the relationship between Cm concentration and current wasn’t 
exclusive to the pRSF CABO + pEC86 bearing BL21(DE3) strain, and therefore dependent 
on its engineered EET circuit, BL21(DE3) bearing an empty expression plasmid with the 
CmR cassette was tested at a higher concentration. Concurrently, to investigate the 
potential effect of Cm resistant plasmid copy number on current in a Cm containing HC, 
pBBR1MCS was used. The pBBR1MCS plasmid has a medium copy number of 30-
40143,144, compared with pACYC Duet-1, which has a low 10-12 copies per cell.145 
Figure 4.12. displays these data, clearly showing a comparable increase for the 5x Cm 
concentration HCs with the pBBR1MCS strain, to that seen previously for the pRSF CABO 
+ pEC86 strain. This observation indicates that the relationship between Cm 
concentration and current persists in the absence of the mtrCABomcA pathway, or 
additional ccm gene expression. While higher error was noted for the pBBR1MCS strain 
compared with the pRSF CABO + pEC86 strain, it does not disrupt the trend observed. 
Such error may be accounted for by greater biological divergence between replicates or 
handling error during HC inoculation and setup, and occasionally occurs within HC runs 
regardless of strain. 
There is minimal current difference between the pACYC Duet-1 strain and the 
pBBR1MCS strain at the 1x Cm concentration. Although there is a slight separation 
between 5-15 hours due to a faster initial current rise for the pACYC Duet-1 strain, 
beyond that they reach similar values. Consequently it can be concluded that plasmid 
copy number, and by extension CAT concentration, does not have a large impact on Cm 
effect dependent current levels at typical working concentrations. 
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Figure 4.12. – Plasmid Copy Number and High Cm Concentration Validation 
 
Chronoamperometry of BL21(DE3) bearing one of two CmR expression plasmids, each 
with a different copy number. A higher concentration of Cm is also used for pBBR1MCS, 
which responds similarly to data for previously tested plasmids. This demonstrates that 
copy number does not have a discernible effect on the electrochemical response to 
chloramphenicol, and that the effect is observable in strains only bearing empty 
expression plasmids. The data for each line represents the average of three replicates 
with error bars highlighting the standard error of the mean. 
 
4.4.4. Chloramphenicol Depletion 
As can be seen in many of the preceding figures, in Cm/CAT containing HCs current often 
rises rapidly within the first 10-15 hours, then begins to slowly decline. This becomes 
more apparent beyond 30 hours, for the remainder. It was hypothesised that this may 
be due to depletion of Cm, resulting in decreased mediator activity. An alternative 
hypothesis that this observation could be attributed to depletion of lactate within the 
media was also put forward. 
In order to test these hypotheses, HCs containing pACYC Duet-1 bearing BL21(DE3) were 
setup and run concurrently. After 90 hours, after the current decrease had begun to 
stabilise, one of either Cm, sodium DL-lactate, or sterile dH2O was added to HCs, with 
three replicates of each. Cm and lactate were added to equal concentrations to those 
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initially inserted into HCs during setup, while a comparable volume of sterile dH2O was 
used. 
As seen in Figure 4.13. the addition of lactate produces a minor increase of around 4 µA, 
but this represents only about 1/9th of the difference between the previous current 
value and the peak current. No change is observed for the water control. However, Cm 
addition produces an increase of 54 µA to current levels around 17 µA above those of 
the previous peak. The shape of this peak, and the subsequent downward trend, is 
similar to that of the initial peak observed in the same run. 
The sharp peak followed by gentle downward trend in current suggests that it is not a 
breakdown product of Cm, or some interaction product thereof that is acting as a 
mediator, unless Cm degradation is unusually accelerated by the HC conditions. This 
conclusion is further supported by the peak currents occurring at similar times in Figure 
4.11. as, assuming degradation rate was unaffected by Cm concentration, if the 
breakdown products were acting as mediators, then we would expect all conditions to 
behave the same, diverging one at a time as each reached maximal current. 
Figure 4.13. – Investigation of Chloramphenicol Depletion 
 
Chronoamperometry data for HCs containing BL21(DE3) bearing pACYC Duet-1. At t=90 
h Cm (blue), sodium lactate (red), or sterile dH2O (green) were added to the HCs. The 
data shows a rapidly rising current following Cm addition, in a similar pattern to initially 
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shown for all strains at the start of the experiment. A small increase is noted for lactate 
addition, but this does not affect the overall trend. The control continues without change. 
These data support the argument for Cm or aCm acting as mediator, rather than a 
breakdown product, and gradually being deplete or degraded rather than the decline 
being due to carbon source depletion. The data for each line represents the average of 
three replicates with error bars highlighting the standard error of the mean. 
The specific degradation rates of Cm and aCm under the conditions within our HCs, if 
elucidated, could provide further insights into the nature of the mediator involved in the 
Cm effect. We contemplated three possible mechanisms for mediator activity 
summarised in Figure 4.14. below. While we accept that intermediate interactions with 
host processes between the CAT reaction and mediator driven WE reduction may be 
possible, in the interest of brevity the reiteration of this will be excluded from the 
descriptions that follow. 
Mechanism A in Figure 4.14. proposes aCm reduces the WE, producing Cm, which can 
then be acetylated once more, regenerating the mediator. In mechanism B aCm reduces 
the WE then is regenerated by acting as an electron acceptor to the cell. In both of these, 
gradual degradation reduces the availability of the mediator, decreasing the current. 
Mechanism C proposes that aCm acts as a mediator, but is degraded in the process. We 
would expect this to result in a faster drop in current, however. 
Looking at the chemical composition of chloramphenicol, as depicted in Figure 4.15., we 
can speculate further as to the specific mechanism. In order to operate as an effective 
mediator Cm would have to be able to oxidise cellular metabolites, be that quinone pool, 
cytoplasmic metabolites, or outer membrane cytochromes. It would therefore need to 
have a functional group that was strongly electron accepting, though we might accept 
an interaction with strongly reducing outer membrane cytochromes could permit a less 
strongly accepting functional group to fill this role. Coupled to this would be an ability 
for the resultant reduced group to be oxidised by the anode. 
The chloramphenicol acetyl transferase acts on hydroxyl groups within Cm, starting with 
that identified in the figure. However, these acetyl groups do not fit the biochemical 
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profile outlined in the previous paragraph. Instead we propose that the nitro group 
highlighted in red is the most likely for the outlined electrochemical activity; nitro groups 
are strongly electron accepting146. The product of this nitro group reduction by the cell 
is likely an amine group (R-NH2) but may be an intermediate, either of which would then 
interact with the electrode to be oxidised back or to a different form. While acetylation 
does not play a direct role in this proposed mechanism, it may have an unforeseen 
negative or positive impact on the rate of the reactions, leading to preference of one 
form or another, but this would require further investigation. 
Figure 4.14. Abstracted Chloramphenicol Mediator Mechanisms 
 
Suggested mechanism abstractions for the chloramphenicol mediated shuttling of 
electrons between cells and electrode are depicted. These portray a cyclic process of 
acetylation and deacetylation by the cell and WE respectively (A); a cyclic process 
whereby another active group of the acetylated Cm is reduced and oxidised by the 
bacterial cell and WE respectively (B); and a linear process whereby acetylated Cm is 
oxidised by the WE in a process that breaks it down or otherwise prevents its 
regeneration. Ultimately the mechanism most recommended by this study lies closest to 
(B), though the acetylation is not considered important to the process. 
A. B. 
C. 
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Figure 4.15. Chloramphenicol Skeletal Structure and Proposed Mediator Mechanism 
 
The skeletal formula for chloramphenicol is depicted, created using ChemDraw. 
Highlighted in blue is the hydroxyl group acetylated first during the CAT reaction, though 
it is possible for Cm to be multi-acetylated. Outlined in red is the nitro functional group 
we propose as responsible for the electron shuttling behaviour observed within our single 
chamber electrochemical testing apparatus. 
High concentrations of Cm might have a desirable benefit for electroactivity, but the 
antibiotic effect and degradation rate under testing conditions raises concerns. Figure 
4.15. identifies the hydroxyl group acetylated first by CAT, but this reaction requires 
acetyl-CoA. And maintaining high concentrations of Cm will deplete this energetic 
resource to some extent, which may have a wider metabolic impact. In order to 
maximise metabolic benefit of Cm or a derivative removing the antibiotic activity and 
increasing stability would be ideal. This could be achieved through the testing of 
available or synthesisable non-antibiotic derivatives, such as those presented by Corbett 
and Chipko147. Modification of different active groups as part of this would also allow 
for confirmation of those relevant to the mediator phenotype. Testing would follow two 
stages, first with synthesised or purchased derivatives tested for antibiotic activity at 
different concentrations or degradation rate if either has not been previously 
documented. Then with selected candidates tested at a range of concentrations within 
HCs as previously done for Cm. 
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4.5. Conclusions 
In this chapter our single chamber half cell setup for bioelectrochemical testing was 
presented, with comparisons made to the literature to validate its efficacy for S. 
oneidensis strains. Following this validation, we attempted to differentiate engineered 
and control strains of E. coli expressing components of a recombinant, heterologous EET 
pathway, previously presented by Jaffe26. In doing so we highlighted the sensitivity of 
electroactive E. coli to methodological changes in BESs. While ultimately successful in 
replicating increased electroactivity in the engineered strain, in doing so the observation 
of a mediator-like current increase was observed for strains using Cm as a selection 
marker.  
This ‘Cm effect’ was investigated further, and shown to occur independently of CmR 
plasmid choice, and being necessary for the resolution between engineered and control 
strains of E. coli expressing the mtrCABomcA pathway. The effect was not restricted to 
E. coli, occurring in S. oneidensis MR-1 bearing the pBBR1MCS plasmid, and was shown 
to be unaffected by plasmid copy number in the former, at the concentrations used.  
The effect was not observed in CAT expressing strains in the absence of Cm, nor at sub-
inhibitory concentrations for BL21(DE3). Furthermore, it was shown that current 
maxima increased with Cm concentration in a linear fashion. Though plotting this 
indicated that the sub-inhibitory concentrations of Cm for BL21(DE3) may have been 
insufficient to provide a discernible impact. However, it was observed that for CmR 
strains at working concentrations of Cm and above, after peak current was reached the 
current would begin to gradually decline. It was concluded that this was due to Cm 
degradation or depletion, and not lactate depletion, with lactate addition having a 
minimal effect on current. Ultimately, we propose a biochemical mechanism for the 
mediator-like EET. 
Together, this work illuminated a previously unknown bioelectrochemical interaction 
that may be of great relevance to the field, particularly given the prevalent use of pEC86 
for cytochrome maturation. Furthermore, given previous use of expensive and toxic 
mediators for E. coli strains within BES, were the mechanisms of this Cm effect mediator 
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activity fully understood, it might be harnessed in place of these in a range of 
applications. Experimental plans for exploring this were discussed. 
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Chapter 5 – Azo Dye Reduction 
Screening of a Genomic Library of S. 
oneidensis MR-1 in E. coli  
5.1. Introduction  
Given the limited research of heterologous expression of electroactive pathways and 
factors in E. coli, as discussed in Chapter 2, much potential appeared to remain within 
the S. oneidensis MR-1 genome. Discovery of such factors might even be made easier 
within E. coli due to redundancy in electroactive systems within dissimilatory metal 
reducing bacteria (DMRB) concealing their involvement through compensatory 
expression of others134. Consequently it was believed that a genomic library of S. 
oneidensis MR-1 within E. coli might lead to the discovery of novel electroactive factors.  
In selecting a method for library creation, the potential issues surrounding the 
throughput of conventional bioelectrochemical analysis methods were considered. 
However, it was determined that a sacrifice in coverage would provide no benefit to the 
practical screening of the resultant library. The use of larger genomic fragments might 
also promote the identification of multigene factors that might otherwise go 
overlooked. In addition to strong promotors placed at the ends of any library fragments, 
the possibility existed for the recognition of heterologous promoters by the host 
transcriptional machinery, as previously discussed. Thus, the use of a Fosmid-based 
system was proposed; the CopyControl system by Epicentre was selected. 
Fosmids are (usually) single copy number cloning vectors derived from the F’ plasmid, 
and are capable of holding large inserts (up to ~40 kbp)148. They have previously been 
used to build genomic libraries, where large fragment sizes might have been 
advantageous149,150. Due to the large insert size, appropriate coverage can be achieved 
with a lower number of clones. Additionally, with the added potential for host 
interaction with heterologous promoters, and the clustered nature of the genes of 
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existing heterologous electroactive pathways in E. coli, it was felt that the possibility of 
identifying operons which contribute to electroactivity was improved 133. 
Due to the challenges relating to throughput for bioelectrochemical systems (BESs), and 
practical considerations with iron reduction assaying28,128 as discussed in Chapter 2, the 
ability to conduct a larger screen, such as would be required for a genomic library, was 
restricted. The use of mediators, such as riboflavin, to improve this process was 
considered, by initial experiments showed no sensitivity of E. coli to such (unsurprising 
given S. oneidensis MR-1’s reliance on its outer membrane cytochromes to use it within 
BESs79). And we were not prepared to resort to toxic mediators. Given the 
bioremediation application of extracellular electron transfer (EET) to azo dye reduction 
(and so degradation) 3,151–153, it was conceived that this might be adapted into a higher 
throughput, colourimetric screen that would be adaptable to a 96-well plate. 
One of the primary structural features of azo dyes is a strong, double bond between two 
nitrogen atoms linking their other groups154. It is this bond that makes them stable, 
unlike other dye types that more readily degrade autonomously. A few bacteria have 
been found to have azoreductases that can catalyse the reduction of this bond, where 
after further degradation can be more easily achieved155,156. However, it has been 
demonstrated that the reductive ability of DMRB EET pathway proteins can catalyse this 
degradation also154. Consequently, this makes such degradation a potential indicator of 
electroactivity. Figure 5.1. illustrates the key bond and the electroactivity mediated 
reduction of it. 
This chapter presents the creation of genomic libraries of S. oneidensis MR-1 in E. coli 
strains including BL21(DE3) and C41(DE3) with the aim of screening these to identify 
novel candidate genes for increasing electroactivity. The development of a high 
throughput dye reduction assay for this purpose is subsequently presented, alongside 
the results of the screening. 
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Figure 5.1. Azo Dye Structure and Degradation 
 
The key double bond that is present in azo dyes is illustrated, followed by the effect of 
electroactivity mediated reduction on it. This diagram created using ChemDraw. 
5.2. Results and Discussion 
 
5.2.1. Fosmid Library Creation 
The “CopyControl™ HTP Fosmid Library Production Kit with pCC2FOS™ Vector” 
manufactured by Epicentre is designed to create a genomic library of ~40 kb fragments 
using a modified F’ plasmid that can be induced to high copy number. The 
methodological workflow is diagrammatised in Figure 5.2., and briefly comprises: the 
extraction of genomic DNA from S. oneidensis MR-1 in our case, shearing and end repair 
of that DNA as necessary, size selection for fragments within the requisite size range, 
ligation of those fragments into the fosmid vector, followed by packaging the various 
clones into phage particles, analysis of the titre, then plating out the required number 
of clones for subsequent harvesting and storage. 
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Figure 5.2. – Fosmid Library Creation Workflow 
 
Comprising: genomic DNA extraction (A), shearing and end repair (B), size selection (C), 
ligation into Fosmid (D), packaging and testing titre (E), transforming and plating out (F), 
and harvesting and storage (G). The workflow for creating a genetic library using the 
CopyControl system is demonstrated. 
A S. oneidensis MR-1 genomic DNA prep was initially required and carried out using the 
DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer’s instructions. The 
concentration was checked by running a 1 µl aliquot on a 1% agarose gel, and found to 
be ~30 ng/µl, which was suitable for the proceeding step. The shearing of the genomic 
DNA was analysed by running a 4 µl aliquot on a 1% agarose gel at a low voltage (30 V) 
overnight, the result of which can be seen in Fig 5.2. below. This level of shearing, a 
product of the genomic extraction process, was sufficient for the purposes of Fosmid 
library production. 
The next stage of the protocol required an end repair reaction followed by size selection 
of fragments around 40 kb in size. The manufacturer’s recommended method suggested 
use of a pulsed field gel electrophoresis machine, useful for effectively separating high 
molecular weight DNA, however one was not available. Furthermore, the alternative 
method they presented, involving the use of low melting point (LMP) agarose and a low 
voltage over a long period of time, was found to require modification after initial 
attempts; it was found that the gel was partially melted during the course of the 
separation, and the recommended time was too short to effectively separate fragments 
of the required size. 
  
                 A              B              C            D                  E F                                              G  
73 | P a g e  
 
Figure 5.3. – Shearing of Genomic DNA 
 
The genomic DNA shearing was tested as part of the CopyControl Fosmid Library creation 
workflow previously outlined. GeneRuler HR was used in addition to the Fosmid control 
DNA, and while the gel did not run evenly and the genomic DNA does show a lot of 
smearing, the pattern indicates a good concentration of fragments at the desired size - 
around 40 kb in size. 
A LMP agarose gel was run in a 4 oC temperature controlled room, at 30 V, for three 
days. After this time the sides of the gel were cut off and stained with ethidium bromide 
according to the manufacturer’s instructions, visualised, and markings made to indicate 
the region corresponding to the size of genomic fragments desired. The whole gel is not 
stained as ethidium bromide, an intercalating agent, would bind the genomic fragment 
DNA and likely disrupt subsequent steps according to the manufacturer’s instructions. 
The gel band was subsequently excised and stored at -20 oC overnight prior to DNA 
extraction, ligation into the pCC2FOS vector, and packaging reaction.  
The pCC2FOS vector contains a T7 promoter and a lac promoter flanking the fragment 
insert site. Given the absence of reference to induction of expression in the available 
documentation, contact with the manufacturers of the CopyControl Fosmid Library 
creation kit was sought. After speaking with the manufacturers, it became apparent that 
the Fosmid library, in the EPI300 T1R E. coli host strain provided, was unsuitable for 
Ladder                          Genomic DNA                Control DNA 
GeneRuler HR 
 
Kbp 
 
48 
24 
20 
17 
15 
14 
12 
10 
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expression of any inserted fragments. The strain did not contain the DE3 lysogen (T7 
RNA polymerase controlled by a lacUV5 promoter), meaning transcription using the T7 
promoter could not be induced. Given that we were interested in proteins expressed by 
heterologous promoters within the large fragments an argument that this did not 
matter was made. However, the T7 RNA polymerase can transcribe very long mRNA, 
which we felt would increase our coverage of fragment ends. If multiple library screen 
hits overlapped in their T7 adjacent regions it would also help us to narrow down the 
causative factor. 
The two expression strains BL21(DE3) and C41(DE3) were selected as hosts for the 
library, consequently. The former due to its use in studying the top down engineered 
strains discussed in Chapters 4 and 6, and the latter due to the likelihood that novel 
electroactive factors that might be identified would be membrane proteins. Strain 
C41(DE3) was derived from BL21(DE3) and contains several mutations, including a 
reduction of the activity of its lacUV5 promoter, which causes it to be resistant to the 
toxic effects of the overexpression of certain membrane proteins 104,140.  Unlike the 
EPI300 T1R strain, however, these strains do not possess the machinery allowing for the 
induction of increased fosmid copy number. This would have an impact on fosmid 
extraction concentrations. It was decided that the benefits of the more commonly 
accepted and available expression strains outweighed those of the considered 
alternative (production and use of an EPI300 T1R(DE3) strain). 
The phage titre was then analysed, and it was calculated that 22 LB agar + 
Chloramphenicol (Cm) plates of E. coli transfected with undiluted phage would be 
required to provide the 600+ clones needed to ensure the desired level of coverage (99% 
probability that a given sequence is represented). This turned out to be an overestimate, 
as the phage titre was significantly higher with these plates. The library was stored using 
the manufacturer’s recommended option, as a glycerol stock containing a mixture of all 
clones at -80oC.  
As with the alternative fragment separation protocol, the manufacturer’s instructions 
for harvesting plates of cells were impractical, as they required a small volume of LB to 
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be transferred between each plate; in practice too much volume was lost when 
transferring the solution between plates. Consequently a sterile loop was used to collect 
cells from the plates and suspend them in LB within a 50 ml Falcon tube, before dilution 
with glycerol, aliquoting into 5 eppendorf tubes, and storage at -80oC. The two host 
organisms were collected and stored separately. 
5.2.4. Development of a Colourimetric Screen for Electroactivity 
As previously discussed, DMRB have been used in the literature to reduce azo dyes, 
degrading and thus decolourising them 3,151–154,157. We hypothesised that this could be 
harnessed to construct a high throughput screen capable of rapidly screening our 
genomic library for novel electroactive factors. As with the HC methodology and 
equipment presented in Chapter 4, following our initial protocol designs engineered and 
control strains of E. coli were used to test them. 
While an agar plate based screen was initially considered it was believed a 96-well plate 
based assay would be more practical for higher throughput, and provide quantitative 
data, if feasible. Colourimetric experiments involving use of Reactive Black 5 (RB5), an 
azo dye, as electron acceptor by Shewanella spp. are documented in the literature 154,158, 
but in order to provide additional screening options for the Fosmid Library (and 
potentially constructed strains in the future) two others were identified for testing. 
Reactive Red 120 (RR120) and Basic Green 5 (BG5) have both been used to study 
bioremediation of waste water from the textile industry where they are used, and were 
readily available, with documented absorbance peaks and assay concentrations 159,160. 
These concentrations were used in initial tests for both categories of assay. 
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5.2.4.1. 96-Well Plate Based Colourimetric Assay Method Refinement 
As described in Chapter 3, overnight cultures of test strains were used to inoculate LB 
broth containing one of the three dyes being tested, which were then added to the wells 
of the 96-well plate. Following an initial absorbance reading at the appropriate relative 
absorbance peak, plates were incubated at 25oC, aerobically and anaerobically, for 48 
hours before final readings were taken. Concentrations observed in the literature were 
used for each of the three dyes 159,160. 
Initially, in addition to uninoculated control wells, wells containing LB broth inoculated 
with test strains but with no dye were used, as illustrated by Figure 5.4. for RR120. 
However, an issue with the concentration depicted became immediately apparent when 
the “zero” reading was taken for this plate; the absorbance of the RR120 at 500 mg L-1 
was too high for the plate reader to measure. Consequently a series of dilutions were 
conducted to find a more suitable concentration. From the results it was gathered that 
a 50 mg L-1 final concentration would be ideal, as this was the highest concentration that 
returned a non-“overflow” result for every well. 
Figure 5.4. – Initial Reactive Red 120 Plates  
 
Aerobically (left) and anaerobically (right) incubated 96 well plates assaying the 
degradation of reactive red 120. Initial protocol used Shewanella baltica (another 
Shewanella species comparable to S. oneidensis MR-1), and E. coli strains bearing either 
pACYC Duet-1 + pRGK333 or pACYC mtrCABO + pRGK333. Decolourisation was clear for 
Shewanella baltica wells, but initial concentration of RR120 was too high for TECAN to 
read. 
           Empty    S. baltica  S. baltica      pACYC        CABO     Empty            Empty    S. baltica  S. baltica      pACYC        CABO     Empty 
77 | P a g e  
 
After incubation of the initial series of plates, absorbance readings were recorded and 
analysed. It was found that, while dye degradation could clearly be observed in the S. 
baltica containing wells for RR120 and RB5, the absorbance from cells present in the 
culture appeared to prevent any quantitative difference from being apparent. Attempts 
were made to compensate for bacterial growth in dye containing wells using absorbance 
readings from LB only wells but even after this, no significant difference was observable.  
In order to eliminate the absorbance of the bacterial cells and get a clearer result of the 
dyes’ degradation, the protocol was modified to include a plate centrifugation step 
proceeding growth. Following centrifugation, it was observed that the cell pellet was 
spread across the bottom of a number of wells, which would likely continue to affect 
absorbance readings, so the protocol was further revised to require transfer of 
supernatant to a sterile 96 well plate following centrifugation. This was carried out and 
the results analysed for absorbance differences correlating to degradation of dye. The 
only significant difference observable was for RR120.  
It is worth noting that as a consequence of transferring the supernatant to a new plate 
bubbles were formed in many of the wells, which affected the readings in a number of 
them. Care was subsequently taken to avoid their formation. It was also noted at this 
stage that there may be a degree of error in the results accordable to uneven 
evaporation in the wells of the 96 well plates though this should be minimal given the 
temperature controlled conditions incubation is carried out under. Nevertheless, plates 
were subsequently sealed with parafilm and wrapped in damp tissue prior to incubation, 
in order to minimise evaporation. 
To confirm the absorbance peak measurements were being taken at appropriate 
wavelengths, and so not responsible for the lack of quantitative difference, wavescans 
of each of the dyes were carried out using a spectrophotometer at the starting 
concentrations used on the last plates, as shown in Figure 5.5. below. RR120 produced 
a high, wide peak around 530 nm, as expected. Both RB5 and BG5 produced wide peaks 
at 595 and 660 nm respectively, each conforming to expectation also. However, the 
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peaks for RB5 were comparatively short, suggesting the need and scope to increase the 
concentration used. 
Given this and the prior need for optimisation of RR120 concentration, it was believed 
that this process would be necessary for both RB5 and BG5. However, due to the 
relatively high concentration of BG5 being used, and concerns over the difficulty of 
producing a more concentrated stock solution, it was decided to discontinue 
development of 96 well plate screens employing it. RB5 concentration was subsequently 
optimised through testing of a range of dilutions; a 1 in 100 dilution of the 1% w/v stock, 
tenfold more concentrated than the previous working concentration, was found to be 
most suitable from those tested. 
  
79 | P a g e  
 
Figure 5.5. – Wavescans of Assay Dyes 
 
 
 
Wavescans of each of three azo dyes initially trialled for high-throughput degradation 
screening for electroactivity: reactive black 5 (A), reactive red 120 (B), and basic green 5 
(C). Data points from the spectrophotometer were transcribed and graphs reproduced in 
GraphPad Prism. Reactive black 5 shows a clear need for a higher working concentration. 
A. 
B. 
C. 
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5.2.4.2. Comparison of E. coli Strains with Colourimetric Screen 
In order to validate the screening protocol, strains previously used in HC experiments 
were tested. Initially this involved BL21(DE3) strains bearing pACYC Duet-1 or an 
mtr/omcA encoding equivalent, alongside the pRGK333 inducible ccm gene plasmid. 
Subsequent to the switch to pEC86 for ccm gene expression in HC experiments 
equivalent strains were also analysed. 
Figure 5.6. – Normalised RB5 Reduction by E. coli Strains 
 
The host for all strains was BL21(DE3) with the relevant genes indicated being borne on 
the pACYC Duet-1 expression plasmid. The pRGK333 ccm gene plasmid was also present 
in all strains save for the BL21(DE3) only strain. The control listed above contained an 
empty pACYC Duet-1 plasmid. Displayed is the consolidated average data from three 
experiments each containing at least 7 replicates for each strain, with error bars 
representing the standard deviation. The mtrCAB strain significantly outperforms the 
others, including the control (unpaired t-test, p<0.05). 
Figure 5.6. displays the data from the initial tests for RB5, which show an increased 
reduction in the mtrCAB strain over the plasmid free and control plasmid strains, as well 
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as omcA containing strains. This observation was made consistently, however the 
margin of difference is minimal making differences more prone to obfuscation through 
error, suggesting that the assay does not provide the same resolution of electroactivity 
as others. Additionally, while the engineered pACYC mtrCAB or mtrCABO +pRGK333 
strains did not outperform their controls in the HC experiments discussed in Chapter 4, 
it was not unreasonable to expect variation in their ability to reduce soluble or insoluble 
electron acceptors under different conditions. Nevertheless, further strains were 
subsequently tested. Not included is the data for S. oneidensis MR-1 for reasons of 
clarity, as complete dye reduction was visually observed within the first hour proceeding 
inoculation. 
In addition to the pRSF strains, the MFe444 (engineered) and MFe408 (control) strains 
published in Jensen et al. 28 were tested to provide a further comparison. In order to 
further validate the length of time required, three identical 96-well plates were set up 
using the same inoculating 96-well plate. These plates were incubated together 
anaerobically for one, two, and three days respectively. The resultant data are 
represented in Figure 5.7.A, 5.7.B, and 5.7.C for the respective plates. 
While the overall trends do not appear to change across the varying incubation times, it 
is clear that the longest incubation results in the lowest error observed. This supports 
the decision to use a longer incubation time in the general protocol. Strain comparison 
highlights an unexpected difference between the engineered and control BL21(DE3) 
based strains and the comparable MFe strains in C43(DE3), with no clear distinction 
between the normalised RB5 reduction for the former, but a very clear one for the latter 
in the expected direction; the engineered strain reduced more dye per OD600 unit than 
the control.  
The improved differentiation of the MFe strains may have been aided by their host 
strain. As can be seen for the non-plasmid bearing BL21(DE3) and C43(DE3) strains, the 
latter displays a higher level of normalised dye reduction. This may be due to variations 
in the cell membrane contributing either to improved uptake of the dye, or facilitating 
non-specific reduction, or in this instance a greater growth rate for BL21(DE3) under 
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these conditions skewing the result. Though, as will be later discussed in Chapter 6, we 
cannot conclusively assign this difference to strain choice or concomitant metabolic 
variation without additional cymA and mtrCAB constructs being produced, it is not 
necessary to do so to indicate that the dye assay is capable of highlighting some 
electroactive factors. While it may overlook some and be susceptible to error, any novel 
factors identified would be interesting, and its high throughput provides a significant 
advantage over other available methods. 
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Figure 5.6. – RB5 Reduction at Variable 
Time Points 
 
 
  
R
B5 reduction of various E. coli strains, after 
one (A), two (B), and three (C
) days incubation. 
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longest incubated plate data. 
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Figure 5.7. – RB5 Reduction at Variable Tim
e Points 
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5.2.3. Library Screening with Dye Reduction Assay 
Libraries were screened using the 96-well plate based assay previously discussed. 
Briefly, a dye-free starter 96-well plate was inoculated with individual colonies from an 
agar plate cultured from the library glycerol stocks. The last column of each plate was 
used for four replicates each of cell free and BL21(DE3) controls, which would remain 
dye free in the dye assay. These starter plates were incubated aerobically at 37 oC 
overnight with 150 rpm shaking, before being used to inoculate the dye plates. 
Subsequently the wells were diluted in a 1:1 ratio with 50% glycerol and stored at -80 oC 
to facilitate access to specific clones identified during the screening process. 
Following data collection, the dye reduction was calculated through the difference 
between the initial and final readings (post-centrifugation) and normalised to the 
average growth of the BL21(DE3) control wells. This decision was made due to concern 
over the likelihood for increased error when dealing with single replicates, and the 
confidence that the growth of BL21(DE3) could be used as a measure of general growth 
on the plate. While this may not be universally true, this formed the first stage of 
screening, with a second stage planned to address this issue. The results normalised 
(divided by growth – calculated by difference in OD between unspun and spun plates) 
in this fashion for the two dyes were combined and analysed. Approximately 1400 
clones across the two (BL21(DE3) and C41(DE3)) libraries were screened. This data can 
be found in the appendix. 
In the second stage of screening, four biological replicates of each clone were inoculated 
into designated columns of a 96-well plate. The cell free and BL21(DE3) controls were 
present as before. These starter plates were then used to inoculate RB5 dye plates, 
which were processed in the same fashion as with the various engineered and control 
E. coli strains tested in the previous section, being normalised to their own optical 
densities at the 595 nm measured. Approximately 60 of the best performing (most dye 
reduction observed) clones were tested in this fashion. 
From the second stage of testing 8 clones were identified as being superior to the other 
strains tested and were taken forward for sequencing. As previously discussed the use 
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of a “Qiagen spin miniprep kit” for the extraction of the fosmid yielded very low 
concentration DNA, understandable given the fosmids’ sizes and single copy number. 
This hindered attempts to sequence the clones, however it was found that the use of 
midiprep volumes with the non-spin miniprep kits by qiagen resulted in improved yields. 
The locations of the ends of four of these clones on the S. oneidensis MR-1 genome are 
displayed in Figure 5.8. below. 
Figure 5.8. – Screen Hit Fragment Ends on Genome Map 
 
Four clones, two of each host strain as denoted by B (BL21(DE3)) or C (C41(DE3)) are 
represented on a S. oneidensis MR-1 genome map produced in SnapGene. The number 
assignment here is arbitrary. The end of each primer relative to insertion in the fosmid is 
denoted by T7 (for the T7 promoter adjacent end) and R (for the reverse end). One clone’s 
end falls in a repeating region (C2 R), while another (B2) is clearly multiple concatenated 
fragments given the separation of the sequenced ends. Two clones (C1 and B1) overlap 
at their T7 ends – the region between B1 T7 and C1 T7. 
Several things can be drawn from this figure. Perhaps most obvious is the vastly distant 
end points identified for the B2 clone. As it can be safely ruled out that the clone 
contained a third of the S. oneidensis MR-1 genome, it is clear that some ligation of 
multiple <40 kb fragments prior to insertion into a fosmid occurred during the ligation 
step of the library creation protocol. We do not believe this presents a problem for our 
purposes, as overall coverage is unaffected. However, it does introduce additional 
challenges for the complete characterisation of such clones, as additional, tailored 
primers and a systematic approach would be required to identify the limits of each of 
the sub-fragments within the greater insert. 
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Secondly, as noted for the C2 clone, the sequence for one end (R) is compatible with 
multiple locations. This is simply due to the recurrence of this particular sequence 
multiple times within the bpfA gene, which encodes a 285.1 kDa protein involved in 
biofilm promotion. 
Thirdly, and most interestingly, the fragments of the B1 and C1 clones overlap at their 
T7 ends. This overlapping region is just over 11 kbp in length, and detailed in Figure 5.9. 
below. We felt that for two different clones to have such an overlapping region made it 
worthy of further investigation; it suggested strongly that the determining factor for the 
increased dye reduction lay in the overlap. That the overlapping region occurred at the 
T7 ends of each of these fosmids further supported this conclusion, as genes within it 
were more likely to be expressed. Furthermore, the identification of this overlap 
occurred across the two base strains, indicating that the phenotypic activity of whatever 
causative element lay within it was strain independent. 
Figure 5.9. – Fosmid Screen Hit Overlapping Region 
 
The overlapping region of two “hit” fosmids - comprises (in order from left to right) a 
heavy metal efflux pump permease component, a monooxygenase protein, a large 
conductance mechanosensitive ion channel protein, a LysR family transcriptional 
regulator, two multidrug efflux pump permease components, a GNAT family 
acetyltransferase, an antibiotic biosynthesis monooxygenase family protein, a radical 
SAM protein, a transcriptional activator of tryptophan biosynthesis, and a truncated 
RhtB family amino acid efflux protein. Only rmrAB appear part of the same regulatory 
element. This map was created using SnapGene. 
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5.2.4. Cloning of Overlap Region 
Further investigation of this overlap region became the subsequent focus of work on the 
fosmid library. The reduced size relative to the expected fragment size (~11 kbp from 
~40 kbp) helped to narrow down the causative loci significantly. It was initially planned 
to sub-clone the two halves separately into pRSF Duet-1 and pRSF mtrCABomcA for 
further bioelectrochemical testing. The primers would divide the overlap between the 
SO_0523 and rmrA genes, such that rmrA and rmrB remained on the same fragment. It 
was thought that this approach would help to narrow down the causative factor (be that 
a single or multiple genes) further. 
Attempts to sub-clone the two halves were persistently unsuccessful, and so a 
secondary approach of individually cloning each gene was pursued. Primers flanking 
each individual gene (including non-coding regions before each, to include potential 
regulatory elements) with compatible restriction sites to permit cloning of each 
individual gene or any number of continuous genes within the overlap (with the 
intention of also cloning rmrA and rmrB together) were designed for insertion into the 
second multiple cloning site (MCS) of the pRSF Duet-1. All primers were designed with a 
Tm between 54 and 58 oC to maximise cross compatibility. 
PCR reactions were set up with the various primer pairs, with duplicate reactions of each 
set up so that both S. oneidensis MR-1 genomic DNA and fosmid DNA (C1 fosmid 
previously described) were separately used as template. Figure 5.10. shows the two gels 
on which the PCR products of expected size were observed for the individual genes, 
though further attempts to PCR the two halves of the overlap region remained 
unsuccessful.  
Though SO_0521 was not successfully replicated using the S. oneidensis MR-1 genomic 
DNA template (Figure 5.10.A and 5.10.C) it was successful with the fosmid template 
(Figure 5.10.B and 5.10.D). The reverse was true for the rmrB construct. For all other 
primer pairs it was possible to produce bands at the relative expected sizes. All of these 
bands were then subsequently gel extracted, and digested with AatII and FseI (New 
England Biolabs, UK) in CutSmart buffer at 37 oC for an hour, in addition to pRSF Duet-1 
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plasmid. The latter was subsequently treated with calf intestinal phosphatase (CIP) to 
prevent recircularisation. Following digestion, all samples were purified by agarose gel 
electrophoresis and gel extraction (Quiagen kit).  
Figure 5.10. Agarose Gel Images of Overlap Gene PCR Products 
  
 
Images of PCR products of each of the reactions for cloning genes identified from the 
fosmid overlap sequence, using S. oneidensis MR-1 genomic DNA (A and C) and C1 
fosmid DNA as template (B and D). Ladder (Hyperladder 1kb, Bioline, UK) used is labelled 
(E) for reference. Images are grouped by target genes. Expected fragment sizes in base 
pairs were as follows: 3028, 423, 574, 1000, 1129, 1655, 532 (A and B), 386, 944, 946, 
520, and 2756 (C and D). 
A 1:1 ratio of vector to insert for the ligation reactions ultimately produced colonies for 
all constructs, excepting SO_0530, following heat shock of DH5α chemically competent 
cells and plating onto LB agar plates containing kanamycin. Construction of pRSF 
SO_0530 was not pursued further; the truncated nature of the protein coded within the 
overlap fragment made it unlikely to be the contributing factor. Selected colonies were 
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grown up in overnight LB cultures and the plasmid DNA extracted using a miniprep kit 
(Quiagen). A nanodrop was used to quantify plasmid concentrations before samples 
were sent for verification by sequencing. 
All individual gene constructs pursued, as well as the rmrAB construct, were successfully 
verified by sequencing, although several were inserted into the vector in the opposite 
orientation to that planned. This orientation was not initially expected to affect 
expression, however later caused concern over the confidence that could be expressed 
in derived data without validation of expression. 
5.2.5. Overlap Gene Construct Comparison  
In order to identify which of the genes from the overlap were responsible for the 
increased dye reduction phenotype, further 96-well plate dye reduction assays were 
planned. While it still remained possible that a combination of genes from the 
overlapping region of two of the ‘hit’ fosmids were accountable, excluding rmrAB which 
were to be tested, it was thought that a single gene would be more likely. 
The RB5 dye reduction assay was used to investigate the overlap gene constructs. The 
protocol remained mostly as previously described. However, due to the loss of access to 
an anaerobic cabinet as used prior, the use of a sealable anaerobic jar was required. 
Once initial readings were taken and the plates sealed within the vessel, the jar was 
placed in a static incubator at 30 oC for the duration of its incubation. 
The dye degradation after three days, normalised to growth, is presented in Figure 
5.11.A and 5.11.B, with two replicate plates represented separately (A and B). While 
differences are marginal, it can be noted that the normalised degradation was 
consistently higher for three of the constructs across the two plates, than the others: 
constructs bearing SO_0520, SO_0527, and rmrAB. The significance of these differences 
was verified by unpaired T-tests (p<0.1). However, growth within these plates was poor, 
and while wells with a final bacterial OD595 less than 0.1 were excluded from the 
normalised degradation data presented, the poor growth casts further doubt on the 
strength of conclusions that can be drawn from this data; the statistical analysis can be 
misleading. 
90 | P a g e  
 
Figure 5.11. – Dye Reduction Assay of Overlap Constructs 
The reduction of RB5, normalised to growth, by various single and multigene constructs 
derived from the overlapping region of hit fosmids is presented for two replicate plates 
(A and B). The respective calculated OD595 corresponding to growth are presented 
alongside (C and D). Normalised degradation data excludes wells with a bacterial OD595 
less than 0.1. Confidently differentiating clones is difficult. 
Figure 5.11.C and 5.11.D show the calculated bacterial OD595 for A and B respectively. 
They clearly present an extremely low (mean of ~0.12) OD for two of the three potential 
strains of interest (SO_0520 and rmrAB construct strains), significantly lower than the 
majority of the rest of the strains. This may have contributed to the higher normalised 
degradation observed; that the higher relative degradation was an artefact resulting 
from the exceptionally low growth of these strains. This conclusion reiterates the 
desirability of longer incubation times for resolving differences between strains, as 
A. 
B. 
C. 
D. 
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discussed in section 5.2.4.2., previously. However, it also emphasises how borderline 
the sensitivity of this technique may be; how much noise is present, and how difficult it 
can be to draw definitive conclusions. 
In comparison, the SO_0527 containing construct did grow comparably to the other 
strains yet was still observed to have a greater normalised degradation than them, 
however this identified “hit” should be taken in the context of the concerns discussed 
previously. 
5.2.5.1. Discussion of Novel Reductive Factor SO_0527 
UniProt Knowledgebase, pooling annotation from the J. Craig Venter Institute and Gene 
Ontology Consortium, describes the protein product of SO_0527 as an antibiotic 
biosynthesis monooxygenase family protein. Monooxygenases incorporate hydroxyl 
groups into metabolites in reactions they catalyse with metal prosthetic groups, so it 
stands to reason that one might be electrochemically active; the enzyme might interact 
to reduce the azo dye bond directly, or else might modify it (or another metabolite) in a 
way that it becomes reactive, leading to the reduction of the bond. However, all 
ontology information is based on inference, either from electronic annotation or 
biological aspect of an ancestor. The “antibiotic biosynthesis” component of the 
descriptor is insufficiently explained to draw any links between this and the 
chloramphenicol resistance pathway mediator activity observed in our HCs as discussed 
in the previous chapter. However it would be something to bear in mind in any future 
work. 
 A Vibrio fischeri ES114 orthologue, VF_0710, was identified through EnsemblBacteria 
but no additional information was gained from this. And, indeed, an NCBI Blast search 
identified orthologues in other Shewanella spp., but again this ultimately did not prove 
enlightening as they were also uncharacterised with no additional auto-annotated 
information of use. 
A general interrogation of the literature was found to be no more illuminating; 
unsurprising given the general quality of curation of the resources mentioned above. An 
attempt was subsequently made to identify SO_0527 detection in available datasets of 
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published “-omics” studies142,150,161–163 in S. oneidensis MR-1. Though no such 
identification was discovered, we do not take this negative to be indicative of anything; 
even were detection of the specific protein guaranteed, the range of foci of the studies, 
as well as the possibility of the bioelectrochemical relevance being specific to E. coli, 
would provide ample reason for it not to appear in processed data. 
Without further validation it is uncertain that SO_0527 did, in fact, have an impact on 
redox activity in E. coli. And even if we were confident in its electroactivity, as with 
soluble and insoluble metal reduction127,128, this would not necessarily mean that 
activity would be reflected in an increase in electrode reduction. A knockout study using 
the original fosmid with each gene in the hit region sequentially knocked out could assist 
with the verification. Unfortunately, further validation of these findings and 
characterisation of this novel factor did not fall under the purview of this study, although 
this is further discussed in Conclusions and Future Work. 
5.3. Conclusions 
In this chapter we demonstrated the production of genomic libraries of S. oneidensis 
MR-1 in multiple E. coli host strains, commenting on potential pitfalls and 
methodological adjustments over the manufacturer’s recommendations. The 
development and refinement of an azo dye reduction assay for the high throughput 
screening of this library for genes contributing to increased electroactivity was also 
presented, though it may be limited by its sensitivity. This assay was subsequently used 
to screen the S. oneidensis MR-1 genomic libraries in E. coli, identifying, among others, 
two clones with an overlapping region. Further investigation provisionally suggested the 
gene SO_0527 as the causative, novel reductive factor. Further validation is required 
before engaging in investigation of the function of this protein. 
 
  
93 | P a g e  
 
Chapter 6 – Quantitative Proteomic 
Analysis of Engineered Electroactive 
Escherichia coli within a 
Bioelectrochemical System 
6.1. Introduction 
The continual, biologically-achieved electron transfer from bacteria to electrode within 
bioelectrochemical systems (BESs) relies on the energetic favourability of the process; it 
grants a metabolic benefit to the bacterial cell through the provision of an end terminal 
electron acceptor 10. Dissimilatory metal reducing bacteria (DMRB) have adapted to be 
able to take advantage of extracellular electron acceptors, as discussed in the 
introductory chapters, utilising a network of sensor/regulators to adjust expression and 
activity of key pathways164. However, with heterologous extracellular electron transfer 
(EET) systems within E. coli it has not been shown that their metabolic processes have 
similar, interactive sensory/regulatory control to do this, nor would we expect 
otherwise165. E. coli is a facultative anaerobe, adapted to make use of a wide range of 
nutrients, within both the intestinal environment that it commonly occupies and 
beyond166. Its responses to anaerobic environments depend on numerous other factors, 
including: quinone pool redox state (ArcAB)166, nutrient availability167, acetate 
concentration168, metal ion availability169, temperature170, and oxidative stress171. This 
complex regulatory web is not so easy to predict in how it will interact with the 
metabolic changes caused by engineered heterologous EET activity. 
Other factors may still influence E. coli metabolic activity, both generally and specifically 
to the interaction with heterologous EET pathways, with consequent impacts on BES 
performance. For example, the maturation of recombinant EET pathway proteins 
following inoculation might be affected by limited availability of haem groups despite 
the additional cytochrome maturation genes, due to other metabolic pathways utilising 
necessary precursors, or an altered gene expression profile leading to more proteins 
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that require them being expressed and so depleting their levels104,172. This is something 
that Goldbeck et al. have investigated for Molecular Foundry strains, testing the levels 
of cytochromes in their strains throughout their experimental process27, but still serves 
to illustrate the validity of such concerns.  
 
The expression, maturation, and localisation of the EET pathway proteins are not the 
only factors that could affect EET. The activity of the heterologous pathway also relies 
on interaction with the host metabolic pathways to provide the electrons to transfer126. 
The exact nature of this interface is not fully understood and may even be greatly 
impacted by simple changes to carbon source or other environmental conditions. 
Indeed, the degree to which carbon source or media selection might impact the 
electroactivity of engineered, non-DMRB strains has not been well explored within the 
literature. In this chapter we set out to address this oversight, initially through 
comparisons within half cells (HCs), then through a global, quantitative proteomics 
approach to provide further insights into the regulation and metabolic activity of 
electroactive E. coli that might inform future strategies. 
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6.2. Results and Discussion  
In order to explore the differences between our methodology and that used by TerAvest 
et al. 126, as well as decisions made as to host strain selection, the MFe444 (engineered 
with mtrCABcymA on an expression plasmid and pEC86 for ccm gene expression) and 
MFe408 (control with empty expression vector and pEC86 plasmids) strains were 
obtained. The host strain for these plasmids was E. coli C43(DE3), a strain usually used 
for overexpression of toxic membrane proteins. 
We initially conducted a HC run, using the protocol previously devised, to allow a direct 
comparison between the strains used previously and these. As the published results for 
the TerAvest et al. strains23,28,126 used different equipment, as well as other 
methodological differences, it was important to establish how different their activity 
was from the strains previously analysed. Thereafter, methodological changes to our 
own experiments could be made to discern the causative factors for any differences 
observed, either between the strains, or between the published results and ours for 
these strains.  
The results are shown in Figure 6.1., where it is clearly observable that the control 
(MFe408) outperforms the engineered (MFe444) strain, in an inversion of the results 
seen for the strains previously tested within our HC setup (highlighted here as pEC86 
and pRSF CABO + pEC86). Though this was reminiscent of the results obtained for 
comparable pRGK333, the inducible ccm plasmid, bearing strains. This could suggest a 
difference in functional expression of the Mtr proteins between the two engineered 
strains under these conditions. As the same ccm plasmid (pEC86) is used for all strains 
shown here, the cause for a possible change in functional expression could be due to 
differences between the expression plasmids used for the EET pathway genes, or the 
expression strain used. Yet given the minimal methodological differences for expressing 
the EET pathway genes in the TerAvest et al. study, and their clear result for a superior 
engineered strain, a metabolic difference seems more likely than drastic expression, 
maturation, or localisation changes. 
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Figure 6.1. – Initial Comparison of Engineered E. coli Strains 
Chronoamperometry of engineered and control strains from different sources, 
and in different base strains, within HCs. C43(DE3) and BL21(DE3) for Blue/Red 
and Purple/Green respectively, the former colour of each pair being the control 
strain. In the M4m media used, unlike the BL21(DE3) strains, the engineered 
strain MFe444 is outperformed by its control; this contradicts expectations based 
on published activity in M1, a very similar media. The data for each line 
represents the average of three replicates with error bars highlighting the 
standard error of the mean. 
With the clear improvement presented by TerAvest et al. 126 for their engineered strain 
using their methodology, this result was surprising. However, it leant evidence to the 
hypothesis that minor differences in media selection may be more important than so far 
presented in the literature; that electroactive E. coli EET was sensitive to minor 
metabolic shifts. Other differences naturally exist between the HC protocol used herein 
and that used for the work where these strains were originally presented, yet equipment 
differences would have been harder to explore, while a change of media and other 
methodology permitted a relatively quick and practical way to test this hypothesis. 
6.2.1. Effects of Pre-Inoculation Growth Conditions on Electroactivity of Recombinant 
Strains 
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To rule out the differences in pre-inoculation growth and induction as responsible for 
the poor performance of the MFe444 engineered strain, the method outlined by 
TerAvest et al. was utilised.  In the protocol used by TerAvest et al. the cultures grown 
for bioelectrochemical testing were grown in 2xYT, a richer media than the LB broth we 
used previously. Furthermore, in order to promote expression of the mtr multi-haem 
cytochromes, aminolevulinic acid, a haem precursor, was supplemented into the pre-HC 
cultures. In order to test the influence that these protocol modifications would have on 
the electroactivity of these strains, cultures were grown using these adjustments and 
tested within HCs. 
The results, presented in Figure 6.2., show no change to the current production of the 
engineered strain with this method change. However, it also shows a drop in current for 
the control relative to the previous results, to levels matching those of the engineered 
strain. This may be an indication that the richer growth media before the minimal, 
anaerobic environment of the HC had an impact on metabolic processes in the control 
leading to a lower utilisation of the chloramphenicol mediated EET; or that it delayed 
the adaptation of the strain to its new environment. While it might be expected that this 
be borne out in lower readings for the engineered strain too, we suggest that the 
increased metabolic burden already depresses the metabolic activity obscuring this 
effect in the strain. The margin of impact may be relatively minimal. 
Regardless, the over performance of this engineered strain relative to its control in a 
similar fashion to that observed in the literature 126 is not reproduced in M4m by the 
alteration of pre-HC growth conditions. Consequently, the investigation into the use of 
alternative minimal media was the next logical step. 
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Figure 6.2. – Effect of Pre-Inoculation Growth Conditions of Current in HCs 
 
Chronoamperometry data for engineered (MFe444) and control (MFe408) 
strains, which varied in their growth conditions prior to inoculation into HCs. Using 
the richer media (indicated by 2xYT Pre-HC – orange and purple lines for 
engineered and control respectively) did not result in an increased performance 
of the engineered strain, though the control strain did perform more poorly. This 
suggests that the pre-inoculation growth conditions do not account for the 
differences in strain performance between our set-up and that published. The 
data for each line represents the average of three replicates with error bars 
highlighting the standard error of the mean. 
6.2.2. Media Selection 
In order to investigate the impact an alternative minimal media had on the 
electroactivity of engineered and control strains of E. coli, those used by TerAvest et al. 
126 were compared in HCs containing M1 against the results for those containing M4m. 
This was followed with a similar comparison for the strains previously used in this work. 
While the full recipes for the media can be found in Chapter 3, the key differences that 
we noted were the addition of vitamin (B1,3,5,6,7,9,12, p-amino benzoic acid, and a-
lipoic acid), and amino acids (glutamic acid, arginine, serine) to M1, and the use of HEPES 
rather than PIPES as buffering agent in M4m. It was thought that the inclusion of these 
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additional vitamins and amino acids might facilitate a higher metabolic utilisation of the 
EET pathway in engineered E. coli strains. 
The results for the MFe408 control and MFe444 engineered strains are shown in Figure 
6.3.A. These data show the engineered strain current increasing rapidly within the first 
10 h, similar to the behaviour observed for the pRSF CABO + pEC86 engineered strain, 
before levelling off and gradually decreasing. The engineered strain clearly outperforms 
its control, but only once this M1 switch is made. It is worth noting that all MFe strains 
presented here were cultured in 2xYT as in the previous section, permitting a direct 
comparison with M4m containing HCs, the data for which are presented in Figure 6.3.A 
also. 
Figure 6.3. – Half Cell Media Comparisons 
 
A. 
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Media comparisons for engineered and control strains of electroactive E. coli 
used by TerAvest et al. (A) and previously in this work (B) in HCs under 
potentiostatic control are presented. The strains in (A) are not distinguishable in 
M4m, however in M1 the control strain clearly outperforms its control, following 
expectations from published results. The strains previously used in this thesis (B), 
show the inverse, however; the engineered strain clearly outperforms the control 
in M4m, but the reverse is true (though to a lesser extent) in M1. This suggests a 
strain dependent susceptibility to small changes in either metabolic activity or 
expression profiles caused by HC media that produces larger changes in EET. 
The data for each line represents the average of three replicates with error bars 
highlighting the standard error of the mean. 
These results indicate a metabolic or biological change has occurred, likely as a 
consequence of an enrichment of the media with amino acids and vitamins, contributing 
to a greater effect of the recombinant EET pathway presence on electroactivity. This is 
unlikely to be accounted for by variations in biomass due to differences in growth 
following inoculation, as both media are still minimal and HCs anaerobic. Biomass is 
typically observed to decrease over the course of a HC run, an observation consistent 
with other BES testing 94,173. Furthermore, clear differences are observed within a matter 
of hours beyond what we would expect possible for minor biomass fluctuations. 
Figure 6.3.B presents the data for HCs containing M1 and the pRSF + pEC86 engineered 
(CABO - mtrCABomcA) and control (Duet-1) strains alongside those for M4m HCs. The 
B. 
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effect the media switch from M4m to M1 has on electroactivity of these strains 
interestingly appears to be the opposite of that seen for the MFe strains; in M1 the 
control outperforms, though only slightly, the engineered strain. This highlights and 
supports our concerns over the lack of clarity surrounding media selection and the 
impact it has on the metabolism, and by extension connectivity and utilisation of the 
heterologous electron transport pathway, of recombinant E. coli strains. 
The changes in current observed for both sets of strains occurs rapidly, with engineered 
and respective control strains differentiating themselves within a matter of hours. While 
a short time frame does lend support to the argument that the activity of existing 
proteins that can influence EET pathway utilisation is being affected, it is also reasonable 
to suggest that expression shifts occur due to media differences, and that these might 
be causative. The trend for the engineered strain (in M1 for 6.3.A, and M4m for 6.3.B) is 
not entirely immediate, as a brief lag before trending upwards can be observed. This 
could be due to a delay in metabolic activity due to the media change and increase in 
temperature (as cultures are kept on ice just prior to inoculation) and the inoculated 
cells settling within the HC, on the working electrode (WE). Though it may also be 
explained as the time necessary to adjust the cells’ expression of metabolically relevant 
proteins. Either way the differences between the two strains, and minor differences in 
the media used, show that heterologous EET pathway utilisation is quite sensitive to 
minor changes in media/metabolism. 
While further analysis of proteomic differences became the focus of subsequent work, 
the differences between the strains compared here were considered for their potential 
influence on the data so far reported. The first key difference between the two pairs of 
strains investigated lies in the recombinant expression of either omcA, an additional 
outer membrane cytochrome similar in function to mtrC, or cymA, an inner membrane 
cytochrome also from S. oneidensis MR-1 that has reported, though contested, 
functional homology to the product of the native E. coli napC in interacting with 
heterologously expressed mtr pathway components and the quinone pool 134,174. The 
former is present in the engineered strain presented by Jaffe 24 and tested previously in 
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this thesis, while the latter is present in the engineered MFe444 strain presented by 
TerAvest et al. 126.  
The expression of cymA has been reported to improve flux through the mtr pathway in 
E. coli strains expressing it heterologously. Comparably, the addition of omcA is 
suggested to provide an alternative contact route between components of the mtr 
pathway and an extracellular electron acceptor (EEA). It may be the case that under 
more resource limiting conditions (M4m) electron flow between the quinone pool and 
the heterologous mtr pathway is not the limiting step, and so not noticeably assisted by 
cymA. Conversely, contact between EEA and mtr pathway under these conditions might 
be, thus the improvement seen in current production for the omcA containing strain. 
However, it is difficult to state this conclusively without further investigation. 
The second key difference between these two strains lies in the host strain choice, 
BL21(DE3) and C43(DE3) for the Jaffe and TerAvest strains respectively, as previously 
mentioned. It might be the case that operation of the heterologous pathway in each of 
these base strains functions better in one media versus another. C43(DE3) is derived 
from BL21(DE3) and includes (among other mutations) a mutation in the LacUV5 
promoter, leading to lower levels of T7 RNA polymerase in the cell175.  
In the context of the previous discussion suggesting that a change in expression profile 
is required by the cell in order to optimally utilise the heterologous EET pathway, this 
chassis strain difference could account for the observed difference between the strain 
pairs.  C43(DE3) requires a richer minimal media to effect this change in expression while 
continuing to express the heterologous proteins. Meanwhile, in the richer media, 
BL21(DE3), with its greater T7 RNA polymerase levels, encounters issues with 
overexpression in the richer media. The latter half of this argument does not entirely 
hold up, considering the much richer media in which both strains are grown up prior to 
inoculation. Other metabolic differences might account for this, but it is difficult to 
speculate without further data. 
It may be that host strain and media selection informed one another in previous studies. 
For example, for the constructs within the TerAvest strains if only M1 were used in BES 
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comparisons C43(DE3) would be observed to be the superior strain for electroactivity. 
We believe that it is the media impact on expression and metabolism, which varies 
between host strains, determining the electroactivity of engineered E. coli strains. This 
does not mark a refutation of the findings made in various publications, on the contrary 
given the sensitivity to metabolic fluctuation we suggest it is incredibly challenging to 
make the distinctions between strains that have previously been demonstrated. 
However, we believe that this presents both a need for greater metabolic control in 
future heterologous electroactivity studies, and highlights an opportunity for a further 
line of inquiry. 
6.2.3. Consideration of Proteomic Investigative Pathways 
For bioelectrochemical, synthetic biology applications, a robust strain that is resistant to 
minor metabolic variations influencing its electroactivity is desirable. Understanding and 
manipulating the metabolism of electroactive strains to better utilise the heterologous 
pathway might also help to close the gap between engineered E. coli strains and 
dissimilatory metal reducing bacteria (modified or otherwise). In order to inform 
potential metabolic engineering to this effect, as well as to generally investigate ways 
that existing strains might be improved, options for analysing the global proteome of 
electroactive E. coli strains were discussed. This work was conducted collaboratively 
with Dr Caroline Ajo-Franklin and Dr Moshe Baruch. Consequently, use of the MFe408 
control and MFe444 strains for comparative purposes was decided upon. 
Through this collaboration, the opportunity to additionally investigate an observed, 
interesting metabolic shift subsequent to carbon source addition (publication pending) 
was also afforded. In that study it had been observed that supplementation of glucose 
into a lactate containing BES following adaptation of the inoculating strains to initial 
conditions, resulted in an immediate increase in current. As increased fitness provided 
by the additional carbon source was ruled out as solely responsible for the increase in 
current, it was hypothesised that this observation was due to a spike in metabolic flux 
ultimately causing an increase in electron flow through the heterologous mtr pathway. 
It was determined that in addition to a control/engineered comparison following 
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adaptation to HCs, a comparison of the same strains subsequent to maximal, post-
glucose supplementation current could provide valuable insights.  
With four conditions to compare, an 8-plex iTRAQ (isobaric tags for relative and absolute 
quantification) was planned, with two replicates of each condition. In an iTRAQ 
experiment protein samples from different conditions are separately tryptically digested 
and labelled with specific isotopically weighted tags that covalently bind N-termini and 
amine groups176. Once labelled the samples are mixed and analysed via mass 
spectrometry. Using a predicted peptide database the resulting data is processed to 
provide quantitative comparisons of protein levels between the different samples177–181.  
6.2.4. Sample Collection for Quantitative Proteomics 
Twelve M1 containing HCs were run concurrently to generate the samples for proteomic 
analysis, six of each strain (MFe408 and MFe444 – control and engineered respectively), 
with inocula grown as discussed in section 6.2.1., in keeping with the method used by 
TerAvest et al. 126. All HCs were supplemented with 0.4% sodium DL-lactate, set at a 
poised potential of 0.2 V vs Ag/AgCl, and maintained anaerobically as previously 
described. Once current levels stably reached their maxima half of the HCs were 
harvested (three of each strain) while the remainder were supplemented with 0.2% 
glucose. These were monitored until they reached their new maxima and harvested 
together. Biomass harvesting is detailed in chapter 3, but briefly involved dissociating 
adhered cells from the working electrode before final OD600 measurement and 
centrifugation. Cell pellets were briefly stored at -20 oC before protein extraction. The 
protocol was designed to improve extraction of membrane proteins, without sacrificing 
proteins from other fractions, but recovering such proteins is widely known to be 
difficult. 
Figure 6.4. displays the chronoamperometry data for the HC run. Due to the limitation 
to two replicates for each condition, one HC of each set was run for redundancy and was 
not used, and thus excluded from the data represented here. Current is observed to 
increase for the engineered strain, with some minor disruption, until 37 hours at which 
point the stability was sufficient that the A samples were harvested. Comparably the 
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control strain showed a slight increase in current between initial and sample A 
harvesting. A slight drop in current followed the addition of glucose in the engineered 
strain, though this subsequently rose until the point at which sample B was harvested. 
While the immediate effect of glucose did not match that reported by our collaborators 
– a prompt, sharp rise in current to a new maximum – the gradual increase is still 
indicative of greater EET activity. It is possible that small amounts of oxygen were 
introduced during the glucose addition, leading to the initial drop. Although we did not 
feel this to be problematic for proteomic analysis, as we would expect any oxygen 
introduced would have been removed rapidly, and a current increase was still observed 
before harvesting of biomass. Alternatively, it may be that the act of injecting the 
glucose into the HCs disrupted the WE associated cells, reducing the number actively 
supplying electrons to the electrode until they settled or that number was built up again. 
A third option, that glucose repression of the EET pathway through lacUV5 repression, 
is unlikely given the immediacy of this effect; impact from changes to expression would 
not be so rapid. Following on from this, concerns over the repression of the T7 controlled 
EET pathway genes due to the presence of glucose following its addition were raised. 
The lacUV5 promoter was derived from the lac promoter to be less sensitive to 
repression by LacI in the presence of glucose104. And investigations into the additional 
mutations present in C43(DE3), including in lacI did not suggest a change in this, simply 
a decrease in leakiness of the lacUV5 promoter and lowered sensitivity to inducer for 
lacI182. 
Figure 6.4. Chronoamperogram of Samples Generated for Proteomic Analysis 
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Combined HC data for the two strains inoculated into HCs and placed under 
potentiostatic control is shown, with indications for sample A and sample B 
harvesting (at 37 and 57 hours respectively, along with glucose addition). The 
control strain current, MFe408 (red), increases slightly from its starting value, but 
stays relatively constant from before glucose addition until the sample B 
extraction. The engineered strain current, MFe444 (blue), increases from initial 
values, with some disruption, until stabilising before sample A collection and 
glucose addition. Thereafter it suffers an immediate drop from which it steadily 
climbs until reaching a new maximum current before sample B collection. The 
data for each line represents the average of four replicates up until 37 h, then 2 
replicates thereafter, with error bars highlighting the standard error of the mean. 
Nevertheless, given the gradual current increase post-glucose addition, concerns were 
raised over the potential that it was due to a glucose driven biomass increase. This would 
not have invalidated the samples for further analysis, as an increase was not observed 
for the control strain, but it would necessarily inform interpretation of any resultant 
data. Figure 6.5. presents the harvested biomass data for the engineered MFe444 strain 
HCs, as determined by spectrophotometry at 600 nm. It shows the two samples to have 
been similar in biomass. No significant difference was detected between the two when 
compared with an unpaired t-test. 
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Figure 6.5. Comparison of MFe444 Biomass Harvested at Different Time Points 
 
Comparison of harvested biomasses from the two time points/conditions MFe444 
strains were extracted at, graphically represented for the MFe444 strain, as 
determined by spectrophotometry using M1 as a blank. Each column represents 
the data for three replicates with the error bars indicating the standard deviation. 
These two results were not significantly different (unpaired t-test, p<0.01), 
indicating that a hypothetical increase in biomass following glucose addition was 
not present, and so was not responsible for observed differences in current 
between the two sample points. 
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6.2.5. Sample Processing for iTRAQ 
Protein extraction was achieved as described in chapter 3, with a 6 M urea, 1 mM EDTA 
containing, TEAB based buffer, and cell lysis achieved through sonication. Following 
extraction, samples were compared using sodium dodecyl-sulphate polyacrylamide gel 
electrophoresis (SDS_PAGE) as presented in Figure 6.6. below. The figure suggests a 
successful protein extraction, at a workable concentration, though quantification would 
be required for subsequent steps. 
Figure 6.6. SDS-PAGE Gel of Extracted Protein Samples 
 
SDS-PAGE gel of all protein samples, including redundant replicates. Condition 
1 relates to those HCs harvested at 37 h, while condition 2 relates to glucose 
supplemented HCs harvested at 57 h. Gel Coomassie stained with InstantBlue. 
The band distribution indicates a sufficiently broad range of proteins extracted 
to proceed, while intensities reassure that an acceptable concentration is 
present. 
A Bradford assay was conducted as described in chapter 3, using a 96 well plate and 
microplate reader, indicating various protein concentrations in the 7.5-10 mg/ml range. 
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This was used to inform volumes used for the subsequent trypsin digest. Sample aliquots 
were diluted 1 in 6 in TEAB to dilute the urea and EDTA concentrations, then, alongside 
BSA and buffer only controls, reduced, alkylated, and tryptically digested in solution 
(1:20 ratio to protein, 37 oC, overnight).  
An SDS-PAGE gel comparison of pre- and post-digestion aliquots (volumes adjusted for 
dilution) was used to verify digestion, with the resultant gel images shown in Figure 6.7. 
below. Alternate rows representing pre- and post-digestion aliquots for each of the 
digested samples make the successful digestion clear. The BSA control was successfully 
completely digested also, and no bands were detected in the buffer only negative 
control. Consequently, labelling of samples with iTRAQ reagents was proceeded with. 
Figure 6.7. SDS-PAGE Gel Analysing Trypsin Digestion of Protein Samples 
  
Alternately pre- and post- digestion aliquots of each protein run on an SDS-PAGE gel and 
Coomassie stained with InstantBlue. Sample pairs, left to right, are ordered: condition 1 
control 1 and 2, then engineered 1 and 2; condition 2 control 1 and 2, then engineered 1 
and 2. Digest controls are labelled. Correct digestion can be observed for all samples. 
iTRAQ reagent labelled samples were mixed according to protocol and fractionated by 
HPLC with an Hypercarb column. Fractions were collected at two minute intervals. Two 
fractions (40-42 and 50-52 minutes) were subsequently checked for quality control 
BSA       Buffer 
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purposes via MS, before 18 fractions from 22 to 58 minutes were run on the QE HF 
Orbitrap.  
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6.2.6. iTRAQ Data Processing 
The raw iTRAQ data was processed using MaxQuant, a freely available software package 
for quantitative proteomics analysis. MaxQuant identifies detected in spectra, with 
corrective measures to minimise false discovery rate (FDR), through reference to a 
provided protein database for the assessed organism180,181. Initially an NCBI protein 
database for C43(DE3), with the 14 additional protein sequences encoded on various 
plasmids used, was utilised in this process. However subsequent use of various 
bioinformatics tools was inhibited by the lack of recognition of the identifiers present in 
the database. While it was possible to individually convert some of these identifiers into 
comparable ones in UniProt reviewed strains, the process was lengthy and not easily 
automatable. Consequently the decision was made to reanalyse the raw iTRAQ data in 
MaxQuant against the UniProt reviewed database for E. coli strain K12183, with the 
additional 14 proteins previously mentioned. 
It was argued that, while some losses in protein identification numbers might occur, the 
strains were broadly similar. Furthermore the potential insights provided by ease of data 
interpretation using the K12 processed data outweighed expected protein identification 
losses. However, in order to investigate the effect of this database selection on protein 
identification figures, subsequently processed outputs from the two processes were 
compared. In total 1517 proteins were identified using the K12 database, compared with 
1556 for the C43(DE3) database, a difference of 39. Of these 1278 and 1316 had two or 
more unique peptides identified for them, respectively, a difference of 38. These 
minimal losses were considered acceptable. 
Relevant data columns were extracted from the MaxQuant evidence output file, and 
placed into an excel document following a format compatible with our in house 
proteomics pipeline. Protein quantification was achieved separately for each of the 
iTRAQ labels using uTRAQ v4.0 algorithms177,184, with comparisons made to detect 
proteins with significant fold changes carried out using Signifiquant v4.0177. Comparisons 
between conditions were conducted relative to each of the replicates present, both with 
and without multiple test correction (MTC) applied, and at a significance level of 0.05 
and 0.01 for the latter, with only 0.05 applied for the former. 
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These three stringency levels were selected to ensure a thorough overview of the 
proteins within each of the samples was achieved, while identifying those whose change 
was considered most indisputable. All identified proteins can be considered valid for 
evaluation in the context of the following discussions. Though greater confidence is 
assured by identification at a higher stringency level, the MTC may remove valid protein 
changes. And given the limitations of protein extraction, particularly with regards to 
membrane proteins and low abundance proteins177, changes in these may only be 
observable at lower stringency values.  
Only proteins with 2 or more unique peptides identified were included in the results. 
And each condition comparison is the compiled result of comparing changes with 
respect to one of each of the four replicates (two per condition) four times, once for 
each replicate, with only proteins presenting in three or more of the resultant lists being 
presented. All of these steps go further towards ensuring confidence in identified 
protein changes. Full protein lists are presented in the appendix, including a breakdown 
of UniProt IDs by frequency across the four protein lists for each comparison and 
stringency level. 
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6.2.6.1. Overview of Processed Data 
To get an overview of identified proteins, a gene ontology breakdown (GO) for each 
comparison was generated using PANTHER (Protein ANalysis THrough Evolutionary 
Relationships)185. This is a large curated database of protein families, and classifies them 
based on a variety of criteria, including molecular function and biological process. 
For the Control vs Engineered strain comparison, more than a third to more than a half 
of the proteins identified are involved in metabolic processes, as can be seen in Figure 
6.8. below. The next largest group represented is cellular processes, covering over a 
quarter of the proteins identified. Proteins involved in localisation, response to stimulus, 
biological regulation, and cellular component organisation or biogenesis make up the 
remainder. As can be seen, the three stringency levels (Figure 6.8.A. and D. being the 
highest, through to Figure 6.8.C. and F. as the lowest) produce similar results. Though 
for biological processes the highest (MTC p<0.05) shows fewer metabolic process 
proteins, with the other processes expanding proportionally. For molecular function, 
catalytic activity makes up the majority of proteins identified, with around a quarter 
being involved in binding. Antioxidant and transporter activity cover the rest for the 
highest stringency level, with signal transducer, structural molecule, translation 
regulator, nutrient reservoir, and receptor activity ontologies being recognised in the 
lower ones. 
For the Control + Glucose vs Engineered + Glucose comparison protein changes 
previously identified for the initial comparison were disregarded, as well as controls for 
unrelated changes due to glucose addition as indicated by overlap with the control vs 
control + glucose comparison. Consequently, a smaller pool of protein changes 
remained, so only the ontology overview for the third stringency level (no MTC, 0.05) is 
presented in Figure 6.9. below. Figure 6.9.A. shows the biological processes breakdown, 
which much like the previous comparison is predominated by metabolic and cellular 
processes. Some cellular component organisation or biogenesis proteins also remain. 
Figure 6.9.B. shows the breakdown of molecular functions, which also broadly mirror 
those for the previous comparison at the medium stringency level.  
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This figure shows the gene ontology breakdown for protein changes 
identified in the control vs engineered strain comparison, for cells 
incubated in HCs. Two replicates of each condition were analysed under 
varying stringency levels – MTC 0.05 (A and D), no MTC 0.01 (B and E), no 
MTC 0.05 (C and F). A-C show biological process ontologies, while D-F 
show molecular function ontologies. The distribution of ontologies remains 
broadly consistent across the stringency levels, though some additional 
molecular function ontologies become present at the two lower levels. 
 
Figure 6.9. Control + Glucose vs Engineered + Glucose Protein Change Ontologies 
 
 
 
This figure shows the gene ontology breakdown for protein changes identified in 
the control + glucose vs engineered + glucose strain comparison, for cells 
incubated in HCs, for the no MTC 0.05 stringency level. Two replicates of each 
condition were analysed under varying stringency levels, with certain protein 
changes filtered out by control comparisons. Biological process ontologies (A) 
and molecular function ontologies (B) both are broadly comparable to those for 
the original comparison. 
  
A. B. 
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6.2.6.2. Heterologous Protein Identification 
In addition to the proteins present in the K12 database downloaded from UniProt, the 
database used for the processing in this study included the protein sequences for the 
additional genes borne on the added plasmids. Unfortunately, as many of these were 
membrane proteins, the likelihood of detecting them with a global proteomic technique 
was low, due to the difficulty in solubilising such proteins during the extraction process. 
Even if low concentrations were detected, these would likely be too small for the data 
processing to confidently list in the protein changes for comparisons. Work carried out 
previously on these strains28 had demonstrated their expression using haem staining 
methods, nevertheless in the interests of further confidence in expression, in each 
comparison we looked to identify any of these heterologous proteins. 
While MtrCAB were all identified with more than two unique peptides following 
MaxQuant processing of the raw data in the engineered strains, only MtrA was found in 
control vs engineered comparison results. This follows expectations, as out of the 
heterologous proteins MtrA is a periplasmic protein (and therefore not an integral 
membrane protein)186. As can be seen in the full protein lists in the appendix, MtrA is 
identified in every comparison of a control vs an engineered strain, glucose or otherwise, 
as we would expect. When the engineered vs engineered + glucose comparison was 
made MtrA was present at the two lower stringency levels.  
Table 6.1. presents these data for the no MTC 0.01 stringency level. It shows a relative 
increase of the protein in the glucose containing condition. This may simply be indicative 
of an increase in metabolic flux leading to higher expression generally but emphasised 
in the heterologous protein by independent regulation of expression. Regardless, it 
definitively counters the argument against repression of the lacUV5 promoter by 
glucose, which would lead to lower expression of the T7 promoter controlled EET 
pathway genes. 
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Table 6.1. Relative Protein Quantification for MtrA 
UniProt 
ID 
Gene 
Name 
Engineered 
1 
Engineered 
2 
Engineered 
+ Glucose 1 
Engineered 
+ Glucose 2 #Unique #Quants 
Q8EG35 mtrA 0.623516 0.644531 0.933484 1 6 24 
Quantified (linear, isotopic and multiple corrections applied) protein differences 
for replicates displayed separately, relative to the second engineered strain + 
glucose condition replicate. The test setting used was no MTC, p-value limit of 
0.01 
6.2.7. iTRAQ Comparison of Engineered and Control Strains of E. coli Following 
Adaptation to a Bioelectrochemical System 
The proteomes of control and engineered strains of E. coli adapted to a BES were 
quantitatively compared with the aims of better understanding the electroactivity of the 
engineered E. coli strain generally, the connection between the central metabolism and 
the heterologously expressed EET pathway specifically, and to identify novel factors that 
might contribute to the electroactivity of that strain. 
6.2.7.1. Outer Membrane Proteins and Ion Dependent Regulation 
The outer membrane proteins encoded by ompA and ompF were identified as having 
particularly large fold changes between the two conditions at hand, as shown in Table 
6.2., with the former lower in the control strain relative to the engineered, and the latter 
higher. Both of these proteins are typically abundant and have porin activity for small 
molecules across the outer membrane, with consequent roles in ion transport, although 
OmpA187,188 has a lower permeability than OmpF189,190. Furthermore, there is evidence 
for voltage gating behaviour in OmpF and similar porins191; beyond a specific membrane 
potential the channels close. Given the potential bioelectrochemical interactions of such 
a mechanism, ion interaction was investigated further. 
A number of other proteins identified in the literature as responsively regulated 
alongside Mg2+ concentration192 were found in our data, as well as two copper/silver ion 
exporters. The former group included PhoP, a component of the PhoP/Q two-
component system which activates and represses a range of proteins in response to 
periplasmic Mg2+ concentration and redox state192; SlyB, an outer membrane lipoprotein 
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evidenced to interact with PhoP, decreasing its activity, and regulated by it in a feedback 
inhibition process 193; DsbA, which assists some periplasmic bounding proteins, including 
OmpA, in disulphide bond formation, and which suppresses PhoP activity194; RstA, 
another transcriptional regulatory protein that is expressed under low periplasmic Mg2+ 
concentration conditions as regulated by PhoP/Q192; and HemL, a biosynthetic protein 
involved in porphyrin production, and so by extension the haem biosynthesis 
pathway192. Without exception, though to varying degrees, these proteins were found 
at lower levels in the control strain compared with the engineered strain. 
The two copper and silver resistance mediating proteins, CusB and CusF, were identified 
as less abundant in our control strain relative to our engineered strain, as detailed in 
Table 6.2. below. Copper toxicity tends to increase under anaerobic conditions, and in 
E. coli resistance to this toxicity is mediated by the tetrapartite transporter consisting 
cus system, which can export copper ions across the cell envelope195,196. CusF acts as a 
metallochaperone, binding and conveying ions for export, to the membrane fusion 
protein CusB, through which they are eventually exported from the cell197. The small 
heat shock protein ibpB, a chaperone that is also induced as part of a copper ion stress 
response, was observed at greatly increased levels in the control relative to the 
engineered strain. However, we believe this to be separate from the regulation 
occurring for the other proteins discussed; other heat shock proteins were observed at 
comparably higher levels in the control strain, likely a product of the expected increased 
stress resulting from the anaerobic, low nutrient environment. As the HCs were 
temperature-controlled induction of heat shock response proteins will not have been 
due to temperature, but may be indicative of metabolic strain disrupting the negative 
transcriptional regulation of heat-shock genes. 
Together these changes help illuminate the differences between engineered 
electroactive E. coli and its control.  The pattern of altered expression, particularly for 
the Mg2+ responsive proteins, suggests that redox states are different between strains 
leading to varying metal toxicity and consequent signal transduction pathway activity. 
Though alternatively the utilisation of the heterologous EET pathway may be having an 
unforeseen interaction with ion concentrations, and thus ion homeostasis. The 
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possibility of bioelectrochemical activity within the BES non-specifically interacting with 
the metal ion sensitive signal transduction pathways was considered, but the differences 
between observed strains only lend weight to the argument of a redox state difference, 
particularly within the periplasm. PhoP, for example, is more active under reducing 
conditions, which makes sense given that metal ion solubility is improved in such a 
situation198. Either through a redox state, or other bioelectrochemical interaction, we 
thus infer a link between the heterologous EET pathway expression in E. coli, and ion 
homeostasis regulated proteins. 
Increased relative HemL expression in the engineered strain is likely a by-product of 
Mg2+ responsive regulation given its induction by PhoP, but its increased activity might 
also be assistive in cytochrome maturation; relevant to the heterologous EET pathway. 
Consequently, adjusting hemL regulation might impact electroactivity, though given that 
it was expressed at greater levels in the engineered strain this would only be relevant 
under conditions adjusted to down regulate the listed Mg2+ responsive proteins 
discussed. With this in mind, analysis of the response of engineered and control strains 
of E. coli to ion concentration within a BES might assist in further characterising the 
effect of this regulatory shift on EET. Primarily, however, we felt that these data 
recommended further investigation of redox processes within the two strains and 
conditions. 
Table 6.2. Relative Protein Quantification for Ion Interactive Proteins 
UniProt 
ID 
Gene 
Name 
Signifiquant 
Settings Used Control 1 Control 2 
Engineered 
1 
Engineered 
2 
P02931 ompF A 1.85 2.00 1.04 1.00 
P0A910 ompA A 0.50 0.51 0.99 1.00 
P0A905 slyB C 0.74 0.70 1.18 1.00 
P23893 hemL B 0.88 0.87 0.99 1.00 
P77239 cusB B 0.51 0.53 1.02 1.00 
P77214 cusF B 0.44 0.43 1.01 1.00 
P52108 rstA B 0.69 0.70 1.13 1.00 
P23836 phoP C 0.73 0.86 1.00 1.00 
P0AEG4 dsbA B 0.78 0.75 1.06 1.00 
Quantified (linear, isotopic and multiple corrections applied) protein differences 
for replicates displayed separately, relative to the second engineered strain 
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replicate. The best test settings each protein detected with are referred to as A 
(MTC, p-value limit of 0.05), B (no MTC, p-value limit of 0.01), and C (no MTC, 
p-value limit of 0.05) for reference. 
6.2.7.2. Electron Transport and Redox Activity 
While, as discussed in the previous subsection, an interest in proteins that might indicate 
differences in cellular redox states between the two strains was cultivated, a focus on 
carbon metabolism was first explored. It was thought that differences in metabolic 
processes, reflected in protein levels detected for various metabolic enzymes, would 
provide insights into utilisation of the heterologous EET pathway in E. coli. Key protein 
differences discussed herein are listed in Table 6.3. below. 
Proteins involved in the Tricarboxylic acid (TCA) cycle, fermentation, respiration, and the 
pentose phosphate pathway (PPP) were selected, and the pathways visualised with the 
EcoCyc cellular overview199, as Figure 6.10. shows. Pathways affected by protein changes 
were coloured on a red to purple scale depending on whether they were quantified at a 
higher or lower level, respectively, than the engineered strain; orange/red indicates a 
relative increase in the control strain, blue/purple in the engineered strain.  
The majority of proteins observed were at a higher relative level in the engineered 
strain, including TCA cycle enzymes SucB, AcnA, and Mdh; TktB and TalA of the PPP; and 
glycolysis enzyme FbaB. Given the expected higher metabolic activity of the engineered 
strain, due to the additional end terminal electron acceptor access afforded by the 
heterologous EET pathway, this observation was consistent with predictions. This was 
further supported by differences in certain branched pathways between the two strains, 
such as a preference for GpmI over GpmA in the glycolysis pathway. Both facilitate the 
same conversion, but GpmA has a 10-fold higher specific activity200, so is better suited 
to a more metabolically active organism. 
Greater fermentative acetate production in the control strain can be inferred from the 
data. Increased Pta, involved in the acetyl-CoA to acetyl phosphate (precursor to 
acetate) reaction, was observed for the control. An increase of alcohol degradation 
pathway proteins (glpK, garR, and the TCA relevant aceB) supports an accumulation of 
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these molecules in the control strain, also. There is also an indication of a reliance on 
fatty acid degradation to generate acetyl-CoA in the control, with FadI and FadJ detected 
at higher levels. Conversely, fatty acid biosynthesis was down in the control relative to 
the engineered strain, with FabA and FabB decreased. Lower fatty acid biosynthesis is 
usually tied to lower levels of OmpF (not OmpA)201, however it is interesting to note the 
opposite was observed herein. 
Beyond the central carbon metabolism, it was noticed that oxidative stress proteins 
OsmC and SodC were present at higher relative values in the engineered strain. OsmC, 
is a peroxiredoxin that reduced hyperoxides and inorganic hydrogen peroxide, 
protecting cells in situations of hyperosmotic or oxidative stress 202. SodC is a superoxide 
dismutase which functions to destroy toxic oxidising radicals produced normally as a 
result of general metabolic processes203,204. Its differential protein abundances may be 
supportive of our conclusion of generally increased metabolic activity in our engineered 
strain. However it may be the result of a higher oxidative stress than accountable for by 
the increased metabolic activity expected. Combined with an inferred reducing 
periplasmic state, this may be suggestive of a bottleneck in EET, one that lies not with 
the heterologous pathway or its interaction with the quinone pool, but with electron 
transport to that quinone pool. 
Two quinone interacting proteins were subsequently observed in the data: WrbA and 
NuoG. These were up and down regulated, respectively, in the engineered strain relative 
to the control. WrbA is upregulated in response to oxidative stress, or disruption of 
specific electron transfer chains, and functions as an NAD(P)H dehydrogenase to reduce 
quinones, though specificity has not been determined205,206. Comparatively, NuoG fulfils 
a similar function, believed to reduce ubiquinone, specifically, though is not considered 
to have oxidative stress gene ontology207,208. This pattern suggests that heterologous 
EET pathway quinone pool interaction might be quinone specific. This bore further 
investigation in the comparison of glucose supplemented cells. 
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Table 6.3. Relative Protein Quantification for Metabolic and Redox Active Proteins 
UniProt 
ID 
Gene 
Name 
Signifiquant 
Settings Used Control 1 Control 2 
Engineered 
1 
Engineered 
2 
P08997 aceB A 1.47 1.42 1.03 1.00 
P25516 acnA B 0.77 0.78 0.94 1.00 
P0A6Q3 fabA B 0.79 0.80 1.01 1.00 
P0A953 fabB B 0.91 0.88 0.98 1.00 
P76503 fadI B 1.29 1.37 1.01 1.00 
P77399 fadJ C 1.16 1.19 0.99 1.00 
P0A991 fbaB C 0.82 0.83 0.98 1.00 
P0ABQ2 garR B 1.23 1.22 0.96 1.00 
P0A6F3 glpK B 1.16 1.21 0.99 1.00 
P62707 gpmA C 0.92 0.93 0.97 1.00 
P37689 gpmI C 1.28 1.25 1.08 1.00 
P61889 mdh B 0.90 0.85 0.95 1.00 
P33602 nuoG B 1.15 1.15 0.99 1.00 
P0C0L2 osmC A 0.77 0.72 1.05 1.00 
P23538 ppsA C 1.07 1.07 1.01 1.00 
P0A9M8 pta B 1.14 1.16 1.00 1.00 
P0AGD1 sodC A 0.58 0.56 1.08 1.00 
P0AFG6 sucB B 0.78 0.79 0.92 1.00 
P0A867 talA A 0.77 0.78 0.96 1.00 
P33570 tktB C 0.83 0.81 0.98 1.00 
P0A8G6 wrbA B 0.89 0.89 1.04 1.00 
 
Quantified (linear, isotopic and multiple corrections applied) protein differences 
for replicates displayed separately, relative to the second engineered strain 
replicate. The best test settings each protein detected with are referred to as A 
(MTC, p-value limit of 0.05), B (no MTC, p-value limit of 0.01), and C (no MTC, 
p-value limit of 0.05) for reference. 
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Figure 6.10. Mapped Proteomic Changes in Central Metabolic Processes 
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Mdh ↓ 
AcnA ↓ 
AcnA ↓ 
Pta ↑ 
SucB ↓ 
FbaB ↓ 
Mdh ↓ 
GpmI ↑ GpmA ↓ 
PpsA ↑ 
AcnA ↓ 
AcnA ↓ 
AceB ↑ 
SucB ↓ 
TktB ↓ 
TktB ↓ 
TalA ↓ 
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This figure shows the proteomic changes identified for proteins involved in central 
carbon metabolism, relative to the engineered strain, with colours and arrows 
denoting whether an increase or decrease was detected. In this instance a down 
arrow indicates that the protein was identified to have a lower relative value in the 
control strain. As with all data in this study two replicates were present for each 
condition. The data for these proteins is also laid out in the preceding table and 
in the appendix. Overall a picture of much higher central carbon metabolism 
activity in the engineered strain is depicted, with greater reliance on acetate 
production in the control strain. 
6.2.7.3. Biosynthetic Processes 
Independently of the above investigation, a few, noteworthy biosynthetic proteins were 
observed to change between the strains, as described in Table 6.4. below. First of these 
was RibF, which catalyses the conversion of riboflavin to Flavin mononucleotide 
(FMN)209, which was observed at a higher level in the control strain. While riboflavin is 
utilised as a mediative molecule in EET by S. oneidensis MR-173,127,128, as discussed in 
Chapter 4 this capability was not shown by our engineered E. coli strain. Nevertheless, 
any future attempts to engineer this capability into E. coli should do so with the host 
riboflavin metabolic processes in mind. 
From broadening our previous investigation into metal ion interacting proteins to 
metalloproteins or those involved in metal homeostasis, three proteins involved in iron-
sulphur cluster assembly were revealed that were observed to be up regulated in the 
engineered strain relative to the control. These were IscU, IscS, and HscA. Iron sulphur 
clusters are required for the maturation of many proteins involved in respiratory and 
biosynthetic processes210. Many oxidoreductases involved in oxidative stress response 
require iron sulphur clusters for maturation however, lending support to our earlier 
conclusions regarding this activity in our engineered strain. 
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Table 6.4. Noteworthy Biosynthetic Proteins 
UniProt ID 
Gene 
Name 
Signifiquant 
Settings Used Control 1 Control 2 
Engineered 
1 
Engineered 
2 
P0AG40 ribF C 1.10 1.12 0.97 1.00 
P0ACD4 iscU A 0.54 0.57 0.97 1.00 
P0A6B7 iscS A 0.52 0.51 1.00 1.00 
P0A6Z1 hscA A 0.63 0.63 0.97 1.00 
Quantified (linear, isotopic and multiple corrections applied) protein differences 
for replicates displayed separately, relative to the second engineered strain 
replicate. The test settings each protein detected with are referred to as A (MTC, 
p-value limit of 0.05), B (no MTC, p-value limit of 0.01), and C (no MTC, p-value 
limit of 0.05) for reference. 
 
6.2.8. iTRAQ Comparison of Engineered and Control Strains of E. coli in a 
Bioelectrochemical System Supplemented with Glucose 
As previously described, HCs containing engineered (expressing mtrCABcymA) and 
control strains of E. coli were supplemented with glucose following adaptation to the 
BES conditions, as represented by maximal current being reached. After glucose 
addition, cells were harvested once the new current maxima were reached. When 
investigating the proteins with significant relative differences between the control and 
engineered strains thus collected, those that were also present in the comparison of 
pre-glucose addition control and engineered strains, as well as those observed for 
control strains pre-glucose compared with post-glucose, were removed. In this way 
those protein changes resulting from the difference between the two strains generally 
within a BES were excluded (since already the focus of the previous subsection), while 
changes due to non-engineered strain specific regulation in response to the presence of 
glucose were similarly controlled for. Consequently, a thorough investigation of the 
‘glucose effect’ on the proteomes of the two tested strains was conducted with the aim 
of informing future engineering of electroactive E. coli strains for bioelectrochemical, 
synthetic biology applications. 
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6.2.8.1. Changes in Respiratory Processes in Glucose Supplemented Strains 
E. coli possesses three types of quinone: ubiquinone, typically involved in aerobic 
respiration, menaquinone, and demethylmenaquinone211,212. The latter two have more 
of a role in anaerobic respiration, having lower redox potentials211. In S. oneidensis MR-
1 CymA functions to reduce quinols, transporting electrons to terminal pathways, such 
as the EET Mtr pathway134. There is evidence for its specificity for the menaquinone 
pool213, though also for a capability to reduce ubiquinol214. 
NuoG and WrbA, proteins which facilitate quinone reduction, were detected at higher 
and lower abundances in the control strain of the previous comparison respectively. As 
discussed this, combined with other signs of redox activity, might be descriptive of the 
Mtr pathway’s heterologous utilisation. With the comparison presently being 
considered, it was hoped that the increased metabolic flux facilitated by the addition of 
glucose might further illuminate differences between the strains from which electron 
transfer pathway activity could be inferred. These proteins were detailed in Table 6.3. 
previously, while other proteins discussed in this section are listed in Table 6.5. below. 
Additional dehydrogenase complex proteins were identified in the glucose 
supplemented strain comparison, with NuoB, NuoC, and NuoF all detected at a 
decreased level in the engineered strain relative to the control. These proteins are all 
involved with ubiquinone reduction in aerobic respiration. Conversely, QorA was 
measured at higher levels in the engineered strain. QorA is not as well characterised215, 
however we feel that the result observed here lends support to a role in anaerobic 
respiration through menaquinone preference. Alternatively, it might just reflect a more 
thorough shift in protein profile facilitated by the higher metabolic activity of the 
engineered strain, but with the addition of glucose we would expect sufficient turnover 
and adaptation to disregard this possibility. 
Metabolism of glucose in E. coli leads to the formation of the toxic product 
methylglyoxal, which is further metabolised in the aldehyde degradation pathway216. 
Three proteins were differentially abundant between strains, within this pathway, that 
are of particular relevance. Gpr, less abundant in the engineered strain, is involved in a 
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detoxification branch of methylglyoxal degradation through reduction with NADPH. Of 
particular interest, however, are Dld and LldD. These proteins are D- and L- lactate 
dehydrogenases, and were more and less abundant in our engineered strain, 
respectively. The particular interest stems from the potential for greater lactate 
utilisation being promoted through glucose addition. They each catalyse the formation 
of pyruvate from the respective lactate isoform, though Dld specifically reduces 
ubiquinone, while LldD quinone specificity has not been determined217–220.  
While seemingly at odds with other observation regarding quinone specificity in the two 
strains, an increase in these proteins in the control strain due to greater methylglyoxal 
production would adequately explain them. This would make sense, given the greater 
reliance the control strain would have to place on anaerobic glycolysis (a primary 
methylglyoxal source216). The considered aerobic nature of the LldD catalysed lactate 
metabolism also lends weight to this argument, as does the noted increase in Gpr. Fatty 
acid degradation, another contributor to methylglyoxal production was also noted to be 
more abundant in the control as inferred from higher quantitation of FadB. Selective 
quinone pool usage is further supported by results for FrdA, down in the engineered 
strain, which oxidises menaquinol in the fermentation reaction that reduces fumarate 
to succinate. 
Collectively, we believe this evidence points to the activity of the heterologous EET 
pathway in E. coli, from quinone pool to EEA, not being the limiting factor in 
electroactivity of engineered E. coli strains under existing experimental procedures. This 
then merits further investigation, such as into the impact of improved menaquinone 
pool utilisation, in a further engineered strain of E. coli, on electroactivity. Furthermore, 
evidence for heterologous CymA preferential interaction with menaquinone in E. coli is 
provided by the differences observed herein, consistent with its activity in S. oneidensis 
MR-1. But further evidence is discussed later in this chapter; and such future work is 
discussed in more detail in the following chapter.  
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Table 6.5.  Glucose Condition Proteomic Changes 
UniProt 
ID 
Gene 
Name 
Signifiquant 
Settings Used Control 1 Control 2 
Engineered 
1 
Engineered 
2 
P0AFC7 nuoB C 1.00 0.98 0.76 0.75 
P33599 nuoC B 1.00 1.02 0.88 0.85 
P31979 nuoF B 1.00 1.06 0.87 0.82 
P28304 qorA C 1.00 0.84 1.12 1.10 
Q46851 gpr C 1.00 1.06 0.91 0.87 
P33232 lldD B 1.00 1.06 0.67 0.62 
P06149 dld C 1.00 0.97 1.07 1.08 
P21177 fadB B 1.00 1.04 0.87 0.80 
P00363 frdA C 1.00 1.01 0.72 0.76 
Quantified (linear, isotopic and multiple corrections applied) protein differences 
for replicates displayed separately, relative to the second engineered strain 
replicate. The test settings each protein detected with are referred to as A (MTC, 
p-value limit of 0.05), B (no MTC, p-value limit of 0.01), and C (no MTC, p-value 
limit of 0.05) for reference. 
6.2.8.2. Cytochrome Biogenesis and Condition Overlaps 
Interestingly, it was noted in the glucose supplemented comparison that a number of 
proteins associated with cytochrome biogenesis were identified as being more 
abundant in the engineered strain relative to the control, as Table 6.6. details. While 
expressed constitutively on the pEC86 plasmid present in both the control and the 
engineered strains, the cytochrome maturation proteins CcmG and CcmH were 
measured at a much higher level in the engineered strain. 
It may be the case that the additional metabolic flux provided by the glucose allowed 
for an increase in the expression of necessary cytochrome biogenesis machinery that 
was otherwise suppressed in the lactate only condition. However, further analysis 
reveals CcmE in the list of proteins excluded for appearing in the non-glucose strain 
comparison, suggesting that the host cytochrome maturation genes may simply be 
expressed in the engineered strain generally.  
Proteins identified in the glucose comparison, continue to support observations 
previously made. Some of these appear in the data for both comparisons, such as CusB 
and CusF. CusC, like the previous two, is part of the copper ion efflux system discussed 
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beforehand. CusR, the signal transduction protein for copper ion homeostasis221, was 
also observed. These all follow the pattern of increased abundance in the engineered 
strain, relative to the control. 
Table 6.6. Cytochrome Biogenesis and Copper Ion Homeostasis Proteins 
UniProt 
ID 
Gene 
Name 
Signifiquant 
Settings Used Control 1 Control 2 
Engineered 
1 
Engineered 
2 
P0AA86 dsbE/ccmG C 1.00 1.17 2.25 2.57 
P0ABM9 ccmH C 1.00 1.20 3.40 3.72 
P69490 ccmE C 1.00 1.06 2.38 2.66 
P77239 cusB B 1.00 1.00 1.79 1.63 
P77211 cusC C 1.00 1.02 1.31 1.32 
P77214 cusF B 1.00 0.94 1.58 1.69 
P0ACZ8 cusR C 1.00 0.92 1.20 1.34 
Quantified (linear, isotopic and multiple corrections applied) protein differences 
for replicates displayed separately, relative to the second engineered strain 
replicate. The test settings each protein detected with are referred to as A (MTC, 
p-value limit of 0.05), B (no MTC, p-value limit of 0.01), and C (no MTC, p-value 
limit of 0.05) for reference. 
6.2.8.3. Insights into Regulation from Engineered vs Engineered Plus Glucose Comparison 
Data 
While differences in the proteomes of control and engineered strains following addition 
of glucose has already been discussed, additional insights can be gleaned from looking 
at changes between the engineered and engineered + glucose samples (EvEG). The 
protein list from this comparison has been refined by removing changes that overlap 
with other comparisons. In addition to the removal of changes from the control vs 
control + glucose comparison, those from the control vs engineered comparison (CvE) 
were also removed. Thereafter the results were compared with the control + glucose vs 
engineered + glucose (CGvEG) results, with overlap visually represented in Figure 6.11. 
and detailed in Table 6.7. below. The overlapping changes are consistent in their 
direction unless otherwise noted; i.e. if down in engineered for EvEG comparison, then 
down in control for CGvEG. 
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6.11. Overlap of Engineered vs Engineered + Glucose and Control + Glucose vs Egineered 
+ Glucose Comparisons 
 
This figure shows the overlap between the two described conditions, when data 
was analysed using the no MTC p<0.05 stringency level. In the highest stringency 
level only 2 proteins overlapped. This highlights a smaller number of proteins of 
particular interest, given their correlation with desirable phenotypes (increased 
current), with non-specific factors such as strain and unrelated glucose response 
regulation controlled for. 
NuoB, as previously discussed, is one of several proteins involved in aerobic respiration 
that are observed to be present at significantly lower levels in the engineered + glucose 
condition when compared with control + glucose. As can be seen in Table 6.7. this is also 
observed when it is compared against the engineered condition. NuoB expression is 
inhibited under anaerobic conditions both by FNR, a regulator that senses the presence 
of oxygen within the cell directly, and ArcA-P, the activated form of ArcA that is 
produced through redox sensing222. The latter, due to its sensing being primarily through 
the redox state of the menaquinone pool, which is sensitive to very low concentrations 
of oxygen, does not match FNR under microaerophilic conditions. This observation may 
be an argument that oxygen was allowed to enter the HCs in small concentrations, with 
the balance altered after the glucose addition, however given the evidence of other 
proteins which suggest a higher ArcA-P activity in engineered + glucose vs engineered 
or control + glucose, this seems unlikely. 
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Many other of these protein changes further reinforce previous conclusions. GdhA is 
induced by PhoP and is more prevalent in the glucose condition of the EvEG comparison, 
fitting with expectation. The lower relative quantification in the engineered sample of 
GrxB, which is induced by the alarmone ppGpp in response to amino acid shortage223, 
as well as many amino acid synthesis proteins fits the proposed view of stress and lower 
metabolic activity. GrxB’s inhibition of protein synthesis is naturally to be avoided to 
maximise electrochemical activity, and these results suggest that a higher metabolic flux 
will achieve this. Though whether that flux is due to increased EET utilisation or glycolysis 
is unclear. Even if it were currently the latter, increasing EET pathway utilisation to 
DMRB comparable levels should have a similar effect. 
Table 6.7. Protein Details for Overlap of Engineered vs Engineered + Glucose and Control 
+ Glucose vs Egineered + Glucose Comparisons 
 
Quantified (linear, isotopic and multiple corrections applied) protein differences 
for replicates displayed separately, relative to the second engineered + glucose 
strain replicate, except for SdhA where it is relative to the first. The test settings 
each protein detected with are referred to as A (MTC, p-value limit of 0.05), B (no 
MTC, p-value limit of 0.01), and C (no MTC, p-value limit of 0.05) for reference.  
In the interest of identifying targets for further investigation of electrochemical 
interaction, YebE presents itself as a suitable candidate. YebE is an uncharacterised 
integral inner membrane protein with domains in both the periplasm and cytoplasm. 
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Higher relative quantification is observed to be present in conditions with higher 
electroactivity in our data. However, yebE is under the regulatory control of CpxR, which 
induces it and other genes involved in the envelope stress response224. It senses several 
associated factors, including membrane lipid composition, and alkaline pH, and as such 
may reflect the increased stress placed on cells in the respective samples. Lower stress 
might be expected in conditions with greater metabolic flux, but this might be 
contributing to membrane instability or influencing one of many other factors. Or this 
might be an artefact of globally increased expression due to this higher flux, with stress 
response genes outcompeting others. It is one to keep in mind going forwards, then, but 
its presence should not be investigated until other more fundamental issues have been 
resolved. 
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6.3. Conclusions 
In this chapter we have demonstrated the impact of small variations in BES media, strain, 
and pre-inoculation growth conditions on electroactivity of recombinant E. coli strains. 
They have been shown to have a far stronger influence on current levels in a single 
chamber BES under a poised potential, than expected from the literature. Consequently 
a global proteomic analysis of engineered and control strains of E. coli was conducted, 
to assist in characterising the effects of heterologous extracellular electron transport 
pathway utilisation within E. coli. This revealed number of insights. The increase of toxic 
ion efflux proteins was identified in the engineered strain, with further suggestion of 
redox activity leading to a reducing periplasmic environment. This, combined with the 
inferred quinone preference of metabolic processes between the two strains, indicated 
that heterologous EET pathway utilisation might be limited in E. coli by flux through 
CymA accessible electron transport chains. The general greater metabolic activity 
expected in the engineered strain was also adequately reflected in the data. 
As previously discussed, across the various comparisons there has been an indication 
that the menaquinone pool has been preferentially reduced by the EET pathway. Upon 
investigation of the regulatory control of many proteins observed to change in the 
preceding comparisons it became clear that many were under the control of ArcA, and 
their altered expression levels were indicative of ArcAB’s response to a reduced 
menaquinone pool. The suggestion that a microaerophilic condition was present within 
the HCs was argued against and disregarded.  
If this conclusion is true, then this could inform a strategy to modify host a strain so that 
it better regenerates the menaquinone pool over ubiquinone pool. This would in turn 
ease the ArcAB regulation, allowing host processes to regulate themselves more 
effectively, no longer reacting to an incorrect situation. And moreover, with increased 
metabolic utilisation of the menaquinone pool as electron acceptor by central 
metabolism, this would be eliminated as a bottleneck for EET. Hypothetically this would 
allow much higher electroactivity to be observed. However, before such an undertaking 
in metabolic engineering is embarked upon, validation of these conclusions must be 
carried out. This proposed work is discussed in detail in the future work chapter. 
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Chapter 7 – Conclusions and Future 
Work  
7.1. Conclusions 
In this thesis we have presented variety of considered approaches into furthering the 
knowledge and development of engineered electroactive E. coli strains. The first 
research chapter explored the progression of a bioelectrochemical cell protocol, with 
comparisons to existing literature and a discussion of the reasoning behind protocol 
changes. This half cell (HC) setup was aimed at achieving a higher throughput than that 
possible with lab scale microbial fuel cells (MFCs), while retaining a high level of 
electrochemical insight; in this we succeeded, which could be of benefit to future studies 
seeking higher throughput electrochemical testing equipment that can be commercially 
procured. Most notably, we observed and investigated the mediator-like behaviour 
resulting from the chloramphenicol resistance products. This presents an opportunity 
for alternative, non-toxic mediators to be developed for energy producing or biosensing 
BES applications. 
The second research chapter of this thesis described the construction of genomic 
libraries of S. oneidensis MR-1 in E. coli strains for the purpose of identifying novel 
electroactive factors. To this end a dye reduction assay was developed to facilitate the 
very high throughput required for screening such a large volume of strains. The stages 
of the screening process were described and the most interesting of the resultant clones 
investigated further. From an overlapping region of two separate “hit” fosmid clones, 
several constructs were produced and tested. Ultimately the gene SO_0527, annotated 
as an antibiotic biosynthesis monooxygenase family protein, was suggested as the 
causative, novel factor for the increased dye reductive phenotype observed in our 
clones. Further work is required to conclusively validate these findings, however. 
In the third research chapter, a closer look was taken at the impact of methodological 
variables on electroactivity of engineered and control E. coli strains, as well as presenting 
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a comparison between strains from different studies within the same 
bioelectrochemical system (BES). It became clear that media choice had a great impact 
on electroactivity, leading to further investigation through a global proteomics 
approach. The metabolic activity of electroactive E. coli expressing the heterologous Mtr 
EET pathway was subsequently characterised in the interest of informing future 
engineering strategies, as it remains clear that a more consistent response to minor 
environmental variables is required for many synthetic biology applications to be viable. 
It was concluded that oxidation of the menaquinone pool by the EET pathway was 
resulting in a regulatory response commensurate with the response to microaerophilic 
conditions. Once validated a metabolic engineering strategy could be devised that might 
drastically improve the performance of engineered E. coli strains for BES applications. 
7.2. Future Work 
As with most scientific research, many avenues of progression lay outside the scope of 
the work presented in this thesis. Some due to time, but others presented themselves 
only in retrospect; a few of the most interesting are discussed here. 
7.2.1. Chloramphenicol Effect Electrode Interaction 
The observed mediator activity may have been a direct result of some component of our 
specific BES, or may have been similarly highlighted by such. Our HCs are single chamber, 
whereas many BESs use two-chamber, air cathode, or otherwise membrane separated 
counter electrode (CE). From this, if we assumed that it was something within our setup 
that was responsible, we could speculate that this was either down to some novel 
interaction with our working electrode (WE), or an unforeseen interaction with the non-
membrane separated CE. In order to investigate these possibilities, we would repeat a 
core set of the chloramphenicol effect experiments using a range of different 
equipment. 
This suggested work would face challenges; as highlighted in this thesis, BES equipment 
and protocols can be highly variable, and not commercially available. Thus this would be 
most practicably achieved through collaboration with other groups focussed on 
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bioelectrochemical research. Nevertheless, such would present its own difficulties, and 
the experimental options would still be limited by available equipment. 
Modification of the WE could be easily achieved and thus investigated. The difference 
between the carbon veil used and other carbon cloths used ubiquitously in the literature 
is minimal, and so we would not expect this to have any effect on the reproducibility of 
the chloramphenicol effect. The nichrome wire threaded through the veil, and linking it 
to the potentiostat connectors is not so commonly used however. A range of alternative 
wire materials (with as identical as possible characteristics) would be tested, and the 
impact on the chloramphenicol effect noted. 
The CE was composed of platinum wire, and is where electrons are donated back to 
elements within the media. Given the lack of oxygen in the system we would expect this 
to result in hydrogen when protons ejected by the respiring bacteria met the CE. 
However, it is possible that acetylated Cm (aCm) or a product of an interaction with the 
bacterial cell or WE could have been acting as an electron acceptor at the CE. The 
separation of the CE by a membrane might present a suitable method for testing this 
hypothesis, providing it was not permeable to aCm. Though if the Cm effect persisted it 
would not rule out other unforeseen products of the resistance reaction from doing the 
same if they were membrane permeable. 
7.2.2. Chloramphenicol Reactivity and Degradation 
The Cm antibiotic is known to naturally degrade over a relatively short time frame, 
however a study of the rates under the conditions observed herein was not identified. 
An analysis of this could provide further insights into the nature of the mechanism of 
the Cm effect, particularly if rates could be matched to bioelectrochemical changes. An 
analysis using HPLC of the concentrations of Cm and derivatives found in HC media at 
various time points and different conditions might facilitate this. Less equipment 
modification would be required relative to the other work previously suggested, as 
sample collection could be achieved with the equipment currently available, however 
the HPLC analysis might introduce additional concerns and limitations (e.g. variable 
degradation of analytes skewing results). 
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More easily achievable would be investigation of the upper limit of the Cm effect’s 
linearity. Would mediator activity reach maximum efficiency before CAT saturation was 
reached (represented by Cm concentrations beyond the tolerance of the CmR strains)? 
While plasmid copy number was briefly investigated, through the creation of a construct 
with CAT under a tuneable promoter (and verification through mass spectrometry or 
western blot), the direct effect of varying levels of CAT expression on the Cm effect could 
be quantitatively explored. 
Following on from the discussion over the potential biochemical interaction of 
chloramphenicol which might lead to its electrochemical activity, it would be logical to 
investigate this. Given the main barrier to use at higher concentrations, and practical 
applications for wider use, is the antibiotic activity of the Cm molecule we would aim to 
test homologues that lacked this activity but retained the active groups we proposed as 
likely accountable for the electroactivity. The commercial availability of such compounds 
would likely determine the testing order, with a HC run analysing the effect of different 
concentrations being run for each. Duplication of the effect with such compounds would 
strengthen our conclusion about the mechanism of the Cm effect. Furthermore, 
depending on factors such as stability and cost of functional homologs for the 
electrochemical activity, these compounds could be assessed for their ability to cost-
effectively improve BES technology to meet real world challenges. 
7.2.3. SO_0527 Investigation and Characterisation 
The identification of SO_0527 as the causative factor for improved dye reduction in two 
of our fosmid clones is potentially greatly interesting within the field of engineered 
electroactivity, however, it solicits further investigation and validation. Expression of 
this and possibly the other proteins for the tested constructs would need to be 
performed. This could be achieved through real time PCR, but this would only check for 
the mRNA of the genes. Ideally confirmation of expression through mass spectrometry 
of extracted protein samples would be carried out, with fractionation to improve purity. 
Other methods, such as western blotting or affinity purification would require further 
cloning to add in appropriate tags, or the expensive acquisition of tailored antibodies.  
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The SO_0527 gene and its product are uncharacterised, with their description generated 
through inference, unsupported by practical evidence. Consequently, following 
validation, future work would attempt to characterise its activity, dependent on scope 
both in S. oneidensis MR-1 and E. coli, as discussed herein. 
The initial priority would be to investigate SO_0527 constructs within E. coli using other 
bioelectrochemical assays. In addition to the existing pRSF SO_0527 construct, others 
containing mtrCAB, cymA, and/or omcA in the first MCS would ideally be produced for 
parallel testing. These would then be compared in a BES, such as our HC setup, and with 
the accepted iron reduction assays (ferric citrate or ferric oxide reduction, soluble and 
insoluble respectively, measured through the ferrozine method) (REF REF). This would 
assist in characterising the bioelectrochemical activity of SO_0527, hopefully allowing 
for continued iterative improvement of an engineered electroactive E. coli strain. 
Concurrent or subsequent testing of a SO_0527 deletion mutant, and additional 
SO_0527 expression plasmid bearing strain, of S. oneidensis MR-1 would also help 
characterise its role and bioelectrochemical activity in its native biological environment. 
With respect to BES testing, riboflavin supplementation would be preferably compared 
additionally with all S. oneidensis strains, as due to the presumed cytosolic localisation 
of SO_0527 soluble, mediative compounds might be required to observe its activity. 
7.2.4. Further Fosmid Library Investigation 
While we have concluded our approach to the screening of our fosmid library as 
successful, other approaches were considered and might still be able to derive further 
novel bioelectrochemical factors from it.  
One such approach to library screening that might offer alternative or additional insights 
would be to conduct selection within a HC. Several HCs would be set up and inoculated 
with a mixed library culture (though pre-HC growth conditions might introduce bias 
within the library culture), where the anaerobicity and poised potential would provide 
a selective pressure that would favour clones with increased electroactivity. The cultures 
from each HC would be reclaimed and used to inoculate another set of HCs. Successive 
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rounds would continue, hopefully resulting in increasing observed current. Clones 
remaining after this process would then be identified and analysed. 
It is possible that such a process might favour a mixed community of clones, which would 
introduce additional difficulties when trying to sequence them. However, it is also 
possible that rather than favouring the clones with electroactive factors, novel or 
otherwise, the selection would favour those best able to survive the HC step and flourish 
in the pre-HC growth step, or those that simply had the lowest burden placed upon them 
by their fosmid. Nevertheless, these outcomes could still be informative, and their 
possibility would not rule out this approach as infeasible. 
7.2.5. Validation and Investigation of Proteomic Findings 
While several individual targets were identified as of potential interest, and the 
influence the HCs conditions had on the regulation of metal toxicity response genes 
bears further investigation, the primary hypothesis in need of testing is that of the 
interaction between the heterologous EET pathway and the host metabolism. 
Specifically, that the EET pathway preferentially reduces the menaquinone pool, the 
redox state of which is consequently the limiting factor in its utilisation by the 
engineered strain. This redox state results in a microaerophilic condition response by 
the cell’s regulatory mechanisms through the action of ArcAB which senses that quinone 
pool redox state, and FNR which senses the lack of oxygen within the cell directly. 
The ArcAB two component system senses redox activity primarily through sensing the 
redox state of the menaquinone pool. Under anaerobic conditions, the menaquinone 
pool is in a predominantly reduced state, the sensing of which causes the 
autophosphorylation of ArcB, resulting in the transphosphorylation of ArcA. ArcA-P 
represses a host of metabolic proteins, impacting the metabolic activity of the strain. 
From analysis of our proteomic data we hypothesise that the heterologous extracellular 
electron transport (EET) pathway within the engineered strain is oxidising the 
menaquinone pool, inhibiting ArcA-P repression. 
In order to test this hypothesis, we intend to visually monitor regulation of ArcAB under 
BES conditions. First, we would construct two strains of E. coli, expressing either iLOV225 
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or superfolder GFP (both of which fluoresce under anaerobic conditions)226 under an 
ArcA-regulated promoter227, using the Mtr nanoconduit, and expression support 
(negative control) strains. Regulatory control would be subsequently validated by 
microscopy of cells under aerobic and anaerobic conditions. Following this, E. coli strains 
containing the Arc-regulated fluorophore protein would be monitored microscopically 
within a flow cell containing an electrode configuration which could be biased to provide 
conditions comparable to those in previously tested bioelectrochemical systems (BES). 
An increase in GFP/iLOV expression under anaerobic conditions when the electrode is 
biased would support our hypothesis. If unsuccessful, a complementary methodology 
would be developed using existing techniques for analysing bioelectrochemical activity 
combined with harvesting of cells and microscopy in order to preclude a false negative 
result. Other regulators could even be probed in the event of a confident negative result 
by exchanging promoters or altering conditions, alongside re-evaluation of the 
proteomic dataset. 
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8. Appendix  
8.1. Plasmid Maps 
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8.2. Azo Dye Screen Data 
 
 
 
 
C41 1A
RB5
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.5908 0.5696 0.4493 0.7167 0.3488 0.2133 0.2977 0.4215 0.3221 0.4242 0.3925 0.1126
B 0.6232 0.4668 0.364 0.4384 0.2519 0.3141 0.327 0.4358 0.4952 0.5461 0.2609 0.1023
C 0.1785 0.3714 0.2802 0.0806 0.3719 0.2502 0.4849 0.3764 0.272 0.3193 0.3377 0.0872
D 0.5411 0.3051 0.3201 0.2644 0.2684 0.3778 0.2902 0.3519 0.3813 0.3353 0.3138 0.109
E 0.2987 0.2887 0.3455 0.4406 0.2018 0.1953 0.2415 0.2606 0.3011 0.2721 0.2286 0.3358
F 0.3468 0.7546 0.6617 0.3997 0.2854 0.2607 0.2558 0.2146 0.3931 0.3787 0.5488 0.2654
G 0.2048 0.4385 0.2983 0.3978 0.2322 0.2713 0.2395 0.2537 0.3398 0.2819 0.1737 0.4144
H 0.2806 0.3697 0.4985 0.3165 0.3948 0.3286 0.3979 0.2052 0.4821 0.3528 0.5422 0.4434
C41 1B
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.3428 0.5704 0.3561 0.4005 0.5827 0.4229 0.4433 0.2964 0.4387 0.3836 0.3294 0.1215
B 0.2508 0.3231 0.3924 0.3359 0.3559 0.3679 0.3497 -0.0399 0.2215 0.3479 0.4836 0.1184
C 0.1541 0.2862 0.368 0.2222 0.4311 0.328 0.4141 0.2499 0.2837 0.3367 0.3444 0.1229
D 0.4046 0.3454 0.3469 0.2348 0.2883 0.3514 0.3192 0.2843 0.3607 0.3843 0.3915 0.1089
E 0.2589 0.3298 0.2667 0.3092 0.2876 0.4169 0.3629 0.078 0.3747 0.3026 0.3451 0.4871
F 0.3213 0.5086 0.3688 0.32 0.3977 0.4224 0.3222 0.2725 0.2985 0.3225 0.3169 0.4231
G 0.7256 0.4093 0.2764 0.2419 0.1851 0.3365 0.2378 0.2226 0.1931 0.2479 0.3997
H 0.6043 0.4423 0.4564 0.4656 0.3578 0.3938 0.341 0.3489 0.4484 0.4456 0.3501
BL21 1A
RB5
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.7562 0.7437 0.6233 0.5247 0.3833 0.3136 0.4039 0.6603 0.5941 0.4837 0.6165 0.1044
B 0.7697 0.6147 0.5844 0.2874 0.3356 0.6328 0.4969 0.4225 0.523 0.4299 0.4398 0.1128
C 0.6071 0.5605 0.6202 0.523 0.3599 0.3755 0.1215 0.5047 0.5768 0.1783 0.502 0.1387
D 0.4193 0.5707 0.6395 0.4962 0.5156 0.4651 0.6489 0.4201 0.5747 0.5199 0.2204 0.1272
E 0.6653 0.6016 0.5921 0.3582 0.2805 0.4169 0.5692 0.5927 0.4071 0.1987 0.3726 0.3161
F 0.6036 0.4607 0.5574 0.5424 0.3277 0.6401 0.1334 0.4042 0.1822 0.3998 0.1161 0.2705
G 0.6977 0.468 0.5728 0.1588 0.3688 0.7134 0.6929 0.2819 0.4928 0.4776 0.319 0.3643
H 0.6415 0.7205 0.6183 0.5645 0.4158 0.7866 0.6281 0.4749 0.5865 0.584 0.6429 0.4759
BL21 1B
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.5882 0.7831 0.8368 0.777 0.5955 0.7514 0.7551 0.6769 0.2263 0.2291 0.5815 0.1229
B 0.6931 0.7488 0.7922 0.8106 0.5968 0.7318 0.7016 0.4826 0.5959 0.7125 0.8004 0.1093
C 0.5636 0.7186 0.7787 0.7044 0.7169 0.4617 0.6403 0.6413 0.7846 0.6888 0.2264 0.1086
D 0.4277 0.7568 0.7994 0.7904 0.5769 0.7584 0.4158 0.675 0.6781 0.6558 0.6286 0.12
E 0.6618 0.7278 0.7761 0.7671 0.6491 0.6587 0.5621 0.6836 0.5486 0.5725 0.6713 0.6479
F 0.7982 0.8494 0.8629 0.6999 0.6076 0.5104 0.6918 0.6328 0.6011 0.6737 0.7614 0.7226
G 0.7027 0.7719 0.6455 0.7581 0.6368 0.7432 0.7836 0.6483 0.7034 0.6092 0.6854 0.7338
H 0.2055 0.1699 0.6803 0.6561 0.8487 0.6871 0.7613 0.6545 0.6695 0.6493 0.7627 0.8369
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BL21 1C
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.6533 0.7436 0.7512 0.8045 0.8093 0.7362 0.7697 0.805 0.8014 0.7531 0.296 0.1149
B 0.7862 0.7283 0.7787 0.7026 0.7656 0.7817 0.6565 0.7231 0.6735 0.7213 0.8289 0.2368
C 0.7616 0.7759 0.7728 0.6707 0.7155 0.7049 0.722 0.7183 0.7032 0.7292 0.6846 0.2418
D 0.758 0.7892 0.7581 0.7734 0.7574 0.7607 0.8643 0.7245 0.788 0.7802 0.7344 0.2296
E 0.8172 0.7772 0.7576 0.7603 0.7494 0.7907 0.8052 0.6624 0.7601 0.7648 0.7194 0.4707
F 0.7414 0.7495 0.6609 0.7443 0.7796 0.6634 0.6452 0.7832 0.8082 0.7185 0.8174 0.612
G 0.8395 0.7829 0.7883 0.6967 0.7935 0.6883 0.7314 0.6962 0.7983 0.78 0.756 0.7311
H 0.7311 0.7533 0.746 0.8412 0.7881 0.7099 0.7206 0.8071 0.7822 0.6795 0.8042 0.6839
C41 2A
RB5
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.2801 0.2643 0.496 0.4522 0.5052 0.4649 0.4632 0.4965 0.4477 0.5195 0.1232 0.0795
B 0.5555 0.4651 0.5261 0.5155 0.4805 0.4602 0.4062 0.5005 0.4896 0.4744 0.5084 0.0892
C 0.5517 0.3445 0.4165 0.4599 0.4022 0.4744 0.4166 0.5941 0.4182 0.3828 0.4772 0.0797
D 0.4886 0.4418 0.4258 0.3656 0.4405 0.4301 0.4424 0.4483 0.5 0.5063 0.3625 0.0809
E 0.4609 0.4342 0.4091 0.421 0.4635 0.4478 0.5082 0.557 0.4516 0.3747 0.5092 0.6651
F 0.5807 0.4716 0.4683 0.408 0.462 0.3224 0.4771 0.4965 0.5154 0.4712 0.4318 0.5935
G 0.2883 0.4703 0.1879 0.3766 0.3684 0.4218 0.4826 0.535 0.5003 0.5536 0.6122 0.6686
H 0.5394 0.4582 0.5206 0.5157 0.3784 0.5739 0.5439 0.546 0.6003 0.5068 0.5714 0.605
C41 2B
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.5719 0.5599 0.6069 0.551 0.5898 0.4789 0.5168 0.6419 0.5587 0.5692 0.6518 0.086
B 0.6575 0.5226 0.5111 0.6235 0.3911 0.6303 0.5026 0.5709 0.5407 0.5912 0.4171 0.0996
C 0.4578 0.4914 0.497 0.5054 0.5991 0.5973 0.5031 0.4565 0.5547 0.6178 0.5699 0.126
D 0.5206 0.5148 0.5879 0.4923 0.5357 0.5387 0.5482 0.5509 0.5429 0.4752 0.5222 0.074
E 0.6057 0.5158 0.5808 0.622 0.6381 0.5056 0.5114 0.599 0.5457 0.4975 0.5843 0.677
F 0.5729 0.5333 0.5291 0.5905 0.5845 0.5996 0.5102 0.567 0.5258 0.4695 0.5679 0.6259
G 0.6187 0.5465 0.5267 0.5857 0.4986 0.4101 0.55 0.566 0.6515 0.3959 0.6375 0.7172
H 0.6259 0.5774 0.6113 0.6402 0.6602 0.6302 0.6436 0.6338 0.6038 0.5946 0.4948 0.7136
C41 2C
RB5
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.5661 0.5782 0.633 0.5651 0.5116 0.5804 0.5317 0.5209 0.4946 0.5705 0.6519 0.0903
B 0.7026 0.6564 0.647 0.5968 0.6542 0.5205 0.5007 0.533 0.6109 0.6738 0.4519 0.1174
C 0.6857 0.556 0.5156 0.6486 0.5353 0.5982 0.5037 0.4999 0.6193 0.5846 0.5697 0.1091
D 0.5834 0.579 0.5955 0.6632 0.5978 0.652 0.5359 0.4507 0.6251 0.5261 0.6327 0.1159
E 0.5515 0.5213 0.5259 0.7357 0.5424 0.5084 0.4732 0.4843 0.6372 0.6794 0.5918 0.6673
F 0.5441 0.6412 0.6229 0.5436 0.5913 0.5941 0.5753 0.3608 0.6389 0.6571 0.5519 0.645
G 0.5747 0.561 0.3773 0.6486 0.6006 0.6019 0.5443 0.5311 0.6199 0.6051 0.6445 0.7034
H 0.5969 0.5751 0.7009 0.6101 0.5347 0.5808 0.7001 0.5988 0.7088 0.6929 0.5202 0.7101
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8.3. Proteomics Data Tables 
8.3.1. MTC p<0.05 
EvC 
Q8EG35 0.909037 1 2.095165 2.14441 
P02925 1.048334 1 1.194304 1.221939 
P02931 0.919341 1 0.525135 0.500669 
P08331 1.027343 1 1.285339 1.268143 
P08997 1.026845 1 0.732879 0.704509 
P09546 0.94136 1 0.712752 0.66237 
P0A6B7 1.025368 1 1.9946 1.98028 
P0A6Z1 0.996895 1 1.562179 1.591719 
P0A6Z3 0.993692 1 0.798645 0.832282 
P0A867 0.982606 1 1.248907 1.289115 
P0A910 0.971689 1 1.946193 1.96004 
P0AC38 0.962094 1 0.666698 0.642227 
P0ACD4 0.94565 1 1.728464 1.768618 
P0AEU0 1.063091 1 1.612392 1.600013 
P0AEX9 1.063309 1 1.517209 1.595819 
P0AFH8 1.086852 1 1.989594 1.961726 
P0AFM6 1.018616 1 0.656998 0.65455 
P0AG80 1.12093 1 1.537928 1.635252 
P0AGD1 1.039674 1 1.949816 1.790465 
BL21 2A
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.5837 0.6662 0.638 0.6769 0.3811 0.3794 0.425 0.6321 0.5838 0.457 0.5626 0.0911
B 0.5048 0.6351 0.558 0.6965 0.501 0.6228 0.5707 0.6185 0.5913 0.5045 0.6409 0.1008
C 0.6358 0.6214 0.574 0.5653 0.6708 0.5569 0.6745 0.6288 0.3846 0.5157 0.6514 0.0953
D 0.5711 0.5876 0.5496 0.6725 0.6069 0.6003 0.5512 0.5157 0.553 0.6272 0.6515 0.0982
E 0.6244 0.6039 0.5807 0.6289 0.6322 0.6177 0.6461 0.5638 0.5462 0.6136 0.3677 0.6609
F 0.207 0.5811 0.4911 0.6206 0.5926 0.4817 0.3727 0.6735 0.5071 0.576 0.5449 0.629
G 0.6498 0.6399 0.6236 0.5958 0.6788 0.5608 0.6149 0.6274 0.2759 0.569 0.5923 0.6638
H 0.3939 0.6478 0.2503 0.6491 0.6255 0.626 0.6209 0.6549 0.6833 0.5588 0.6345 0.6943
BL21 2B
<> 1 2 3 4 5 6 7 8 9 10 11 12
A 0.5214 0.5744 0.5521 0.6441 0.4326 0.5526 0.5354 0.6257 0.6141 0.6114 0.441 0.0924
B 0.6117 0.1482 0.379 0.5624 0.4881 0.5188 0.4979 0.6393 0.3183 0.4529 0.5377 0.1012
C 0.5774 0.5289 0.3978 0.6174 0.6057 0.5059 0.4476 0.5702 0.6468 0.5728 0.5239 0.0987
D 0.4912 0.476 0.5998 0.5607 0.5648 0.5789 0.628 0.6086 0.6062 0.4084 0.5128 0.0955
E 0.47 0.3879 0.6223 0.5004 0.2375 0.4155 0.5418 0.6832 0.5882 0.5831 0.4547 0.7119
F 0.5418 0.51 0.6148 0.1838 0.4511 0.5166 0.5843 0.6709 0.5942 0.6497 0.4966 0.6966
G 0.4731 0.5567 0.4671 0.3368 0.5228 0.5009 0.5379 0.505 0.6186 0.2379 0.5125 0.6879
H 0.6395 0.5706 0.5618 0.5013 0.6644 0.6097 0.6029 0.6221 0.652 0.4367 0.6585 0.7433
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P0C058 1.106047 1 0.372247 0.401381 
P0C0L2 1.066708 1 1.46672 1.390492 
P16700 0.937762 1 1.545952 1.379703 
P23847 1.002681 1 1.311454 1.274673 
P24215 1.050842 1 0.769439 0.807131 
P37095 0.927487 1 1.440997 1.53958 
P39325 1.056473 1 1.468737 1.448392 
P63284 1.007243 1 0.826805 0.818201 
P68206 1.013655 1 1.734359 2.005057 
P69441 1.002389 1 1.202482 1.287798 
P75691 0.997266 1 1.543496 1.457047 
P77754 1.047996 1 2.525321 2.713997 
Q46857 1.041052 1 1.604933 1.542253 
 
EGvCG 
 117 118 119 121 
Q8EG35 1 0.931949 2.426631 2.591319 
P04983 1 1.022114 0.826474 0.822723 
P09373 1 0.935734 1.20309 1.229006 
P09546 1 1.097103 0.794979 0.737294 
P0A6B7 1 1.097887 2.142049 2.285163 
P0A6Z1 1 1.004848 1.772948 1.709612 
P0A6Z3 1 0.991814 0.867106 0.824433 
P0A910 1 1.082218 1.703784 1.53637 
P0ABB4 1 0.993327 0.798491 0.840734 
P0AC38 1 0.994272 0.682341 0.648377 
P0ACD4 1 1.104682 2.367168 2.569853 
P0AFH8 1 1.059403 1.62514 1.387454 
P0AFM6 1 0.952832 0.679738 0.626294 
P0C058 1 0.988028 0.444198 0.426164 
P0C0L2 1 0.99448 1.328872 1.337222 
P16700 1 0.984015 1.365952 1.280224 
P24232 1 0.999383 1.49822 1.56231 
P37095 1 1.009936 1.763371 1.588439 
P39377 1 1.033474 1.669346 1.891937 
P68206 1 1.026078 1.806196 1.48112 
P77754 1 1.017488 2.37743 1.875388 
Q47537 1 0.939349 0.759541 0.656198 
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EvEG 
P00561 1 1.17739 1.913879 1.726395 
P00579 1 1.053554 1.314123 1.29564 
P00963 1 0.935532 1.878459 1.736074 
P00968 1 1.002199 1.323752 1.679406 
P05793 1 1.020193 1.771947 2.018086 
P06959 1 0.933999 1.313707 1.372727 
P07024 1 0.986432 0.789871 0.711161 
P08331 1 0.993275 0.760659 0.73023 
P08839 1 1.012337 1.365416 1.551718 
P09373 1 1.051579 2.02245 2.073324 
P09831 1 1.004328 1.587367 2.121669 
P0A6P9 1 1.055515 1.398065 1.597497 
P0A799 1 1.071985 1.321802 1.398369 
P0A8T7 1 0.978119 1.268451 1.265864 
P0A9C5 1 1.041406 1.437092 1.829547 
P0A9M8 1 0.998036 1.182206 1.226357 
P0A9Q7 1 1.009505 1.639015 1.917346 
P0AFG8 1 0.959751 1.2975 1.363059 
P0AG80 1 1.070453 0.803301 0.689938 
P24232 1 1.078199 2.578773 2.698599 
P25665 1 1.045837 1.485415 2.026024 
P39099 1 1.003378 0.840602 0.815451 
P39325 1 0.992798 0.757081 0.616139 
P39377 1 0.999482 1.477108 1.679989 
P63284 1 0.996268 1.301961 1.147473 
Q46857 1 0.967426 0.799884 0.726582 
 
CvCG 
P00561 0.652233 0.653389 1 0.998596 
P00963 0.484926 0.503265 1 0.875954 
P00968 0.87667 0.871121 1 1.009989 
P04982 1.735987 1.649087 1 1.03381 
P05791 0.600745 0.613162 1 0.81337 
P05793 0.471856 0.477488 1 0.829817 
P06959 0.734178 0.75389 1 0.997449 
P09373 0.602384 0.595835 1 0.935734 
P09831 0.713109 0.743662 1 1.001397 
P0A6P1 0.896048 0.842659 1 1.031978 
P0A6P9 0.721886 0.677777 1 0.886858 
P0A799 0.815478 0.800843 1 0.941708 
P0A8T7 0.804141 0.81818 1 1.048418 
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P0A8V2 0.848627 0.865163 1 1.033908 
P0A910 0.816289 0.838372 1 1.082218 
P0A9Q7 0.591761 0.598284 1 0.930942 
P0A9T0 0.518677 0.55317 1 0.915443 
P23847 0.795977 0.792243 1 0.964249 
P25665 0.614091 0.597274 1 0.913694 
P27302 0.884958 0.838167 1 0.975329 
P76177 0.662459 0.712397 1 0.947269 
Q47537 0.407946 0.439205 1 0.939349 
 
8.3.1. No MTC p<0.01 
EvC 
Names total elements 
user_list1 
user_list2 
user_list3 
user_list4 
106 
P0ABT2 P04982 P0AAG8 P23843 P0AC62 P77214 P0A9R4 P0AFH8 
P04983 SH00003 P0ACB0 P0ABB4 P75797 P0A8G3 P00582 P08331 
P0AFJ1 P0A6Q3 P0A817 P30860 P0ACD4 P63020 P02931 P45578 
P68206 P24215 P0AE91 P0A6B7 P03841 P77243 P33362 P0AG80 
P69783 P21179 P00490 P0AB77 P0AFM6 P0ADV7 Q46857 P0AE63 
P76503 P76108 P25665 P16681 P0A7U7 P31802 P13482 P77239 
P0AGD1 P09551 P77754 P0ABZ6 P0AC38 P33136 P33363 P25516 
P07024 P64588 Q46871 P75691 P63284 P28861 P77541 P0A6Z1 
P39325 P0ADE6 P30859 P0A867 P23893 P77581 P0C058 P76128 
P37095 P0ACF8 P02925 P45464 P61889 P76177 P0A910 P0AEX9 
P68679 P0ABK5 P69441 P39377 P45523 P52108 P16700 P0C0L2 
P75694 P0AEU0 P0A9M8 P0A6F3 P09394 P45955 P0A6W5 P08997 
P0AFG6 P0AEG4 P23847 P0A6Z3 P09546 P39099 P0A7E5 P0AG82 
P0A6M8 P06986 
user_list1 
user_list2 
user_list4 
3 P0ABQ2 P0ABH9 P00968 
user_list1 
user_list3 
user_list4 
1 P33602 
user_list2 
user_list3 
user_list4 
2 P0A7X3 P76116 
user_list1 
user_list4 3 P0ACA3 P0C8J8 P0A9A6 
user_list1 1 P00448 
user_list2 3 P0A8G6 P0A953 P0A805 
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EGvCG 
Names total elements 
user_list1 
user_list2 
user_list3 
user_list4 
95 
P04982 P00370 P0AAG8 P77214 P0A9R4 P0AFH8 P04983 P21177 
P16095 P0ABB4 P06999 P0A8G3 P0AAI3 P0AFJ1 P0ACD4 P63020 
P31979 P02931 P33218 P0A8G6 P08660 P68206 P0A6B7 P69490 
P0A8V2 P0A905 P77243 P33362 P0AG80 P21179 P21889 P0AFM6 
P0ADV7 P33232 P15254 P09373 Q46857 P0AG30 P0AE63 P76503 
P68191 P31802 P31660 P00448 P77239 P0AGD1 P77754 P69797 
P0AC38 P25516 P64588 Q46871 P0AFZ1 P75691 P77541 P0A6Z1 
P0A867 P64596 P0AE37 P0A9C5 P23893 P0AC59 P77581 P0C058 
P76128 P37095 P33599 P0C8J8 P0A910 P0AEX9 P68679 P0ABK5 
P69441 P39377 P45523 P35340 P52108 Q47537 P0C0L2 P16700 
P75694 P09831 P77258 P0ABB0 P0A6F3 P00968 P60422 P33570 
P08997 P17846 P0AEG4 P0A6Z3 P09546 P60438 P24232 
user_list1 
user_list2 
user_list3 
1 P0A6W5 
user_list1 
user_list2 
user_list4 
1 P00960 
user_list1 
user_list4 1 P0AB77 
user_list2 2 P0A6Q3 P76217 
user_list3 1 P0AD49 
user_list4 2 P00961 P76585 
 
8.3.1. No MTC p<0.05 
EvC 
P00448 1.254399 1.178013 1.075067 1 
P00490 0.9155 0.931282 1.010753 1 
P00582 1.134887 1.087249 1.004084 1 
P00959 1.129937 1.151314 1.040999 1 
P00968 1.086176 1.075247 0.997806 1 
P02925 0.855004 0.818335 0.964069 1 
P02931 1.846884 1.997327 1.041841 1 
P03841 0.645739 0.644943 1.027746 1 
P04982 1.333494 1.261984 0.939712 1 
P04983 1.186677 1.314518 1.051792 1 
P06610 0.64987 0.628696 0.963197 1 
P06720 1.215036 1.132562 0.993576 1 
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P06986 0.798757 0.775702 0.974152 1 
P07012 1.085391 1.081835 0.93877 1 
P07024 0.762386 0.732605 1.013754 1 
P08331 0.814819 0.788555 1.006771 1 
P08997 1.465994 1.419428 1.0333 1 
P09394 0.777942 0.764727 0.973885 1 
P09424 0.839768 0.884266 1.0636 1 
P09546 1.429449 1.50973 1.068854 1 
P09551 0.854309 0.834076 0.990694 1 
P0A6B7 0.521032 0.505209 1.00094 1 
P0A6F3 1.159725 1.206628 0.985749 1 
P0A6J5 1.404509 1.531392 1.107465 1 
P0A6K6 0.937218 0.918548 0.980257 1 
P0A6L9 0.610501 0.580046 1.023348 1 
P0A6M8 0.927511 0.943098 0.993092 1 
P0A6Q3 0.786859 0.79927 1.011655 1 
P0A6W5 0.830569 0.824481 0.931122 1 
P0A6X7 0.774478 0.801079 0.941561 1 
P0A6Y1 0.85085 0.84039 1.006176 1 
P0A6Z1 0.629936 0.628252 0.974867 1 
P0A6Z3 1.200867 1.201516 0.953156 1 
P0A7E5 1.130603 1.137117 0.995343 1 
P0A7M2 1.118131 1.075283 0.982868 1 
P0A7S9 0.867575 0.910455 0.986358 1 
P0A7U7 0.83381 0.901366 1.071462 1 
P0A7W1 0.778067 0.709814 0.845316 1 
P0A7X3 0.896381 0.926479 1.061265 1 
P0A805 0.874827 0.827716 0.985418 1 
P0A817 1.172758 1.163325 0.978628 1 
P0A855 0.7664 0.677328 0.938934 1 
P0A867 0.766658 0.775726 0.962319 1 
P0A8G3 1.311752 1.266935 0.939175 1 
P0A8G6 0.889998 0.891732 1.040232 1 
P0A8M3 1.070762 1.053025 1.010105 1 
P0A8N5 1.084117 1.108039 0.921988 1 
P0A8X2 0.789421 0.753537 1.077936 1 
P0A905 0.744629 0.704209 1.179068 1 
P0A910 0.498627 0.510194 0.986284 1 
P0A953 0.906509 0.880555 0.978038 1 
P0A991 0.820434 0.830809 0.977714 1 
P0A9A6 1.112748 1.101346 1.010155 1 
P0A9B6 1.278676 1.246817 0.996712 1 
 0.675432 0.694744 1.011598 1 
P0A9M8 1.137378 1.158284 1.001968 1 
P0A9P4 1.104943 1.064658 0.992536 1 
P0A9R4 0.498498 0.50154 1.04069 1 
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P0AAG8 1.337998 1.41003 1.035349 1 
P0AAI3 1.380181 1.284501 1.065425 1 
P0AAT6 0.868694 0.847874 1.042833 1 
P0AB61 0.908838 0.899484 1.020676 1 
P0AB65 0.786873 0.838752 1.026082 1 
P0AB77 1.130813 1.081238 0.998742 1 
P0ABB4 1.107147 1.104189 1.006008 1 
P0ABD3 0.775052 0.813914 1.014109 1 
P0ABH9 1.219101 1.17698 1.03188 1 
P0ABK5 0.894408 0.864698 1.015911 1 
P0ABQ2 1.226058 1.217727 0.959393 1 
P0ABQ4 0.943456 0.876122 1.090147 1 
P0ABT2 0.699207 0.629969 0.928206 1 
P0ABZ6 0.873049 0.83932 1.011357 1 
P0AC38 1.506754 1.557081 1.031148 1 
P0AC62 0.643577 0.639083 0.892306 1 
P0ACA3 1.153179 1.116713 0.961381 1 
P0ACB0 1.23521 1.223958 1.030375 1 
P0ACD4 0.537786 0.565413 0.97075 1 
P0ACF0 0.840843 0.826546 0.922446 1 
P0ACF8 0.811314 0.789261 0.909175 1 
P0ACL2 1.260974 1.105108 0.970573 1 
P0ACX3 0.908414 0.897608 1.079503 1 
P0ADE6 0.845181 0.822526 1.017169 1 
P0ADS6 0.785714 0.714273 0.997465 1 
P0ADU5 0.352767 0.364189 1.042111 1 
P0ADV7 0.62654 0.60333 1.062459 1 
P0ADZ4 0.850917 0.862398 0.957428 1 
P0AE63 0.814344 0.761119 1.02591 1 
P0AE91 0.843383 0.784057 1.060444 1 
P0AED0 0.905724 0.915852 0.976672 1 
P0AEG4 0.779412 0.749923 1.055363 1 
P0AEM4 1.294272 1.139883 0.993839 1 
P0AEU0 0.668283 0.624995 1.000986 1 
P0AEX9 0.670177 0.626637 0.944371 1 
P0AF28 0.857282 0.893603 0.962181 1 
P0AFG6 0.778083 0.785974 0.921988 1 
P0AFH8 0.557244 0.509755 1.007412 1 
P0AFI7 1.15676 1.208116 0.957056 1 
P0AFJ1 0.759835 0.754524 1.016502 1 
P0AFK9 0.795685 0.863025 1.070611 1 
P0AFM6 1.565241 1.527767 0.997016 1 
P0AFZ1 0.716746 0.562888 0.981126 1 
P0AG40 1.102012 1.118968 0.96979 1 
P0AG80 0.689457 0.611527 0.934184 1 
P0AG82 0.821055 0.756955 1.011551 1 
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P0AGD1 0.584043 0.558514 1.081705 1 
P0C054 1.490758 1.565984 0.912018 1 
P0C058 2.771603 2.491401 0.921204 1 
P0C0L2 0.771597 0.71917 1.047755 1 
P0C8J8 1.131417 1.124861 1.023618 1 
P13482 0.570921 0.625258 0.933751 1 
P16456 1.090536 1.079805 0.948993 1 
P16681 0.733887 0.747589 0.961916 1 
P16700 0.683629 0.724794 1.11299 1 
P19926 0.819456 0.786246 0.914261 1 
P21179 0.724353 0.704369 0.932689 1 
P21367 0.594501 0.492354 0.979427 1 
P23538 1.068428 1.070009 1.014144 1 
P23836 0.731838 0.862829 0.999514 1 
P23843 0.891453 0.860584 0.99279 1 
P23847 0.791184 0.784515 1.021963 1 
P23869 0.907744 0.884453 0.975828 1 
P23893 0.876713 0.871015 0.99176 1 
P24178 0.863518 0.834673 1.003364 1 
P24215 1.309505 1.238957 0.946916 1 
P25516 0.769334 0.776576 0.938871 1 
P25665 1.312784 1.272039 0.956172 1 
P25738 0.740667 0.77161 1.017278 1 
P27306 1.132181 1.200689 1.002358 1 
P28861 0.763788 0.786229 1.041196 1 
 0.831842 0.834043 1.014783 1 
P30859 0.748066 0.736364 0.92294 1 
P30860 0.764658 0.688023 1.064527 1 
P31802 1.157321 1.243288 1.010122 1 
P32144 1.274839 1.170909 1.02182 1 
P33136 0.881308 0.903019 1.098603 1 
P33362 0.667494 0.663287 0.952336 1 
P33363 0.87773 0.886889 1.009291 1 
P33570 0.831962 0.810203 0.977962 1 
P33602 1.146591 1.147015 0.986838 1 
 0.807369 0.714816 0.892792 1 
P37051 1.111593 1.144924 1.011655 1 
P37095 0.60613 0.649626 0.935574 1 
P37689 1.282358 1.248425 1.081044 1 
P39099 0.826895 0.826232 0.996633 1 
P39325 0.733645 0.690421 1.007254 1 
P39377 0.751243 0.751394 1.000518 1 
P45464 0.731982 0.751034 0.958176 1 
P45523 0.770564 0.784249 0.946164 1 
P45578 0.892539 0.871275 0.992761 1 
P45955 0.749436 0.800236 1.02852 1 
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P52108 0.688563 0.698529 1.131678 1 
P60624 1.062341 1.078756 0.986737 1 
P61517 1.233912 1.165527 0.986886 1 
P61889 0.89544 0.845583 0.94669 1 
P62707 0.921898 0.929652 0.974775 1 
P63020 0.786304 0.754714 0.952036 1 
P63284 1.238192 1.222193 1.003746 1 
P64476 1.47776 1.527183 0.877269 1 
P64588 0.57799 0.57058 1.145138 1 
P68187 1.258108 1.294903 1.062682 1 
P68206 0.508484 0.498739 0.859198 1 
P68679 0.833479 0.869283 0.984795 1 
P69441 0.782893 0.776519 0.927495 1 
P69490 0.652647 0.567991 1.097856 1 
P69783 0.815087 0.749302 0.95885 1 
P69797 1.185377 1.147868 1.047392 1 
P75691 0.688416 0.686319 1.052235 1 
P75694 0.548618 0.47001 0.948327 1 
P75797 0.806797 0.798295 0.964363 1 
P76004 0.778665 0.807684 1.014278 1 
P76108 0.579301 0.621368 1.046187 1 
P76116 0.879105 0.879776 0.989109 1 
P76128 0.698843 0.648978 1.09857 1 
P76177 0.733308 0.785624 0.996523 1 
P76503 1.287326 1.365087 1.011143 1 
P76585 1.20335 1.144286 0.898262 1 
P77214 0.44265 0.43158 1.009837 1 
P77239 0.513658 0.526378 1.020934 1 
P77243 0.639885 0.712855 1.000294 1 
P77399 1.155646 1.188303 0.990479 1 
P77499 1.228587 1.201045 1.060583 1 
P77541 0.753962 0.751041 1.013849 1 
P77581 0.785735 0.798094 1.132481 1 
P77754 0.389937 0.36843 0.920091 1 
Q46857 0.678939 0.648402 1.033671 1 
Q46871 0.373279 0.319299 1.016696 1 
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Names total elements 
user_list1 
user_list2 
user_list3 
user_list4 
173 
P04982 P0C054 P23843 P0AC62 P77214 P0A9R4 P0AFK9 P0ABB4 P75797 
P0A7X3 P08331 P0A6Q3 P77399 P63020 P27306 P02931 P37689 P0A8G6 
P45578 P68187 P0A7S9 P69490 P0A7M2 P03841 P77243 P33362 P21179 
P00490 P0AB61 P0AG40 P76004 P0ACF0 Q46857 P0AE63 P76108 P16681 
P00448 P77239 P0AGD1 P77754 P69797 P0AED0 P33363 P07024 P64588 
P0A953 P0AFI7 P75691 P77541 P39325 P0ADE6 P76585 P30859 P0A867 
P23893 P0A805 P0A6X7 P77581 P0A6Y1 P76128 P0ACF8 P23869 P0A6K6 
P0A6L9 P23538 P61889 P76177 P0AEX9 P0ACX3 P0ABK5 P69441 P52108 
P16700 P0C0L2 P0A6F3 P25738 P0A6W5 P33602 P0AFG6 P06720 P0AEG4 
P23847 P23836 P09546 P0A6Z3 P0AG82 P0A6M8 P06986 P0ABT2 P0A8N5 
P0AAG8 P0A991 P64476 P0AFH8 P04983 SH00003 P0ACB0 P0A8G3 P19926 
P00582 P0AAI3 P0ABQ2 P0ABQ4 P0AFJ1 P0A817 P0AEM4 P30860 P0ACD4 
P0ADZ4 P0ACA3 P68206 P0A6B7 P0ADU5 P0AE91 P24215 P0A905 P0AG80 
P69783 P0AB77 P0ADV7 P0AFM6 P0AB65 P0AAT6 P76503 SH00002 
P0A7U7 P25665 P31802 P13482 P09551 P0ABZ6 P0AC38 P33136 P0ABH9 
P25516 Q46871 P24178 P32144 P0AFZ1 P63284 P0A7W1 P28861 P0A6Z1 
P06610 P0A855 P0A6J5 P0C058 P37095 P76116 P02925 P45464 P0ABD3 
P0C8J8 P0A910 P68679 P39377 P45523 P0A9A6 P75694 P0AEU0 P0A9M8 
P00968 P09394 P33570 P16456 P45955 P08997 P21367 P0A8X2 P09424 
P39099 P0A7E5 P0ADS6 
user_list1 
user_list2 
user_list3 
1 P0AC69 
user_list1 
user_list2 
user_list4 
2 P61517 P07012 
user_list1 
user_list3 
user_list4 
3 P37051 P00959 P60624 
user_list2 
user_list3 
user_list4 
2 P0AF28 P62707 
user_list1 
user_list4 5 P0A9B6 P0ACL2 P0A8M3 P77499 P0A9P4 
user_list1 2 P42593 P0A825 
user_list2 7 P16095 P0AEP7 P0AA25 P12282 P21499 P0A850 P0AEU7 
user_list3 1 P0ACF4 
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EGvCG 
P00363 1 1.007273 0.722577 0.763277 
P00370 1 1.003286 1.195792 1.569898 
P00448 1 0.974512 0.795191 0.790243 
P00909 1 0.961162 1.105199 1.200677 
P00960 1 0.963347 0.87306 0.875532 
P00961 1 1.056181 0.949301 0.918141 
P00968 1 1.009989 1.071312 1.354351 
P02931 1 0.926902 0.622678 0.605201 
P03023 1 1.038809 1.180765 1.101333 
P03841 1 1.013475 1.371312 1.130096 
P04036 1 0.887204 1.17858 1.227654 
P04982 1 1.03381 0.774747 0.802628 
P04983 1 1.022114 0.826474 0.822723 
P06149 1 0.970806 1.071321 1.077997 
P06988 1 0.947884 1.07647 1.10919 
P06999 1 0.972788 1.105911 1.13053 
P08660 1 0.806225 1.579898 2.196234 
P08997 1 1.033534 0.789901 0.770309 
P09373 1 0.935734 1.20309 1.229006 
P09546 1 1.097103 0.794979 0.737294 
P09551 1 1.010641 1.085964 1.138222 
P09831 1 1.001397 1.098933 1.463652 
P0A6B4 1 0.996042 0.901629 0.875938 
P0A6B7 1 1.097887 2.142049 2.285163 
P0A6F3 1 1.045522 0.908391 0.88831 
P0A6J5 1 1.028853 0.775206 0.752656 
P0A6L9 1 0.937035 1.589162 1.560875 
P0A6P1 1 1.031978 1.085236 1.075159 
P0A6Q3 1 0.993916 1.092618 1.082107 
P0A6W5 1 0.996234 1.066907 1.097363 
P0A6Z1 1 1.004848 1.772948 1.709612 
P0A6Z3 1 0.991814 0.867106 0.824433 
P0A799 1 0.941708 1.07599 1.134508 
P0A7J3 1 1.002117 0.915984 0.882746 
P0A7K6 1 1.001365 0.888395 0.905594 
P0A7L0 1 0.995792 0.904685 0.893364 
P0A7R1 1 0.999381 0.903233 0.912124 
P0A817 1 0.934809 0.81407 0.878218 
P0A867 1 1.033308 1.307632 1.199741 
P0A8G3 1 0.967028 0.777815 0.779325 
P0A8G6 1 1.024314 1.180355 1.138746 
P0A8J4 1 0.915377 0.682313 0.693835 
P0A8N5 1 1.076444 0.950976 0.940746 
P0A8V2 1 1.033908 0.930567 0.924638 
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P0A905 1 1.093088 1.792002 1.858613 
P0A910 1 1.082218 1.703784 1.53637 
P0A991 1 1.047231 1.169338 1.277952 
P0A9A6 1 1.055155 0.888616 0.885979 
P0A9C5 1 0.939696 1.080434 1.37064 
P0A9M0 1 1.01467 0.95445 0.925431 
P0A9R4 1 1.070038 2.073581 2.060193 
P0AA86 1 1.170792 2.248142 2.572144 
P0AAB6 1 0.92678 0.834944 0.860424 
P0AAG8 1 0.99386 0.787366 0.772989 
P0AAI3 1 1.099478 0.804606 0.818136 
 1 1.077645 0.729368 0.649392 
P0AB40 1 1.020773 0.700511 0.596681 
P0AB77 1 0.976884 0.92868 0.894229 
P0ABA4 1 0.995454 0.841055 0.889918 
P0ABB0 1 1.021689 0.910039 0.933043 
P0ABB4 1 0.993327 0.798491 0.840734 
P0ABK5 1 0.951177 1.122966 1.062694 
P0ABM9 1 1.197775 3.402123 3.718618 
P0AC38 1 0.994272 0.682341 0.648377 
P0AC41 1 1.133562 0.908064 0.917227 
P0AC55 1 0.971199 1.258213 2.63453 
P0AC59 1 0.91608 1.216132 1.314471 
P0AC69 1 1.116977 1.471449 1.43171 
P0ACC3 1 0.957661 1.177757 1.213402 
P0ACD4 1 1.104682 2.367168 2.569853 
P0ACF0 1 0.898796 1.168662 1.078547 
P0ACF8 1 0.942348 1.09228 1.059434 
P0ACW6 1 0.978084 0.878759 0.816218 
P0ACZ8 1 0.917046 1.204613 1.343209 
P0AD49 1 0.950761 1.250953 1.143624 
P0ADE8 1 1.043519 0.925683 0.930369 
P0ADS6 1 1.02698 1.099168 1.161317 
P0ADU5 1 0.959318 1.725337 1.392224 
P0ADV7 1 0.915004 1.561366 1.32133 
P0AE37 1 1.077992 1.475107 1.450803 
P0AE63 1 0.981296 1.245615 1.220793 
P0AE85 1 0.961833 1.516972 1.28757 
P0AEG4 1 0.955868 1.297484 1.418558 
P0AEU0 1 0.94746 1.180518 1.217502 
P0AEX9 1 1.022039 1.389495 1.147912 
P0AFC7 1 0.977819 0.755345 0.74702 
P0AFH8 1 1.059403 1.62514 1.387454 
P0AFJ1 1 0.923134 1.190655 1.19509 
P0AFM6 1 0.952832 0.679738 0.626294 
P0AFZ1 1 0.951157 1.961748 1.933084 
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P0AG30 1 0.986288 0.889174 0.885591 
P0AG80 1 1.01909 1.343795 1.150088 
P0AG84 1 0.945117 1.355582 1.188105 
P0AGD1 1 0.955617 1.471518 1.316282 
P0C054 1 0.957607 0.609527 0.576419 
P0C058 1 0.988028 0.444198 0.426164 
P0C0L2 1 0.99448 1.328872 1.337222 
P0C8J8 1 1.059276 0.817239 0.860666 
P15254 1 0.936469 1.146691 1.38098 
P15640 1 0.931999 1.084214 1.44555 
P16095 1 0.984992 1.245589 1.202351 
P16659 1 1.017219 0.931021 0.909938 
P16700 1 0.984015 1.365952 1.280224 
P17846 1 1.017219 1.215082 1.120646 
P21177 1 1.035599 0.867523 0.795772 
P21179 1 1.136756 1.411357 1.348829 
P21889 1 0.987199 0.888416 0.879345 
P22333 1 0.953086 0.892532 0.837548 
P23836 1 0.935678 1.220803 1.187649 
P23893 1 0.991875 1.164811 1.172982 
P24232 1 0.999383 1.49822 1.56231 
P25516 1 1.018126 1.24637 1.141051 
P25526 1 1.034318 1.389608 1.232349 
P25738 1 0.964764 1.287011 1.22025 
P27302 1 0.975329 0.926139 0.904543 
P28304 1 0.84219 1.118271 1.099287 
P31660 1 1.083845 1.280291 1.169975 
P31802 1 1.06035 0.815836 0.780549 
P31828 1 0.93387 0.664269 0.611486 
P31979 1 1.059609 0.866374 0.817686 
P33218 1 0.968002 1.345067 1.473347 
P33232 1 1.059689 0.665355 0.616809 
P33362 1 1.040082 1.322677 1.263234 
P33570 1 0.954497 1.246847 1.141304 
P33599 1 1.023262 0.881242 0.847251 
P33602 1 0.921217 0.814657 0.760358 
P35340 1 0.975123 0.846436 0.881925 
P37095 1 1.009936 1.763371 1.588439 
P39377 1 1.033474 1.669346 1.891937 
P45523 1 0.91 1.18113 1.09074 
P45799 1 1.023762 0.862948 0.896992 
P52108 1 0.928446 1.36005 1.5178 
P60422 1 1.00398 1.196173 1.120102 
P60438 1 0.917729 0.81028 0.808744 
P60546 1 0.954424 0.898124 0.895659 
P61175 1 0.993583 0.921072 0.927364 
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P62620 1 0.949259 1.04509 1.123133 
P63020 1 1.069956 1.431705 1.37522 
P64455 1 0.992255 1.218969 1.170672 
P64588 1 1.073151 1.992156 1.897465 
P64596 1 1.084499 0.820969 0.873235 
P68191 1 0.875979 1.166298 1.218794 
P68206 1 1.026078 1.806196 1.48112 
P68679 1 0.923691 1.136842 1.15343 
P68767 1 1.033527 1.129905 1.136218 
P69441 1 0.960842 1.113925 1.097358 
P69490 1 1.058022 2.378027 2.657074 
P69797 1 0.966346 0.819156 0.840722 
P75691 1 1.050237 1.366207 1.258021 
P75694 1 1.023186 1.611272 1.310055 
P76128 1 1.031173 1.417591 1.304053 
P76215 1 1.01571 1.230805 1.339619 
P76216 1 1.021689 1.31808 1.308442 
P76217 1 1.034543 1.34189 1.324896 
P76503 1 1.02848 0.812951 0.712933 
P76585 1 1.043317 0.878683 0.866663 
P77202 1 0.946239 1.125757 1.121275 
P77211 1 1.024341 1.310181 1.315889 
P77214 1 0.940118 1.58235 1.688527 
P77239 1 1.004951 1.789047 1.633271 
P77243 1 1.042862 1.506707 1.288469 
P77258 1 1.011275 0.59546 0.561051 
P77541 1 1.016242 1.266186 1.182448 
P77581 1 1.047754 1.27736 1.284457 
P77674 1 1.04215 1.315891 1.209568 
P77754 1 1.017488 2.37743 1.875388 
P77774 1 1.028359 0.905997 0.930654 
Q46851 1 1.056388 0.910915 0.866256 
Q46857 1 0.984793 1.303333 1.179721 
Q46871 1 1.120204 2.689245 2.205477 
Q47537 1 0.939349 0.759541 0.656198 
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Names total elements 
user_list1 
user_list2 
user_list3 
user_list4 
165 
P04982 P0C054 P0ADE8 P77214 P0A9R4 P21177 P16095 P0ABB4 P06999 
P76215 P68767 P0A6Q3 P0AB40 P00961 P63020 P0A7L0 P45799 P31979 
P02931 P0AC41 P0A8G6 P00960 P69490 P03841 P0A8V2 P77243 P33362 
P04036 P21179 P21889 P0ACF0 Q46857 P0A7K6 P0AE63 P76217 P00448 
P0AA86 P77239 P0AGD1 P77754 P69797 P28304 P0AC69 P64588 P0AG84 
P75691 P77541 P76585 P0A867 P64596 P23893 P16659 P77581 P76128 
P0A6L9 P33599 P06988 P0AEX9 P0ABK5 P69441 P35340 P52108 Q47537 
P16700 P0C0L2 P0ABM9 P09831 P0A6F3 P25738 P0A6W5 P33602 P0A7R1 
P60546 P0ABA4 P0AEG4 P23836 P0AFC7 P09546 P0A6Z3 P77211 P60438 
P00370 P0A8N5 P0AAG8 P0A991 P0AFH8 P25526 P04983 SH00003 P0A8G3 
P0AAI3 P62620 P0AFJ1 P15640 P0A817 P0ACD4 P00363 P0AAB6 P33218 
P08660 P76216 P68206 P0A6B7 P0ADU5 P0AC55 P0A905 P0A7J3 P0AG80 
P0ACC3 P0AB77 P0ADV7 P0AFM6 P33232 P09373 P15254 P0AG30 P64455 
P76503 P68191 P0AD49 P0AE85 P31660 P31802 P0A8J4 P09551 P0AC38 
P77202 P25516 P0A799 Q46871 P0AFZ1 P03023 P22333 P27302 P0A6Z1 
P0A9M0 Q46851 P0AE37 P0A9C5 P0AC59 P0ACW6 P0A6J5 P0C058 P37095 
P61175 P31828 P0C8J8 P0A910 P68679 P39377 P45523 P00909 P0A9A6 
P75694 P77258 P0ABB0 P0AEU0 P00968 P77674 P60422 P33570 P08997 
P17846 P0ADS6 P24232 
user_list1 
user_list2 
user_list3 
4 P0ACF8 P06149 P0ACZ8 P0A6P1 
user_list1 
user_list3 
user_list4 
2 P77774 P0A6B4 
user_list2 2 P75797 P69783 
user_list3 4 P69506 P32131 P76108 P0AB65 
user_list4 7 P77737 P0A6J8 P0A6F5 P00957 P0ABQ2 P38489 P77499 
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EvEG 
Names total elements 
user_list1 
user_list2 
user_list3 
user_list4 
199 
P04982 P0ADE8 P05793 P77214 P0AG63 P69506 P00963 P0A7X3 
P08331 P0AB40 P10408 P0A8T7 P0AEZ1 P02924 P02931 P0AB91 
P0A7D4 P0AFR4 P37689 P0A8G6 Q8EG35 P0AG78 P77739 P0A6T1 
P76097 P69490 P03841 P05020 P0A8V2 P33362 P69811 P0AB80 
P05055 P25553 P31142 P18843 Q46857 P40120 P00452 P76108 
P00448 P77239 P0AGE0 P0AGD1 P0A6H1 P77754 P21170 P64503 
P21156 P0AGD3 P33363 P07024 P23845 P0AFI7 P75691 P77541 
P0ADS9 P0ABU2 P39325 P0ADE6 P0AC53 P30859 P76128 P30850 
P0A9Q7 P0A6P9 P22106 P0A9W9 P06988 P0AEX9 P0A8M3 P0A879 
P00864 P0ABK5 P0AB89 P05791 P35340 P0AES4 Q47537 P16700 
P0AFG8 P09831 P0AC33 P0A877 P0ADG7 P00935 P0A9B2 P39187 
P0AFC7 P09832 P0AG82 P0A8Y5 P0ABT2 P00370 P00562 P0A9T0 
P69828 P64476 P0AFH8 P04983 P0AGL2 P00934 P19926 P17993 
P04805 P00582 P06959 P0AAI3 P08312 P15640 P38489 P25888 P0A817 
P08839 P23721 P30860 P0ACD4 P0ADZ4 P33218 P08660 P07813 
P0A6B7 P0AE91 P0AC55 P0AG80 P69783 P77625 P00579 P37610 
P0A705 P0AB77 P0AES6 P0AFM6 P15254 P09373 P0A6F1 A5A614 
P22259 P0A912 P25665 P0A7U7 P68191 P0A7U3 P77395 P09551 
P27248 P0AD96 P21499 P0A799 P04816 P0ACR9 P63284 P28861 
P03023 P27302 P22333 Q2M7R5 P76193 P00547 P0AE37 P0A9C5 
P0AC59 P0ACW6 P0A6P1 P0A9M5 P76116 P02925 P45464 P0C8J8 
P00956 P39377 P0AA16 P00909 P0A9Q1 P0AB71 P0A9J8 P75694 
P0AB52 P0ABB0 P0AEU0 P00393 P00968 P0A9M8 P09394 P16456 
P0A7D7 P0AEU7 P0A8X0 P32695 P0A9Q9 P08178 P00561 P09424 
P28904 P39099 P0A7E5 P07395 P68066 P24232 
user_list1 
user_list2 
user_list3 
1 P0AC41 
user_list1 
user_list3 
user_list4 
2 P0ACF4 P02359 
user_list1 
user_list3 3 P0C0L2 P0AEZ3 P26646 
user_list1 1 P77581 
user_list2 3 P0A6L2 P28635 P0AFI2 
user_list4 1 P69924 
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CvCG 
Names total elements 
user_list1 
user_list2 
user_list3 
user_list4 
145 
P04982 P42593 P23843 P05793 P16095 P0ABB4 P69506 P0A796 P00963 
P08331 P0A6Q3 P0AB40 P0A8T7 P0C0V0 P02924 P02931 P0AB91 P37689 
P0A8G6 P0AG78 P0A761 P0A7M2 P0A8V2 P69811 P0A884 P05055 P21889 
P0A6F5 P0A7K6 P0A7G6 P0A9L5 P00448 P0A6H1 P0AED0 P64503 P21156 
P0A7Z4 P23845 P0AFG0 P39325 P0AC53 P30850 P0A9Q7 P0A6P9 P22106 
P0A9W9 P76177 P0A8M3 P00864 P0A879 P0A6A3 P0ABK5 P05791 P69441 
P35340 Q47537 P16700 P0AFG8 P09831 P0AC33 P0A877 P0ADG7 P39187 
P0AEZ3 P0AFG6 P0ABA4 P23847 P09832 P0A6Z3 P06986 P0A8Y5 P0A9T0 
P69828 P04983 P00934 P19926 P06959 P28635 P00904 P0A817 P08839 
P04968 P23721 P0A9L3 P0AG80 P69783 P77625 P00579 P37610 P0AB77 
P0AE08 P0AFM6 P09373 A5A614 P22259 P0ACB2 P0A6T9 P0A912 P25665 
P68191 P00509 P60716 P0A7U3 P09551 P27248 P0AC38 P0A870 P0A799 
P17854 P21499 P04816 P22333 P27302 P0A6A6 P00547 P0AE37 P0A9C5 
P0ACW6 P0AFF6 P0A6P1 P0C058 P02925 P45464 P0A836 P0C8J8 P0A910 
P0A9P0 P39377 P0AA16 P77735 P00909 P0A6D3 P77258 P0A850 P0ABB0 
P00393 P00968 P0A9M8 P09394 P16456 P08997 P00561 P37330 P0ADS6 
P24232 
user_list1 
user_list2 
user_list3 
1 P32132 
user_list1 
user_list2 
user_list4 
2 P0AG44 P24215 
user_list1 
user_list3 
user_list4 
1 P06720 
user_list1 
user_list4 2 P60624 P76015 
user_list2 1 P0ABA0 
user_list3 7 P02358 P0A8L1 P76422 Q8EG35 P0A6T1 P0A953 P0AEE1 
user_list4 2 P77754 P06149 
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